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Purpose: People with secondary progressive multiple sclerosis (MS) 
experience high rates of depression. Behavioural activation may represent 
an accessible therapeutic intervention for this group. We aimed to: (a) 
examine preliminary evidence of efficacy of a behavioural activation 
intervention, for people with secondary progressive MS experiencing low 
mood; (b) understand the feasibility of recruiting, retaining, and delivering 
the intervention; (c) explore whether/how the intervention has a positive 
impact on mood, fatigue, and quality of life (QoL) using process measures; 
and (d) understand participants’ experience of the intervention. 
 
Research method/design: A mixed-method multiple single-case 
experimental design was used to investigate the effectiveness of a five-
session behavioural activation intervention on depression for people with 
secondary progressive MS. An AB design was used, and intervention was 
delivered after establishing a stable baseline for depression on the Patient 
Health Questionnaire 2. Depression was measured using the Hospital 
Anxiety and Depression Scale – depression subscale and activation was 
measured using the Behavioural Activation for Depression Scale – Short 
Form. The intervention was delivered using an initial face-to-face session 
followed by telephone or Skype-delivered sessions. Data were analysed 
using visual analysis (conservative dual-criterion and percentage exceeding 
the median) and reliable and clinically significant change analysis.  Post-
intervention change interviews were completed and analysed using 
framework analysis.  
 
Results: Eight people were recruited, of which six established a stable 
baseline and proceeded to intervention. Five participants completed the 
intervention and one participant withdrew. Five participants, including the 
participant who withdrew, completed change interviews. Systematic 
reduction in depression was observed in three of five completers and 
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reliable and clinically significant reduction was observed in two of these 
three participants. Three of five participants demonstrated highly effective 
treatment (≥.9) and two participants demonstrated moderately effective 
treatment (0.7-0.9). Systematic increase in activation was observed in two 
of five completers and reliable change was observed in one participant. In 
most cases, in change interviews, participants reported benefits from the 
intervention and that it was acceptable, even in the face of competing 
demands. No changes were observed in fatigue or physical components of 
health related QoL. Reliable change was observed in two participants for 
mental health related QoL.   
 
Conclusion: There was some evidence to suggest that behavioural 
activation for people with secondary progressive MS led to a reduction in 
depressive symptoms when engagement in positively reinforcing behaviour 
increased. Changes in fatigue or physical health QoL were not observed 
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Abstract 31 
Objective: To evaluate the effectiveness of behavioural activation interventions for 32 
people with neurological conditions with co-morbid depression, and explore content and 33 
adaptations.  34 
Data sources: PsycINFO, MEDLINE, CINAHL, AMED, and EMBASE databases 35 
were searched on the 19/11/19. Reference lists of selected full-texts were screened by title.  36 
Review methods: We included peer-reviewed studies, published in English that used 37 
behavioural activation for treatment of depression in adults with a neurological condition. 38 
Single case reports, reviews, and grey literature were excluded. Methodological quality was 39 
assessed by two authors independently and quality was appraised using Critical Appraisal 40 
Skills Programme checklists. 41 
Results: From 2714 citations, 10 articles were included comprising 590 participants. 42 
Behavioural activation was used to treat depression in people with dementia (n=4), stroke 43 
(n=3), epilepsy (n=1), Parkinson’s disease (n=1), and brain injury (n=1). Sample size ranged 44 
from 4 to 105 participants. There were seven randomised-controlled studies, however, no 45 
studies compared behavioural activation to an alternative psychological therapy. The effect 46 
sizes varied between small and large in the studies where effect size could be calculated 47 
(d= 0.24-1.7). Methodological quality of the included studies was variable. Intervention 48 
components were: identifying and engaging in pleasurable activities, psychoeducation, and 49 
problem solving. Adaptions included: delivering sessions via telephone, delivering 50 
interventions via primary caregivers, and giving psychoeducation to caregivers.  51 
  Conclusion: The effectiveness of behavioural activation in randomised-controlled 52 
trials varied from small to large (d= 0.24-1.7) in reducing depression. The content of 53 
behavioural activation was comparable to established treatment manuals. Adaptations 54 
appeared to support individuals to engage in therapy.  55 
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 56 
Review registration: PROSPERO 2018, CRD42018102604. 57 
Key words: Neurological conditions, depression, behavioural activation, behavioural therapy, 58 
activity scheduling 59 
  60 
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Behavioural activation treatment for depression in individuals with neurological 61 
conditions: A systematic review 62 
 63 
Introduction 64 
People with neurological conditions experience higher rates of depression than those 65 
in other patient groups without neurological conditions 1. Decreased social activities 66 
contribute to the continuation and exacerbation of depression through a loss of contact with 67 
contingencies that were previously reinforcing and mood enhancing 2. Conversely, 68 
engagement in social and leisure activities for people with multiple sclerosis promotes 69 
positive mood and wellbeing 3, 4. With depression and reduced or declining physical abilities 70 
(common in many neurological conditions), individuals find it difficult to identify with and 71 
engage in activities that have pleasurable or reinforcing consequences 2. 72 
In the UK, National Institute of Health and Clinical Excellence recommends the use 73 
of cognitive behavioural therapy for treating depression in individuals with chronic physical 74 
health problems (including neurological conditions) 5. However, cognitive-behavioural 75 
therapy is not best suited for people with neurological conditions 6, because many have 76 
cognitive difficulties that may make accessing and engaging with cognitive-behavioural 77 
therapy difficult 7. Therefore, adapting psychological therapies to better consider the 78 
interaction of co-morbid psychological and physical conditions may be more acceptable to 79 
people with neurological/physical health conditions 8.  80 
Behavioural activation is a type of psychological therapy that encourages individuals 81 
with depression to engage in activities they have been avoiding. Individuals define goals and 82 
activity schedules 9. Behavioural activation is a relatively simple, easy to understand, 83 
intervention that does not require a highly trained therapist or complex skills from the patient 84 
10, and may be suitable for individuals with cognitive and physical difficulties. 85 
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In non-neurological populations, the behavioural activation component of cognitive-86 
behavioural therapy is as effective alone compared to when used in combination with 87 
cognitive aspects 11 – and has been found to be as effective as antidepressant medication 12. A 88 
meta-analysis of activity scheduling (a type of behavioural activation) interventions for the 89 
treatment of depression found a pooled effect size (d) of 0.87, favouring activity scheduling 90 
over waitlist or placebo controls or alternative psychological therapies (95% CI: 0.60~1.15) 91 
13. Behavioural activation is also considered cost-effective for depression 14. However, the 92 
evidence for the effectiveness of behavioural activation in people with neurological 93 
conditions is inconclusive.  94 
Therefore, this review aimed to: (i) report the evidence of the effectiveness of 95 
behavioural activation interventions for individuals with neurological conditions with co-96 
morbid depression, with outcomes of interest being mood, function, activity, and quality of 97 
life; (ii) describe the content of behavioural activation interventions; and (iii) identify the 98 
adaptations made to the behavioural activation intervention specifically for people with 99 
neurological conditions.  100 
 101 
Method 102 
We followed the PRISMA-P 2015 guidelines 15 and the protocol was prospectively registered 103 
on PROSPERO (CRD42018102604). 104 
 105 
The following online databases were searched: Medline (1970-present), CINAHL (1970-106 
present), PsycINFO (1970-present), EMBASE (1980-present), and AMED (1980-present). 107 
The last search was completed on 19/11/2019. The following keywords were used: 108 
Behavioural activation, behaviour therapy, activity scheduling, depression, and neurological 109 
conditions. We used variations of these terms including medical subject headings (MeSH) 110 
where available. For a complete list of the search terms please refer to Appendix A. Terms 111 
  
Page 18 of 362 
were ‘exploded’ and used singularly or in conjunction with similar terms based on the 112 
database being searched. The reference lists of the selected full-texts were screened by title, 113 
as an additional way of identifying relevant articles.  114 
 115 
Included studies were: Peer-reviewed, quantitative or qualitative, and published in 116 
English. Studies were required to include: (a) behavioural activation for treatment of 117 
depression (clinician confirmed diagnosis or scoring above defined thresholds on validated 118 
depression measures); (b) adults (≥16 years) with a neurological condition, defined as a 119 
condition or disease of the brain, as a result of illness or injury. Studies using behavioural 120 
therapy were included where the use of activity scheduling and monitoring was of primary 121 
focus; which was defined as the targeting of behavioural avoidance and increasing contact 122 
with environmental positive reinforcement. We were primarily interested in clinical 123 
effectiveness of the intervention on the patient, but we also included outcomes that related to 124 
the care-giver. We excluded articles that were policy papers, books, theses, or conference 125 
proceedings.  126 
 127 
Data extraction was completed by the first author and accuracy was checked by the 128 
other authors. Table 1 summarises the data extracted. Following the database searches, results 129 
were transferred to Microsoft Excel and duplicates were removed. The first author screened 130 
titles and abstracts, before reviewing full text articles. Data extraction was completed using a 131 
predefined template informed by the reader's guide to critical appraisal of cohort studies 16-18 132 
(for the template headings please see Appendix B).  133 
 134 
Following PRISMA guidance 16-18, the first and one other author independently 135 
assessed the methodological quality of each included article. Discrepancies were resolved 136 
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through discussion. The quality appraisal framework selected was informed by the study 137 
design of the included articles: Critical Appraisal Skills Programme Randomised Controlled 138 
Trials checklist 19, cohort studies checklist 20, qualitative checklist 21, and Mixed Methods 139 
Appraisal Tool– Version 2011 22. 140 
 141 
A narrative summary for data analysis was conducted due to the low number of 142 
articles identified. A meta-analysis was not considered because we only had a small number 143 
of studies, with considerable heterogeneity in terms of study designs, outcome measures, and 144 
measurement time-points. Therefore, to compare and synthesise effectiveness data, effect size 145 
estimates were used (with effect size determined from study data when not reported). Where 146 
multiple depression measures were used the primary measure was used. Through conversion 147 
into standardised between-condition effect-sizes, we treat studies as comparable with respect 148 
to the comparison condition (e.g., that usual care is similar across studies); however, if 149 
comparators (e.g., forms of ‘usual care’) differ systematically across studies, then this 150 
assumption (of transitivity) would be violated: the treatment effect will not be defined 151 
independently of individual comparators (i.e., there will be a treatment-by-study interaction). 152 
   153 
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Results 154 
 155 
Initial database searches identified 2714 articles, 49 full text articles were considered 156 
for inclusion, and 10 articles (with 590 participants) met our inclusion criteria. Figure 1 is the 157 
PRISMA flow diagram.  158 
 159 
Figure 1. PRISMA Flow Diagram  160 
 161 
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Additional records identified 
through other sources 
(n = 18) 
Records after duplicates removed 
(n = 1829) 
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and abstract  
(n = 1829) 
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(n = 1780) 
Full-text articles assessed 
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(n =39) 







2 subsidiary paper 
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All included articles were quantitative intervention studies: seven randomised-163 
controlled trials 23-29, one cohort study 30, and two multiple baseline experimental design 164 
studies 31, 32.  The articles were published between 1991 and 2019, based on studies from the 165 
USA 23, 26-32, UK 24 and Australia 25. The components and format of the behavioural 166 
activation interventions are summarised in Table 1, which also describes the clinical context 167 
of each intervention, and the comparator groups (where used).168 
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Table 1 169 
Summary of the extracted data 170 
Study number, 
author(s), date, 
and country  
31 Feliciano, Steers, 
Elite-
Marcandonatou, 
McLane, & Areán 
(2009), USA 







32 Teri and 
Uomoto (1991), 
USA 
24 Thomas, Walker, 
Macniven, 
Haworth, & 
Lincoln (2013), UK 
27 Kirkness, Cain 
et al. (2017), USA 
28 Mitchell, 





Chaytor et al. 
(2010), USA 
30 Butterfield, 
Cimino, et al. 
(2017), USA 
29 Hart, Vaccaro, 
Collier, Chervoneva 
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n=10; Wait list 
control n=20 
Age (Years): Range 
= not reported, 
M=76.4 (SD=8.2); 
BT-PE M=72.8 
(SD=8.2); BT-PS M 
=78.5 (SD=7.9); 
Usual care M=79.5 
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Wait list control 
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Measurement 


















& BT-PS effect size 
ranged from d=0.9-
1.7 on the HDRS 
and CSD 
BT-PE BDI d=0.4; 
BT-PS BDI d=1.0  
Caregiver: HDRS 
[F(3,66) 
= 4.73, p < .01] 
6-month follow up 
Significant effects 
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Effect size: NR 
Summary 




depressed - change 
was observed in two 
of the four. 
One participant had 
a clinically 
significant change 
(a 11-point drop) 
and one participant 
had a small decrease 
in score that was not 
clinically 
significant.  
PES was completed 
with eight 
participants (73%) 
the remaining 3 
were completed by 
family members or 
care staff. 
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no significant 
difference.  
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caregivers in active 
treatment conditions 























was collected for 
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reduction in 









Note: * all favoured intervention. NR = Not reported.  171 
ADL; Katz Basic Activities of Daily living scale, AES; Apathy Evaluation Scale, BADS; Behavioural Activation for Depression Scale, BATD; Brief Behavioural Activation 172 
Treatment for Depression, BDI; Beck Depression Inventory, BI; Barthel Index, CMAI; Cohen -Mansfield Agitation Inventory-Long form, BT-PE; Behavioural therapy 173 
pleasant events, BT-PS; Behavioural therapy problem-solving, CSDD; Cornell Scale for Depression in Dementia, CSI; Carer Strain Index, DRS; Dementia Rating Scale, 174 
DSM-III; Diagnostic and Statistical Manual of Mental Disorders-III, EROS; Environmental Reward Observation Scale, FAST; Frenchay Aphasia Screening Test, GDS; 175 
Geriatric Depression Scale, HDRS; Hamilton Depression Rating Scale, HSCL-20; Hopkins Symptom Checklist – 20, MAS; The motivation assessment scale, MMSE; Mini–176 
Mental State Examination, NIHSS; National Institutes of Health Stroke Scale score, NLQ; Nottingham Leisure Questionnaire, PDQ-39; Parkinson’s Disease Quality of Life, 177 
PEARLS; Program to Encourage active, Rewarding Lives for Senior, PES; The pleasant events schedule, PHQ9; Patient Health Questionnaire-9, QOL-AD; Quality of life -178 
Alzheimer's disease, QOLIE-31; Quality of life in Epilepsy – 31, RAISD; Reinforcer assessment for individuals with severe disabilities, RIL; Record of Independent Living, 179 
SADQH-10; Stroke Aphasic Depression Questionnaire Hospitals-10 item, SADQH-21; Stroke Aphasic Depression Questionnaire Hospitals-21 item, SIS; Stroke Impact 180 
Scale, SST; Sheffield Screening Test, UPDRS; Unified Parkinson's Disease Rating Scale, VASES; Visual Analogue Self-Esteem Scale, ZBI; Zarit Burden Inventory.181 
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The quality of the studies, as seen in Table 2, was variable. All had a clearly stated 182 
aim and identified their target sample. Participant demographics were adequately detailed in 183 
almost all studies, but one 32. Studies and sample representativeness varied from low to high. 184 
Sample sizes ranged from 4 to 105 participants 24, 32.  185 
The quality of reporting of the studies also varied. In randomised-controlled trials the 186 
method of randomisation was reported in all but one study 23, with most studies using 187 
computer generated algorithms 24-30, 32. In five randomised-controlled trials assessors were 188 
blinded to participant group allocation 23, 26-29; in one study assessors were only blinded to 189 
secondary measures 24; and in one study there was no blinding of data collection 25. Only two 190 
studies reported data on treatment fidelity 24, 30, with most studies collecting no or minimal 191 
data on the delivery of the intervention 23, 25-29, 31, 32. All studies included or described data 192 
pertaining to the validity and reliability of assessment measures.  193 
Additional sources of possible methodological biases were evident, such as reporting bias 194 
(not detailing all outcomes) 27, use of self-report methods to assess depression 23-28, 30-32, and 195 
caregivers completing depression assessments on the participants’ behalf 23, 31, 32. One study 196 
31 used a single-case experimental design but did not report any statistical analysis or present 197 
any data for depression. One study 32 used a single-case experimental design but did not 198 
consistently establish a baseline before introducing the intervention, as recommended by 199 
multiple single case experimental design standards 33.  200 
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Table 2 201 










exclusion criteria  
Standardised 
measures  
Attrition Randomisation Blinding  Treatment 
fidelity 





Yes Moderate No (n=11), 
participants with 
depression (n=4) 
No Yes Yes N/A N/A No Selection bias 
Reporting bias 
Confounders 
Teri, Logsdon 23 Yes Yes Yes (n =72) Yes Yes Yes Moderate Yes No Confounders 











Yes Yes Yes (n =105) Yes Yes Yes Yes Moderate Yes  
Kirkness, Cain 
27 





Yes Yes Yes (n =101) Moderate Yes Yes Yes Yes No Change scores 





Yes Yes Yes (n =80) Moderate Moderate Yes Yes Yes Moderate   
Butterfield, 
Cimino 30 
Yes Moderate Moderate (n =34) Moderate Yes Yes N/A N/A Yes  
Hart, Vaccaro 29 Yes Yes Yes (n = 65) Yes Yes Yes Yes Yes Moderate  
 Note. Table collates Critical Appraisal Skills Programme tools for a single point of reference   
203 
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Variants of behavioural activation processes, such as activity scheduling or 204 
monitoring were used in samples with dementia 23, 25, 31, 32, stroke 24, 27, 28, epilepsy 26, 205 
Parkinson’s disease 30, and brain injury 29. Participants were recruited from nursing homes, 206 
hospital clinics and the community. The mean age range was 38.5 to 86.5 years. A number of 207 
studies recruited patient-caregiver dyads and investigated the effects of using paid and unpaid 208 
caregivers as intervention aids 23, 25, 31, 32. Additionally, studies reported the impact of 209 
behavioural activation for patients, on caregivers’ depression, quality of life, and/or perceived 210 
burden 23, 30, 32.  211 
The following assessments were used to assess depression outcomes: The Cornell 212 
Scale for Depression in dementia 34 [23, 31], The Hamilton Depression Rating Scale 35 [23, 27, 28, 213 
32], Stroke aphasic depression questionnaire 21-item hospital version 36 [24], Geriatric 214 
Depression Scale-12 37 [25, 27, 28, 30], The Patient Health Questionnaire 38 [29], and the Hopkins 215 
Symptom Checklist – 20 39 [26]. Caregiver depression was consistently assessed using The 216 
Hamilton Depression Rating Scale 35 [23, 32].  217 
Seven studies used comparator groups; six used a two-arm design, of which, four used 218 
usual care for one arm 24, 26-28, one used a walking and talking intervention as a comparison 219 
group 25, and one used a motivation intervention 29. Another study 23 had four arms 220 
(behavioural therapy and pleasant events, behavioural therapy and problem-solving, usual 221 
care, and waitlist control). Attrition rates were reported for all studies and ranged from 5% 25 222 
to 27% 31.  223 
 224 
In terms of effectiveness (aim i) eight of ten studies reported a positive outcome for 225 
behavioural activation in terms of improving depressive symptoms 23, 24, 26, 28-32. In studies 226 
reporting effects favouring the intervention, estimable effect size ranged from d = 0.38–1.7 227 
(for parity, where multiple follow-up assessments were reported, the first post-intervention 228 
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effect-estimate was selected). When the lowest quality studies were not considered (i.e., 229 
limiting to 23, 24, 26, 28) the effect size range remained the same. 230 
Conversely, two studies did not favour behavioural activation, reporting non-231 
superiority for reducing depression relative to usual care (d at first [8-week] follow-up = 232 
0.24, p = 0.30) 27 or a walking-and-talking intervention (d not reported, p = 0.61) 25. 233 
Overall, across the six studies for which effect-sizes were estimable 23, 24, 26, 27, 28, 30 23, 234 
24, 26, 27, 28 , effects of behavioural activation ranged widely at first follow-up (post-235 
intervention): from small-to-large magnitude (ds = 0.24–1.7). The same range (ds = 0.24–1.7) 236 
was observed when limiting to the five studies that estimated effect-size against a comparator 237 
23, 24, 26, 27, 28; all these effects were estimated relative to a usual care condition, in a 238 
randomised-controlled trial design, although the nature of ‘usual care’ likely differs across 239 
populations and between individual studies. 240 
Considering findings by population, there was at least one favourable finding for each 241 
study population. Behavioural activation treatment was favoured in three of four dementia-242 
focussed studies (observed ds 0.9–1.7 [at first follow-up]) and two of three stroke-focussed 243 
studies (largest observed ds 0.24–1.17), with favourable findings in each of the (single) 244 
studies examining effects for patients with epilepsy (d = 0.38), Parkinson’s disease (d = 245 
0.70), and brain injury (d unreported). 246 
In terms of effect-sizes at longer-term follow-ups, four randomised-controlled trials 24, 247 
26, 27, 28 provided estimates of effect-size (comparing behavioural activation with usual care) at 248 
5–6 months: these ranged from negligible (0.05 27) to moderate (0.77 24) magnitude. Of the 249 
four randomised-controlled trials, three further provided estimates of effect-size at 12 250 
months, and these again ranged from negligible (0.10 27) to moderate (0.70 26) magnitude. 251 
Further to effects on patient outcomes, there were reported benefits of patient-focused 252 
behavioural activation on caregivers’ depression in two studies 23, 32 (reduced caregiver 253 
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depression on the Hamilton Depression Rating Scale). Another study 24 found no significant 254 
effects of patient-focussed behavioural activation on caregiver strain or leisure activities – 255 
although caregivers expressed high satisfaction with the care provided. 256 
In terms of content (aim ii), behavioural activation interventions included the use of 257 
psychoeducation, identifying pleasurable activities, scheduling pleasant activities, graded task 258 
assignments, and problem-solving. The interventions were delivered by study therapists, care 259 
home staff, master’s degree students, and unpaid caregivers. In one study, behavioural 260 
activation was delivered in two formats (face-to-face and telephone) and was compared to 261 
usual care 27, however, due to low recruitment numbers and being under-powered the 262 
interventions arms were combined and compared to usual care. Across studies, the number of 263 
sessions delivered ranged from one 29 to twenty 24, with most studies delivering between six  264 
and nine sessions 23-28, 30, 32. Where reported, the duration of sessions ranged from 10 minutes 265 
27, 30 to one hour 23, 24, 32. The duration of the intervention in most studies was one hour. One 266 
study used a single session followed by eight weeks of daily text messages 29.   267 
 268 
With respect to aim (iii), few adaptations were made to the content of the delivered 269 
behavioural activation intervention. Where adaptations were made, the most frequent 270 
addition to the programme was problem-solving 25-28. In one study the problem-solving 271 
content was focused on the behavioural challenges, presented by patients with dementia, 272 
whereas one study used problem-solving to support access to pleasant activities 25.  273 
Carers were involved in four studies. For instance, psychoeducation was delivered to 274 
the caregiver rather than the patient 23, 32, or caregivers (paid and unpaid) assisted in the 275 
delivery of behavioural activation 23, 25, 31, 32 or to support access to pleasant activities 25, 31. 276 
Where caregivers were used to deliver behavioural activation, reduction in low mood for 277 
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patients was shown in two studies23, 32, but mixed results were found in relation to reduction 278 
in patient depression when paid caregivers supported access to pleasant activities.  279 
Finally, the method of delivery in all studies was one-to-one, and no group studies 280 
were identified. In one study 32 both the caregivers and patient attended sessions, with the 281 
first three sessions attended by both parties, and the remaining five sessions only the 282 
caregivers attended. In all but two studies26, 30, sessions were delivered face-to-face. 283 
However, one study used a single face-to-face session followed by a series of text messages; 284 
the content of the messages having been agreed during the initial session 29. In one study 27, 285 
one treatment arm received telephone contact, however, the results were combined with the 286 
face-to-face arm and compared to usual care.   287 
 288 
Discussion 289 
 Overall, we found some indication that behavioural activation is effective in the treatment of 290 
depression in individuals with neurological conditions with effects maintained beyond a six-291 
month period. Behavioural activation had a varied effect between small and large in the 292 
studies where effect size could be calculated (d= 0.24-1.7, in six of seven randomised-293 
controlled trials) in reducing depression. The largest effect size includes the combined 294 
reporting of the intervention arms of behavioural therapy pleasant events and behavioural 295 
therapy problem solving [23], when excluding the combined intervention arms the same 296 
varied range of small to large effect sizes were observed across included articles.  This 297 
finding is consistent with a previous meta-analysis, which concluded that behavioural 298 
activation for depression in individuals without a neurological condition is effective (d = 299 
0.87)13. In our review, participants with Parkinson’s disease or epilepsy benefitted the most 300 
on depression, quality of life, and apathy outcomes. In studies with dementia or stroke 301 
samples, varying levels of effectiveness were found. However, these results should be treated 302 
with caution, because the quality of some studies was not optimal.  303 
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Most studies reported statistically significant differences in the reduction of 304 
depression, but effect sizes were not reported in all cases. The variance in the reported 305 
outcomes may be a result of the design and delivery of the intervention, clinical condition, 306 
outcome measures, timing of assessments, and comparators (or lack thereof). The good 307 
quality studies suggested that behavioural activation was clinically and cost effective, and 308 
they were reported in a way that would enable replication. The findings from the other 309 
studies, however, must be treated with caution because depression was not always the 310 
primary presenting difficulty. Furthermore, studies had small sample sizes. Only five of ten 311 
studies conducted a sample size calculation or power analysis 24, 26-28, 30, and three studies did 312 
not reach their recruitment target 24, 26, 27.  313 
Half of the trials included follow-ups of six-months or longer 23, 24, 26-28. This is 314 
beneficial as it provides an insight into continued benefits of the intervention. All but one 27 - 315 
which had no significant benefits in depression outcomes at the end of treatment - reported 316 
significant continued benefits at long-term follow-up.  317 
Few studies reported making any adaptations to the intervention specifically for the 318 
populations studied. Where adaptations were mentioned, these included adding a problem-319 
solving component to the behavioural activation intervention, delivering sessions by 320 
telephone, and teaching caregivers (paid and unpaid) to facilitate behavioural activation and 321 
provide access to pleasurable activities.  322 
One study added a problem-solving component to standard behavioural activation, but 323 
it was unclear whether this additional component was specific to overcoming barriers to 324 
activities or providing support for individuals’ difficulties in day-to-day tasks. A more 325 
generic problem-solving approach may have introduced a deviation from behavioural therapy 326 
interventions. A lack of fidelity assessment and assessment of participant adherence makes it 327 
difficult to determine what the participants actually received in terms of ‘content’ and the 328 
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‘dose’ of the intervention. Where reported, the average number of pleasant activities 329 
completed increased significantly (p< 0.005) from baseline, and a significant positive 330 
relationship between depressed mood and duration and frequency of pleasant events was 331 
identified (mean = 0.72, SD = 0.16, t(3) = 2.07, p<0.08).  332 
In terms of intervention delivery format, we were not able to determine the relative 333 
effectiveness of telephone versus face-to-face delivery, as only one study made this 334 
comparison, and the outcomes did not differ significantly from each other, however, data 335 
were not presented detailing the comparison. Two studies reported a medium effect size in 336 
the reduction of depression using a combination of face-to-face and telephone (d=0.70), 337 
which suggests that telephone as a mode of delivery may be of benefit to individuals, 338 
particularly because some may experience physical difficulties and may struggle to attend 339 
appointments. Behavioural activation sessions varied in number and length of sessions. In 340 
clinical settings the variability may support clinicians and services with limited resources. 341 
However, more research is needed to investigate the effectiveness of behavioural activation 342 
in fewer sessions.    343 
Using unpaid caregivers to support the delivery of behavioural activation may be a 344 
benefit to both the person with a neurological condition and the caregiver themselves. 345 
Caregivers experienced a reduction in depression, but behavioural activation had no impact 346 
on perceived strain/burden. This may be because the person they care for continues to have 347 
care needs, with or without the presence of depression, which the caregiver continues to 348 
facilitate. Indeed, high care need is associated with higher levels of caregiver strain and 349 
poorer quality of life 40.  350 
 351 
One strength of this review is that the search strategy was tested, and the search terms 352 
were refined with a specialist study librarian before the final search, which increased the 353 
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likelihood of identifying papers. The electronic search and hand search of full-text reference 354 
lists increases confidence that most relevant research was included in this systematic review 355 
and that the conclusions made in the review are based on a synthesis of available evidence.  356 
Our findings, however, must be viewed in light of the review’s limitations. We could 357 
only find a small number of studies to include, and many of the studies had small sample 358 
sizes, and considered few neurological conditions. None of the studies compared behavioural 359 
activation with another psychological or pharmacological intervention, therefore no direct 360 
comparisons of effectiveness were possible. Only peer-reviewed literature was included and 361 
as a result the exclusion of unpublished findings may bias the results to demonstrate a 362 
positive effect of the intervention. This exclusion criterion was applied to ensure that only 363 
methodological robust studies were included. When considering the potential of publication 364 
bias, future reviews might benefit from including grey-literature. Finally, only one author 365 
screened articles for inclusion. 366 
Future research should consider and address methodological and conceptual 367 
limitations of published studies as highlighted in this review. For example, data should be 368 
reported for each arm of randomised-controlled trials. Studies should assess the fidelity of the 369 
delivery of the behavioural activation intervention, and activity participation should be 370 
recorded as an outcome to determine whether changes are directly related to behavioural 371 
activation. A fully powered randomised-controlled trial with longer-term follow-ups, and 372 
head-to-head comparisons with alternative psychological therapies, with an evaluation of the 373 
cost-effectiveness, to determine which is most effective intervention is warranted.  374 
 375 
  376 
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Clinical messages 377 
• There is some evidence that behavioural activation is beneficial in reducing 378 
depressive symptoms in several neurological conditions, although the low quality of 379 
studies means the findings should be interpreted with caution. 380 
• Behavioural activation interventions have been delivered in a number of formats such 381 
as telephone, face-to-face, and carer supported, with varying number and length of 382 
sessions. 383 
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Abstract 1 
Purpose: People with secondary progressive multiple sclerosis (MS) experience 2 
high rates of depression. Behavioural activation may represent an accessible therapeutic 3 
intervention for this group. We aimed to: (a) examine preliminary evidence of efficacy 4 
of a behavioural activation intervention, for people with secondary progressive MS 5 
experiencing low mood; (b) understand the feasibility; (c) examine impact on mood, 6 
fatigue, and quality of life (QoL); and (d) understand participants’ experience of the 7 
intervention. 8 
Research Method/Design: A mixed-method multiple single-case experimental 9 
design was used to investigate the effectiveness of a five-session behavioural activation 10 
intervention. Depression was measured using the Hospital Anxiety and Depression 11 
Scale. Data were analysed using visual analysis and reliable and clinically significant 12 
change analysis. Post-intervention change interviews were completed and analysed 13 
using framework analysis.  14 
Results: Eight people were recruited, of which six established a stable baseline 15 
and proceeded to intervention. Five participants completed intervention and change 16 
interviews. Systematic reduction in depression was observed in three of five completers 17 
and reliable and clinically significant reduction was observed in two of these three 18 
participants. Participants reported benefits from the intervention and that it was 19 
acceptable, even in the face of competing demands. No changes were reported in fatigue 20 
or physical health related QoL. Two participants reported reliable improvement for 21 
mental health related QoL.   22 
  Conclusion: There was some evidence to suggest behavioural activation led to a 23 
reduction in depressive symptoms when engagement in positively reinforcing behaviour 24 
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increased. No changes in fatigue were reported suggesting engagement in behavioural 25 
activation does not negatively affect fatigue.  26 
 27 
Trial registration: ClinicalTrials.gov Identifier NCT03935529 28 
Key words: Depression, Behavioural Activation, Secondary Progressive Multiple 29 
Sclerosis, Behavioural Therapy, Activity Scheduling 30 
 31 
 32 
  33 
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Impact 34 
• Identifying accessible psychological interventions in those with long-term 35 
neurological problems is important. This study provides early support for the use 36 
of behavioural activation for people with depression and secondary progressive 37 
multiple sclerosis. 38 
• Behavioural activation is an acceptable intervention for people with secondary 39 
progressive multiple sclerosis, which reduces low mood when engagement in 40 
positive reinforcement occurs. 41 
• Despite increasing activities to engage in positive reinforcement there were no 42 
adverse effects to individuals’ mental or physical health.   43 
Introduction 44 
Multiple Sclerosis (MS) is a neurodegenerative disease and one of the most 45 
prevalent neurological conditions affecting young adults (Confavreux & Vukusic, 46 
2006),1 with a mean age of onset of 30 years (Rejdak et al., 2010). Initially, the disease 47 
has repeated events of symptom presentation before symptoms subside, in a phase 48 
known as relapse remitting MS (Confavreux & Vukusic, 2006). Over time, many 49 
people with MS find that symptom presentation becomes unremitting, leading 50 
neurologists to confirm transition to secondary progressive MS (a stage of MS; 51 
Confavreux & Vukusic, 2006). Symptoms then continue to gradually worsen and 52 
include increased weakness; difficulties with coordination; muscle stiffness; and 53 




1 See Extended Introduction 1.1 and 1.2 for further details about neurological conditions and multiple 
sclerosis 
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Depression in MS 57 
Reported rates of depression in people with MS are high, with a lifetime 58 
prevalence of around 50% (Siegert & Abernethy, 2005). These prevalence rates are 59 
higher than in the general population and for other conditions, such as stroke (Galeazzi 60 
et al., 2005; Patten et al., 2003). In a study exploring point prevalence, depression was 61 
reported in 41.8% of participants (Chwastiak et al., 2002). The authors found that 62 
people with advanced MS were much more likely to experience clinically significant 63 
depression than those with minimal disease symptoms. This was further supported by a 64 
large-scale UK-based survey (n=4187) demonstrating higher prevalence of depression 65 
in those with secondary progressive MS versus other types of MS (Jones et al., 2012).2  66 
 67 
Factors contributing to depression in people with MS 68 
The high prevalence of depression in MS may result from illness-related 69 
challenges, such as the unpredictable nature of the disease which leads to a loss of 70 
contact with environmental contingent reinforcement. For example, people with MS 71 
report changes in behaviour (e.g., lethargy), and mood (e.g., depression) because of the 72 
unpredictability of their condition (Wilkinson & das Nair, 2013). In addition, people 73 
with MS report a breakdown in employment, poorer medication adherence, and 74 
increased risk of self-harm and suicide, due to their depression (Hind et al., 2014).  75 
Once diagnosed, people with MS often reduce their social and leisure activities, 76 
that were known to promote positive mood and wellbeing (Hakim et al., 2000; Motl et 77 
al., 2009). Decreased activity can contribute to the development, maintenance, and 78 
exacerbation of low mood through loss of contact with contingencies that were 79 
previously reinforcing and mood enhancing (Kanter et al., 2006). Due to physical 80 
 
2 See Extended Introduction 1.3 for further details about depression 
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difficulties, people with MS struggle to find new activities that have reinforcing or 81 
pleasurable consequences (Motl et al., 2009). 82 
The relationship between functional disability and depression, however, is 83 
debated, with some studies reporting a positive relationship between MS-related 84 
disability and depression, and others claiming depressive episodes are independent of 85 
MS-symptom severity (Chwastiak et al., 2002; Millefiorini et al., 1992).3 86 
 87 
Interventions for depression in people with multiple sclerosis 88 
In the UK, there are no specific guidelines for the treatment of depression in 89 
people with MS. Rather, practitioners are referred to more general guidance for treating 90 
depression in chronic physical health problems, which recommend Cognitive 91 
Behavioural Therapy (CBT; National Institute for Health and Care Excellence, 2009). 92 
CBT is a time-limited psychotherapy which aims to use problem solving strategies, 93 
alongside challenging negative thought-patterns through reappraisal, to bring about 94 
change in emotions and behaviours (Beck, 1964).4  95 
In a review examining the efficacy of CBT for people with MS, seven studies 96 
were analysed (Hind et al., 2014). A medium effect-size (standardised mean difference 97 
of 0.5) was reported, favouring CBT over standard care for reducing depression in 98 
people with MS. However, the authors concluded that further studies should explore 99 
duration and modalities of therapy for individuals at differing disease stages. Studies 100 
included in this review had small sample sizes in the intervention group (n=9-63) and 101 
effects were reported for combined patient groups, rather than distinguishing effects for 102 
 
3 See Extended Introduction 1.3.3 and 1.3.4 for further details about maintenance of depression and 
impact 
4 See Extended Introduction 1.4 and 1.5 for further details about interventions 
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people with secondary progressive MS versus relapsing-remitting MS. Where 103 
individual comparisons were made, sample sizes were small (n ≤18). 104 
Indeed, when considering the accessibility of therapy, it is necessary to explore 105 
the impact of the client’s physical difficulties in relation to psychological interventions. 106 
In a recent study examining CBT for people with MS, Ytterberg et al. (2017) reported 107 
that CBT therapists can find it difficult to determine whether client-reported symptoms, 108 
such as fatigue, are attributable to depression or physical characteristics of MS. In 109 
addition, due to cognitive difficulties and problems understanding content, therapy 110 
needed to be conducted at a much slower pace.  111 
The effectiveness of computerised-CBT for people with MS has also been 112 
investigated (Hind et al., 2010). Participants reported issues with the format, including 113 
the burdensomeness of computer-based tasks, increased social isolation, and difficulty 114 
setting goals in the absence of human support. Therefore, therapy needs to be adapted 115 
and supported by practitioners.   116 
The influence of number and duration of intervention sessions has not been 117 
investigated in people with MS. However, there is increasing evidence for the 118 
effectiveness of short-term CBT in general. For example, services offering guided self-119 
help for depression, with an average of six, thirty-minute sessions, have seen recovery 120 
rates ranging from 44-77% (Gyani et al., 2013). However, reported rates of recovery do 121 
not include data for individuals with physical difficulties, nor do they identify data 122 
pertaining to people with MS. 123 
Consequently, CBT may not be the most beneficial intervention for people with 124 
MS and investigating other therapy types or adaptations, may lead to a helpful 125 
alternative. Given the cognitive difficulties people with MS report, therapies that are 126 
less cognitively demanding may be more suitable than CBT.  127 
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Behavioural activation as a potential intervention for depression in secondary 128 
progressive multiple sclerosis 129 
The behavioural theory of depression posits that depression is a result of reduced 130 
contact with response-contingent positive reinforcement and inadequate social skill 131 
(Lewinsohn, 1974). Using behavioural theory, Lewinsohn et al. (1976) developed a 132 
treatment manual for depression known as behavioural activation. Behavioural 133 
activation aims to reduce behaviours that maintain or exacerbate depression, by 134 
promoting counteracting behaviours (Martell et al., 2001), using strategies such as 135 
activity monitoring and scheduling (Jacobson et al., 1996). By using activity strategies, 136 
environmental deficits in positive reinforcement and difficulties in obtaining and 137 
maintaining reinforcement are addressed (Kanter et al., 2010).  138 
 Jacobson et al. (1996) found that the behavioural elements of CBT are as 139 
effective as using a combination of behavioural and cognitive interventions. In a study 140 
comparing behavioural activation, cognitive therapy, and antidepressant medication in 141 
the treatment of adults with depression, behavioural activation was comparable to 142 
antidepressant medication and both were significantly more effective than cognitive 143 
therapy (Dimidjian et al., 2006). Behavioural activation has also been used with people 144 
with other neurological conditions, such as stroke (including those with aphasia; 145 
Thomas et al., 2016). As people with secondary progressive MS can experience fatigue 146 
and cognitive difficulties, which can complicate engagement, behavioural activation 147 





5 See Extended Introduction 1.6 for further details about behavioural activation 
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Behavioural activation and values 152 
Although behavioural activation may be less burdensome than CBT, individuals 153 
can have difficulties identifying activities as targets for promotion and increased 154 
engagement. For example, individuals with depression often select aversive, difficult to 155 
complete activities that have delayed reinforcement (Lejuez et al., 2011). To overcome 156 
this, some psychological interventions, such as Acceptance and Commitment Therapy 157 
(ACT), encourage individuals to modify their behaviour by adhering to their values. 158 
Values are defined as verbally constructed global desired life consequences (Hayes et 159 
al., 1999). Functionally, values are seen as reinforcing and values identification may 160 
orientate an individual toward a defined set of multiple positive reinforcers (Bonow & 161 
Follette, 2009). However, ACT is similar to CBT in that – when delivered 162 
comprehensively – it contains multiple core components that are cognitively demanding 163 
(Hayes et al., 1999) and thus likely to present similar barriers to engagement for an MS 164 
population (particularly individuals with advanced symptoms/ secondary progressive 165 
MS).  166 
In behavioural activation, the function of values may be used to motivate and 167 
sustain behaviours, when reinforcement from the behaviour is not expected to 168 
immediately occur (Kanter et al., 2009). This is because values are seen as verbally-169 
derived reinforcement, meaning behaviour may be sustained in the face of competing 170 
aversive consequences that can stop behaviour and lead to avoidance (Kanter et al., 171 
2010).  172 
As a result, comprehensive manuals for behavioural activation have been 173 
developed (Lejuez et al., 2011), some of which include values-led behaviour. One such 174 
manual is the Brief Behavioural Activation Treatment for Depression - Revised 175 
(BATD-R; Lejuez et al., 2011). The BATD-R is a ten-session manual for the treatment 176 
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of depression (Lejuez et al., 2011). In a randomised-controlled trial, the original manual 177 
significantly reduced depression (d =.73; Hopko et al., 2003). Further, there is evidence 178 
supporting the efficacy of this intervention using varying formats and length 179 
(Gawrysiak et al., 2009). Whilst between-group benefits have been demonstrated, less is 180 
known about between-person variability in response to the BATD-R, or about the 181 
mechanisms that achieve change.  182 
 183 
Study rationale 184 
Depression is highly prevalent among people with MS. More specifically, as the 185 
disease progresses, people with MS are more likely to develop depression and there is 186 
limited evidence in suitable interventions in this group. CBT has demonstrated reduced 187 
rates of depression in people with MS. However, there are few studies that investigate 188 
the most appropriate duration, delivery modality, or individual adaptations. 189 
Furthermore, less is known about CBT for people with secondary progressive 190 
MS. This is problematic, because continued reduction in physical and cognitive ability, 191 
combined with greater incidence of depression, may make accessing and engaging in 192 
therapies difficult. The need for therapeutic interventions for this group of people is 193 
highest, yet existing research is sparse. Behavioural activation may offer an accessible, 194 
parsimonious approach.6 195 
 196 
Aims of Investigation 197 
The aims of the study were to explore:  198 
• the preliminary efficacy of a behavioural activation intervention, for people with 199 
secondary progressive MS experiencing low mood. 200 
 
6 See Extended Introduction 1.7 for further details about rationale 
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• the feasibility of recruiting, retaining, and delivering the intervention.  201 
• mechanisms of change in outcomes (where observed) using process measures 202 
• participants’ experience of the intervention. 203 
Method 204 
A mixed-methods, multiple single-case experimental design (MSCED) was used.7 The 205 
study was registered on ClinicalTrials.gov (reference NCT03935529). Original data were 206 
collected for the purpose of testing the hypotheses in the manuscript.  207 
 208 
Ethics 209 
Ethical approval for the study was granted by the East Midlands – Nottingham 2 210 
ethics committee (ref: 19/EM/0013). Informed consent was obtained from each 211 
participant by the study researcher (LLO). Participants received a £20 Amazon voucher 212 
following the completion of the interview post-intervention.8  213 
 214 
Participants 215 
Participants were recruited through a neurology outpatient clinic at an acute 216 
hospital in Nottingham, UK, and through an advertisement placed in a regional MS 217 
Society newsletter. Participants were aged 18-years or over with a verified diagnosis of 218 
secondary progressive MS. Participants were English speaking, willing and able to give 219 
consent, and had access to and were able to use a telephone and computer. Potential 220 
participants were screened for depression using the Hospital Anxiety and Depression 221 
Scale (HADS; Zigmond & Snaith, 1983). Participants were eligible if they scored eight 222 
 
7 See Extended Methods 2.1 and 2.2 for further details about epistemology and design 
8 See Extended Methods 2.3 for further details about ethics 
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or above on the depression subscale, indicating at least mild levels of depression. 223 
Participants receiving other psychotherapy were excluded.9 224 
 225 
Measures 226 
Screening and primary outcome 227 
The HADS was used to screen participants for inclusion and in line with study 228 
aims, used to investigate change in depression. High sensitivity and specificity have 229 
been reported versus clinical interview and other measures in people with MS 230 
(Honarmand & Feinstein, 2009; Nicholl et al., 2001). In a systematic review completed 231 
by Hind et al. (2016) comparing mood measures in MS studies the HADS had a 232 
sensitivity of 90% which was the highest of all the measures compared. The HADS also 233 
had a specificity of 87% which was the third highest of all measures compared. For the 234 
purpose of the study, selection based on sensitivity was selected. The measure consists 235 
of 14 questions split into two subscales of seven questions (depression and anxiety). 236 
Participants rate their responses to statements over the last week from 0 to 3 with higher 237 
scores indicating a greater presence of depression or anxiety.10  238 
 239 
Baseline 240 
The Patient Health Questionnaire 2 (PHQ2; Kroenke et al., 2003) was used to 241 
establish a baseline on the outcome of primary interest (depression). The questions were 242 
altered from asking ‘over the last week’ to ‘over the last two days’. Higher scores 243 




9 See Extended Methods 2.4 for further details about participants and recruitment 
10 See Extended Methods 2.5 for further details about measures 
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Process measures 247 
The Behavioural Activation for Depression Scale Short Form (BADS-SF; 248 
Manos et al., 2011) was used to track participant engagement in behavioural activation. 249 
The measure consists of nine items on a Likert sale from 0 (not at all) to 6 (completely) 250 
and scores range from 0 to 54, with higher scores representing higher activation.  251 
The Engaged Living Scale (ELS; Trompetter et al., 2013) was used to identify 252 
alignment to values, to allow us to understand the impact of values-based action. The 253 
measure assesses an engaged response style, in response to an individual’s values and 254 
committed action toward those values. Participants rate 16 statements on a Likert scale 255 
from 1 (not at all) to 5 (totally agree). Total scores range between 16 and 80, with 256 
higher scores indicating a more engaged response style. 257 
 258 
Secondary outcomes 259 
 The Modified Fatigue Impact Scale Short Form (MFIS-SF; Vickrey et al., 260 
1995) was used to assess fatigue. The measure consists of five questions on a Likert 261 
scale from 0 (not at all) to 4 (almost always) and total scores range from 0 to 20, with 262 
higher scores indicating greater fatigue. 263 
Changes to participants’ health-related quality of life (QoL), were investigated 264 
using the Short Form-12v2 Health Survey (SF-12v2; Ware et al., 1996). The SF-12v2 265 
addresses health concepts from the participant’s perspective. The measure has 12 266 
questions and comprises physical and mental health concepts. 267 
  268 
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Intervention 269 
The BATD-R manual (Lejuez et al., 2011) was adapted for supported self-help 270 
from ten sessions to five. The five unique sessions of the manual were used for the 271 
sessions. The manual had phrases relating to cancer removed.11 272 
 273 
Design 274 
A MSCED was used to investigate study aims. Participants received the 275 
behavioural activation intervention to investigate changes to mood and whether/how 276 
behavioural activation processes accounted for any observed change. As the 277 
intervention involved learning, it cannot be unlearned, therefore the effect of the 278 
intervention (or component phases) cannot be readily taken away. The study used an 279 
AB design, where A was baseline and B was the intervention.  280 
Post-intervention, one-to-one interviews were conducted to inform feasibility 281 
aims (acceptability of the intervention and research procedures). The interview schedule 282 
was based on the Elliott and Timulak (2005) change interview.  283 
 284 
Data collection and assessment 285 
Data were collected online, via participant self-report using Qualtrics (Qualtrics, 286 
Provo, UT). A single reminder was sent via the system if participants had not responded 287 
within 48-hours. Demographic data included: age, gender, relationship status, care 288 
support (paid /unpaid carers, hours per week), ethnicity, education level, and 289 
employment status. Clinical data included: diagnosis, and disease duration and 290 
progression history.  291 
 
11 See Extended Methods 2.6 for further details about design method 
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Pre-intervention assessments were completed by participants, after obtaining 292 
consent, prior to establishing a baseline. The assessments were re-administered at mid-293 
intervention and post-intervention (final session). The assessment battery included: The 294 
HADS, ELS, BADS-SF, MFIS-SF, and SF-12v2 Health Survey. In addition to the pre-, 295 
mid-, and post-intervention battery, the HADS, ELS, and BADS-SF were administered 296 
weekly.  297 
The PHQ2 was administered every-other-day during the baseline phase, to 298 
establish a baseline for the primary outcome variable of interest (depression). Questions 299 
were adapted to ask ‘over the last two days’ because no alternative, high frequency, 300 
measure exists. Trend scores were plotted to convert to HADS equivalent.   301 
 302 
Procedure 303 
Potential participants were provided with study information and were contacted 304 
by telephone after one-week to answer questions and to complete screening using the 305 
HADS. Those meeting inclusion criteria were recruited. Those not meeting the 306 
inclusion criteria were excluded from the study and provided with a leaflet on managing 307 
emotions and signposted to seek further support from their GP.  308 
Participants completed the pre-intervention measures. The following day 309 
participants received an email with a link to complete the measures, using Qualtrics, to 310 
establish a baseline. Participants received an email every-other-day to complete baseline 311 
measures.  312 
A baseline for each participant was established over two weeks in which no 313 
other contact or procedure was introduced. The baseline was considered stable 314 
(established) when the participant had recorded no less than three data points on the 315 
PHQ2 that showed no trend toward improvement. If stability had not been 316 
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demonstrated, the baseline was extended on a week-by-week basis, for a maximum of 317 
two weeks. If a stable baseline had not been established by the fourth week, the 318 
participant exited the study and was provided with information about managing distress 319 
and accessing further support. 320 
For participants with an established baseline the intervention was introduced. 321 
Participants received five sessions with an optional troubleshooting session. All 322 
sessions were delivered by LLO (a trainee clinical psychologist, working under the 323 
supervision of two qualified clinical psychologists) and audio recorded. The first 324 
session took place at the participant’s home and lasted up to two hours; all further 325 
sessions used Skype or telephone depending on the participant’s preference. Sessions 326 
three, four, and five were fortnightly, with the optional session between session three 327 
and four. Following the fifth session participants received a treatment evaluation session 328 
to review the homework tasks from session five. 329 
 330 
Post-intervention 331 
Participants completed a 30-minute, one-to-one, audio recorded phone interview 332 
conducted by CM (another trainee clinical psychologist, with experience of conducting 333 
interviews) who had not been involved in the study design or analysis.12 334 
  335 
Analysis 336 
Single-case experimental design 337 
Visual analysis was used to identify any phase-related changes in process and 338 
outcome variables. Time-series data from the HADS depression subscale and BADS-SF 339 
were graphed and inspected visually for phase related change (see Figures 2 and 3).  340 
 
12 See Extended Methods 2.7 for further details about intervention/procedure 
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 The analysis provided a visual representation of the covariation between 341 
process and outcome measures, to explore whether and how the intervention had an 342 
impact on mood and activation. Conservative dual-criterion (Fisher et al., 2003) and 343 
percentage exceeding the median (Ma, 2006) were used. Conservative dual-criterion 344 
analysis was used as the primary analysis. Conservative dual-criterion analysis 345 
extrapolates baseline mean and trend lines through the intervention-phase, to enable 346 
identification of intervention-phase datapoints that are indicative of positive change 347 
(i.e., those ‘exceeding’ baseline level and trend, in the direction of improvement). 348 
Conservative dual-criterion was used to account for any potential trend in baseline when 349 
PHQ2 scores were converted to HADS scores.13 Percentage exceeding the median 350 
analysis explores how many intervention-phase data points exceed the baseline median 351 
in the direction of improvement, and provides an effect size (highly effective treatment 352 
≥.9, moderately effective treatment .7-.9, and questionable or non-effective treatment 353 
<.7). Reliable and clinically significant change indices were used to provide quantitative 354 
decision criteria for identifying the statistical robustness, and practical importance, of 355 
visually apparent shifts over time.14 356 
 357 
Interviews 358 
Framework analysis (Gale et al., 2013) of telephone interviews was used to 359 
explore participants’ experience and to assess feasibility. The analysis was conducted 360 
by LLO. Predefined codes regarding the feasibility of the study were assigned to the 361 
data and summarised into a feasibility framework. 362 
  363 
 
13 See Extended Methods 2.8.2.2 for baseline establishment 
14 See Extended Methods 2.8 for further details about analysis 
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 364 
Intervention fidelity 365 
Audio recordings of the intervention sessions were evaluated by NM. Fidelity 366 
was investigated using a set framework, to investigate content delivery adherence.15 367 
Results 368 
The study ran from July 2019 to March 2020. In total 11 individuals were 369 
screened, and eight participants were recruited. Baseline stability was established for six 370 
participants. Of the six participants, one participant withdrew from the study after the 371 
second intervention session. Sessions ranged from 38 minutes to 120 minutes. There 372 
were no missed sessions. Participant demographics of those who established a baseline 373 
can be seen in Table 3.16   374 
 375 
Table 3  376 
Participant demographics of those who established a baseline 377 
Note. All participants were of white British ethnicity. 378 
a SPMS, Secondary progressive multiple sclerosis 379 
  380 
 
15 See Extended Methods 2.8 for further details about analysis 
16 See Extended Results 3.1-3.5 for further details about results: demographics, feasibility, attrition, 
sessions, and baseline data 
Demographic PS01 PS02 PS03 PS04 PS05 PS06 
Age (years) 66 56 60 64 51 73 
Gender Male Male Female Male Female Male 
Relationship Divorced Married Widow Widower Married Married 
Care status Paid (15hr) Unpaid None Paid (5 hours) Unpaid (<4) Unpaid 
(42 hours) 
Education University Sixth 
form 
College University School School 
Employment Retired Retired Retired Retired Unemployed Retired 
Diagnosis 
duration 
29 years 20 years 38 years 12 years 27 years 16 years 
SPMS duration 10 years 3 years 19 years 12 years 3 years 3 years 
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Visual Analysis of Change 381 
HADS Depression 382 
Changes in depression can be seen in Figure 2. 383 
 384 
Figure 2 385 






Note. This figure demonstrates participants’ weekly depression scores from baseline to 392 
the end of intervention. Higher scores on the Hospital Anxiety and Depression Scale 393 
(HADS) – depression subscale indicate greater presence of depression, possible 394 
maximum of 21 and minimum of 0. The clinical cut off is 8.  395 
a Baseline phase is denoted by section A. Intervention phase is denoted by B. A vertical 396 
line is presented to distinguish between phases. 397 
b Dashed lines in phase B represent mean baseline score plus .25 Standard Deviation and 398 
projected trend from baseline scores. 399 
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d The first baseline score is the participant’s HADS – depression subscale score. The 401 
following baseline scores were converted from the Patient Health Questionnaire 2 trend 402 
to HADS- depression subscale equivalent 403 
e PS06 had additional weekly measures due to requesting no sessions over the Christmas 404 
break time point nine and ten. 405 
 406 
Overall, depression appeared to reduce across phases in three of five participants 407 
(PS03, 05, & 06). There were sufficient data points below mean and trend lines to 408 
conclude systematic change occurred from baseline to treatment in two of five 409 
participants (PS03 & 06). At the end of intervention, two participants (PS02 & 05) were 410 
one observation point on the HADS from recording the necessary number of 411 
observations below mean and trend lines to demonstrate systematic change. Generally, 412 
gains appeared to show gradual improvement, except for PS02, where there was no 413 
change. When assessing percentage exceeding the median, three of five participants 414 
(PS01, 03, & 06) demonstrated highly effective treatment (≥.9) and two participants 415 
(PS02 & 05) demonstrated moderately effective treatment (0.7-0.9). Reliable and 416 
clinically significant change was observed from baseline to end of intervention in two 417 
participants (PS05 & 06). Of note, participant 03 was at cut off (8) for the final session. 418 
Participant pre-, mid-, and intervention scores can be seen in Table 4.17 419 
 420 
  421 
 
17 See Extended Results 3.4 for further details about baseline establishment and conversion 
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BADS Activation 422 
Changes in activation can be seen in Figure 3. 423 
Figure 3 424 




  429 
 430 
Note. This figure demonstrates participants’ weekly activation scores from baseline to 431 
the end of intervention using the Behavioural Activation for Depression Scale – Short 432 
Form (BADS-SF). Higher scores on the BADS-SF indicate greater engagement in 433 
activities, possible maximum of 54 and minimum of 0.  434 
a Baseline phase is denoted by section A. Intervention phase is denoted by B. A vertical 435 
line is presented to distinguish between phases. 436 
b Dashed lines in phase B represent mean baseline score plus .25 Standard Deviation and 437 
projected trend from baseline scores. 438 
c Time on the x axis is equivalent to one week. 439 
d PS06 had additional weekly measures due to requesting no sessions over the Christmas 440 
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Overall, activation scores appeared to covary with depression scores: such that 443 
participants demonstrating systematic change in one tended to demonstrate systematic 444 
change in the other (and vice-versa) – providing some evidence for theoretically-445 
congruent process-outcome mapping. However, PS06 was an exception. PS06 446 
demonstrated a clear change in depression but (partly owing to baseline trend) not in 447 
activation.  448 
Where systematic changes did not occur on the HADS, the scores on the BADS-449 
SF were similar, Covariation between depression and activation can be seen in Figure 4. 450 
There were sufficient data points above mean and trend lines to conclude systematic 451 
change occurred from baseline to treatment in two of five participants (PS03 & 05). 452 
Gains appeared to show gradual improvement. Whilst systematic change was not 453 
observed on the HADS for participant 05, the systematic change in activation scores 454 
coincides with reliable and clinically significant improvement. Participant 06 did not 455 
demonstrate systematic improvement in activation from expected observations using 456 
baseline data, however, baseline activation levels were increasing which coincides with 457 
the observed systematic reduction in depression scores. When assessing percentage 458 
exceeding the median, two of five participants (PS03 & 05) demonstrated highly 459 
effective treatment (≥.9), two participants (PS01 & 06) demonstrated moderately 460 
effective treatment (0.7-0.9). Reliable change was observed in one participant (PS05), 461 
but clinically significant change was not.  462 
 463 
  464 
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Figure 4 465 
Covariation of depression and activation scores for each participant throughout 466 







  474 
Note. This figure demonstrates participants’ weekly depression and activation scores 475 
from baseline to the end of intervention using the Hospital Anxiety and Depression – 476 
depression subscale (HADS) and the Behavioural Activation for Depression Scale – Short 477 
Form (BADS-SF). Higher scores on HADS indicate greater presence of depression, 478 
possible maximum of 21 and minimum of 0. The clinical cut off is 8. Higher scores on the 479 
BADS-SF indicate greater engagement in activities, possible maximum of 54 and 480 
minimum of 0.  481 
a Baseline phase is denoted by section A. Intervention phase is denoted by B. A vertical 482 
line is presented to distinguish between phases. 483 
b Dashed lines show the linear trend throughout the study. 484 
c Time on the x axis is equivalent to one week. 485 
d PS06 had additional weekly measures due to requesting no sessions over the Christmas 486 
break time point nine and ten. 487 
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Engaged living 489 
Overall, weekly observations of engaged living varied amongst participants, but 490 
increased engaged living corresponded with changes in reduction of depression and 491 
increase in activation in two of three participants (PS05 & 06), no changes were 492 
observed in two participants which coincided with no change in depression (PS01 & 493 
02). Reliable and clinically significant change was observed in two participants (PS05 494 
& 06), however, reliable deterioration was observed in one participant (PS03). A 495 
comparison of engaged living scores can be seen in Table 4. At observation seven, 496 
participant 02 scored their highest engaged living score which demonstrated reliable 497 
improvement from baseline before they had a relapse in symptoms. Participant 04 498 
scored within non-clinical cut off pre-intervention (50) and at final data collection was 499 
still within non-clinical cut off (57).18 500 
 501 
Fatigue 502 
Fatigue was recorded pre-intervention, at mid-point, and post-intervention. 503 
Reliable and clinically significant change was not observed in any participants. A 504 
comparison of fatigue scores can be seen in Table 4. Fatigue did not increase for any 505 
participant from pre-intervention to post-intervention. Participant 04’s fatigue score pre-506 
intervention was 5 and no further data were collected as they withdrew from the study.19 507 
 508 
Quality of life 509 
Scores on the SF-12v2 failed to meet clinically significant change in all 510 
participants. However, two participants demonstrated reliable improvement on the 511 
 
18 See Extended Results 3.6 for further details on Engaged Living Scale and subscales 
19 See Extended Results 3.7 for further details on Modified Fatigue Impact Scale 
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Mental Component Scale (MCS). No reliable change was observed on the Physical 512 
Component Scale (PCS). Further, no participants showed reliable deterioration on the 513 
MSC or the PCS. Comparison of scores is shown in Table 4. Participant 04’s pre-514 
intervention scores were 38.22 on the MCS and 44.22 on the PCS.  515 
  516 
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Table 4 517 
Participant scores on measures pre-, mid-, and post-intervention and reliable and 518 
clinically significant change criteria 519 
Participant Outcome 
measure 
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Note. This table demonstrates participants’ scores on each measure pre-, mid-, and 520 
post-intervention. 521 
a RC = reliable change (i.e., minimum change-score required to demonstrate 522 
statistically reliable change [at 95% confidence]). 523 
b Cut off = caseness threshold for determining clinically significant symptoms. 524 
c Arrows (↑/↓) indicate direction of desired change (improvement) for each measure. 525 
d * = reliable improvement in relation to first available score. 526 
e + = clinically significant improvement in relation to first available score.  527 
f ± = reliable deterioration in relation to first available score 528 
g HADS-DS, Hospital Anxiety and Depression Scale – depression subscale; BADS-SF, 529 
Behavioural Activation for Depression Scale-Short Form; ELS, Engaged Living Scale; 530 
MFIS-SF, Modified Fatigue Impact Scale-Short Form, SF12v2 PCS, Short Form 12 531 
version 2 Physical Component Score; SF12v2 MCS, Short Form 12 version 2 Mental 532 
Component Score 533 
 534 
Fidelity 535 
A sample of intervention session-recordings were checked for fidelity in terms 536 
of adherence to BATD-R session checklist. Six recordings (19% of available 537 
recordings) were selected and rated by NM; who had not been involved in intervention 538 
delivery. In terms of adherence to session plan, all sampled sessions covered all planned 539 
topics (100% adherence) in a suitable flexible and facilitative manner.20  540 
 541 
Feedback 542 
In total, five change interviews were completed up to two weeks post-543 
intervention. The participant who withdrew from the sessions completed a change 544 
interview. Participant 02 who did not complete a change interview reported a relapse in 545 
his MS symptoms which he reported negatively impacted his mood and ability to 546 
engage in activities. 547 
 Overall, reports from change interviews were predominantly congruent with 548 
quantitative data (Table 5). Three participants found behavioural activation helpful and 549 
attributed change in mood to the intervention. For those not reporting change they found 550 
 
20 See Extended Results 3.9 for further details about fidelity 
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the idea of increasing or identifying activities in the face of physical difficulties hard. 551 
Some participants reflected that monitoring their activities and keeping diaries was 552 
helpful because they had not realised how low their mood had become. Using the diary 553 
provided an opportunity to reflect on week-to-week changes and see how they 554 
overcame periods of low mood on certain days. Additionally, planning activities led 555 
individuals to look forward to events. For some participants they reported thinking that 556 
external events limited the effects of behavioural activation and participant 03 stated 557 
that without the intervention she believed her mood would have been worse than at the 558 
start.21 559 
 
21 See Extended Results 3.8 and 3.10 for Change Interviews and participant summaries 
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Table 5 560 
Participant change interviews 561 
Question Participant 1 - unchanged Participant 3 - 
unchanged 
Participant 4 - 
unchanged 





Didn’t have high expectations as 
I didn’t think things would 
change. Expectations were 
minimal, but it highlighted 
where my problems were, but I 
didn’t overcome them. I don’t 
think asking the same questions 
of people with secondary 
progressive MS is of benefit as 
asking those without. It didn’t 
provide me with solutions to 
overcome difficulties, but I think 
that would have been difficult 
any way. 
Very good. When he 
came to see me, it was 
lovely to see him, and 
it made me more 
interested in the 
research. I liked the 
fact I knew somebody 
was contacting me and 
I kept diaries. Despite 
all the life stressors the 
researcher was a 
support for me, I knew 
I could talk to him. He 
was somebody to 
offload to and I don’t 
think that I have that. 
It was really good to 
have someone there 
who understands.  
 
Reflecting on the 
diaries allowed me to 
relay to the researcher. 
I found the hourly 
diary a bit too much, 
but I do like keeping 
diaries and I did it and 
managed it.  
Too much information 
to grasp. 
 
I know who I am, I 
know what enjoyment, 
achievement that I get 
from the activities I 
do. I have been alone 
for a long time and to 
change lifestyle just 
was not going to 
happen. I don’t think I 
could achieve anything 
better than I am doing 
as I am set in my 
ways. I know who I 
am.  
Interesting. I have had 
therapy before but it 
usually just talking to 
someone. But this one was 
different we did things; it 
was talking too but we did 
diaries and I have never 
thought about writing 
things down. I am making 
lists to plan my day now 
and record what I have 
done. It was quite new. In 
comparison to previous 
therapy this wasn’t about 
getting things off your 
chest but to do things 
actively, which made 
things clearer by writing 
things down. I am still 
doing it now and I have 
bought a journal. 
 
It has shown where things 
have affected me mood 
wise. I was able to see 
where I was bringing my 
mood down and how things 
were bothering me. I know 
what makes me feel worse 
and what makes me feel 
better.   
We had a discussion 
then he came to see 
me. I used some 
diary sheets which I 
did then when we 
spoke, we used them, 
he led me to go back 
through them to think 
about when I was 
down what picked 
me up. Using that 
system that is what I 
am still doing now, 
to get it in my mind. 
It seems to be 
working so far, quite 
well.  
 
At times when I have 
been down it was 
hard to complete 
some days on the 
diaries, but other 
than that I have 
found it useful. It 
was not that time 
consuming.  
 
The sessions were 
good, the researcher 
was pleasant to talk 
to and he listens and 
steers you on the 
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Question Participant 1 - unchanged Participant 3 - 
unchanged 
Participant 4 - 
unchanged 
Participant 5 - recovered Participant 6 - 
recovered 
right track which was 
very good.  
 
I found it helpful and 
would recommend it 
to anyone else. 
 
Any changes in 
self or depression 
More focused on trying to 
overcome problems, but unsure 
if I have made much ground.  
 
Very little change in depression, 
I think I have low mood, but I 
don’t think that I am depressed.  
 
Positive: I have been 
able to express myself. 
Being able to talk 
about everything even 
with everything going 




No changes Positive: I overthink things 
but now I am putting them 
into perspective by writing 
things down and it makes 
me think about things 
rationally. I have also 
started writing down 
worrying thoughts which 
has helped. My husband 
finds me calmer and more 
relaxed and we have both 
noticed a difference.  
 
I am feeling less tearful 
and there was one occasion 
when I received a letter and 
previously, I would have 
been vomiting but now I 
was able to better deal with 
it. As I make a list of how 
and when I can tackle parts 
and build into my week.  
 
My mood has increased 
 
Negative: None reported 
 
Positive: I am more 
positive. My mind 
has been working on 
things rather than 
being in that “can’t 
be bothered place.” I 
look at the diaries 
and learn what was 
going on in the past 
so I can help apply to 
now.   
 
My mood, I feel 
much brighter. I still 
experience low mood 
to an extent, but I 
suffer from anxiety. 
 
My wife has noticed 







Things are much the same 
Therapy: Focused on what the 
problems are and thinking about 
solutions. Solutions were 
Therapy: I was able 
to realise in therapy 
that I am such a 
determined person.  
Therapy: I don’t think 
therapy would help 
because I am set in my 
ways.  
Therapy: Using diaries to 
organise my week which 
has created lists and has 
also helped worry. 
Therapy: Talking to 
him made me realise, 
such as if I saw 
someone struggling 
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Question Participant 1 - unchanged Participant 3 - 
unchanged 
Participant 4 - 
unchanged 
Participant 5 - recovered Participant 6 - 
recovered 
identified but they’re difficult 
and something that needs to be 
ongoing because of my MS as it 
will get worse. 
 
External: Condition dictates 
how I live my life; it is difficult 
to make changes to that 
 
Using the diaries and 
having time to talk 
was important. 
 
It was hard for me to 
open up as I don’t 
usually do that. 
 
External: 
Mum has been ill 
which has been so 
upsetting throughout 
the last few months 
and having end of life 





physical symptoms of 
my MS prevent me 
from changing other 
things and my reliance 
on carers. Things are 
only going to get 
worse. 
 
Anxiety made it 
difficult because I 
knew what was going 
to happen. 
 
External: None reported 
the way I did what 
would I say to them 
because that helped 
me prioritise, plan, 
and pace the 
activities I wanted to 
do. 
 
Using the diaries to 
reflect on how to 
plan and overcome. 
 
External: Talking to 
my wife and 
including her, 
therapy helped me 
bring it up. So, she 
can now help put 
plans in to place as 
she can notice my 
mood dropping 
before sometimes, I 
realise. 
 
Aspects of life 
situations to use 
therapy to deal 
with problems 
Strengths: None reported 
 
Stressors: Mobility, being in a 
wheelchair, my MS makes it 
time consuming to do things and 
therefore I do not have a lot of 
spare time. My time is taken up 
by coping with life as it is, 
which is getting through the day. 
So, to try and put more into that 
is very difficult. I cannot cut out 
those things and adding fatigue 
makes it difficult to put extra 
things into my life. Living alone 
Strengths: I think my 
determination helped 
me stick with the 
therapy, otherwise the 
fatigue may have 
wanted me to stop. 
 
Stressors: Mum has 
been ill  
 







of MS and the time it 
takes me to complete 
activities. What may 
be a two minute job 
for someone can take 
me an hour so I don’t 




Strengths: Taking each 
day as I can. I know there 
is a time when I won’t be 
able to achieve certain 
things, but I am working 
out each day. 
 
Stressors: The MS has 
made things difficult. My 
walking has changed which 
makes me avoid and makes 
my mood worse if I don’t 
go out. I avoid people who 
do not know that I have 
Strengths: Being 
able to hear the 
things the researcher 
picked up and 
thinking about 
different ways to try 
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Question Participant 1 - unchanged Participant 3 - 
unchanged 
Participant 4 - 
unchanged 
Participant 5 - recovered Participant 6 - 
recovered 
makes it very difficult to make 
changes, if I was with someone 
else, they could relieve some 
pressure to give me more time. I 
think if I had someone else, 
therapy would have been easier. 
 
Public transport makes 
accessing activities difficulties 
because routes and times are set, 
so I cannot access different 
things.  
 
I am a support to 
others with MS which 
I have found tough to 
be a support to others 
and not have support 
prior to the study for 
myself. 
I can’t make a plan of 
action because I am 
dependent on others, 
such as carers.  
MS due to worry about 
their judgement. 
Helpful aspects Focusing more on what the 
problems are, I could think 
about the solutions.  
 
Lists of values and process to 
identify them 
It was important that 
sessions were 
confidential and gave 
me space. 
 
Somebody to talk to, 
who is understanding, 
and confidential. The 
researcher was a really 
nice person. 
 
Using Skype was good 
as we could see each 
other face-to-face. I 
could see body 
language and facial 
expression which you 
can’t on the phone, so 
you know what the 
other person is aiming 
for or getting at. I 
much preferred that to 
the telephone, in fact I 
would like my 
Highlighted that I am 
having to fight for 
everything. It 
reinforced knowing 
that things will happen 
again and again. 
I enjoyed the 
communication with the 
researcher as it was a 
different point of view, the 
diaries help but the 
researcher had a different 
point of view and I am 
going to miss that. I 
thought it was sad but then 
I thought I have these tools 
and I can use these to help 
myself. 
I realised I don’t have to 
beat myself up or stress 
over things when I have 
not managed to do some 
things.  
 
I have tried things that I 
was avoiding by thinking 
about barriers. I faced 
things rather than thinking 
of excuses. 
 
I got back into my 
hobbies and interests 
and have made plans 
for going forward. 
So, it was helpful to 
get me there and then 
doing the activities 
was helpful. 
 
Made me realise that 
there is a life beyond 
where I have been. It 
has picked me up 
tremendously. It has 
made me realise I am 
not just a waste of 
time. You get to a 
stage when you think 
you are hopeless and 
you try and do 
something on a bad 
day and you get 
frustrated but now I 
can reflect on it and 
think on that day I 
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Question Participant 1 - unchanged Participant 3 - 
unchanged 
Participant 4 - 
unchanged 
Participant 5 - recovered Participant 6 - 
recovered 
daughter to Skype 
now.  
I prepare for things if I am 
not able to do an activity 
what will I do instead. I 
think about something else 
that I can do.  
 
Which helps with the 
diaries and lists. I did not 
think I would manage the 
diaries to start with, but it 
went really well.   
 
can’t physically do 
something so I would 
do something 
different or plan 
when I can next do it.  
Unhelpful aspects Putting in to practice the 
solutions was hard.  




The aims of the 
course, you wanted to 
try and help me, but 
nothing was said that I 
thought could help me. 
Nothing, he even 
introduced me to Skype 




Interesting to some extent, it 
highlighted certain things and 
focused me on areas of interest 
in terms of things I should be 
looking at. You don’t usually sit 
down and make a list of things 
you are interested in but as life 
is changing it was helpful to 
highlight values and interests 
and how you would like to live 
your life.  
It has been good, 
beneficial, because it 
made me realise that I 
need some help too, 
rather than me just 
giving help to 
everyone else. 
Someone to talk to and 
understand.  
I was not sure what 
taking part in the 
course would lead to. I 
discontinued the 
course because I knew 
what my importance, 
achievement, and 
enjoyment would be 
before completing 
activities.  
The researcher was flexible 
which in one case was 
great because we moved a 
session later in the day 
which allowed me to 
achieve one of my goals 
linked to my values. 
 
I’ve done other research 
before; I did one by 
textbook, but I found that 
hard. In this one it suited 
me better because there 
were no medical terms, it 
was about what I put into 
it, it is what I got out of it.  
 
Being able to 
complete online 
questionnaires was 
good, because on 
some evenings when 
I was experiencing 
pain or spasms I 
could do them late at 
night which took my 
mind off things.  
Changes to 
quality of life 
I wouldn’t say I have made 
many. It was a difficult period of 
time as I broke my leg 5 months 
None reported None reported I am getting out more and 
making sure if something 
goes wrong, I have a B 
plan.  
It has made me more 
positive and helped 
with the 
communication in 
BEHAVIOURAL ACTIVATION IN MULTIPLE SCLEROSIS  
         Page 74 of 362 
 
Question Participant 1 - unchanged Participant 3 - 
unchanged 
Participant 4 - 
unchanged 
Participant 5 - recovered Participant 6 - 
recovered 
ago which made everything 
more difficult.  
my marriage. My 
wife thinks I have 
been more like my 





None They are about the 
same 
None reported None, I am going through 
physio at the moment and 
that’s not helping at the 
moment. But I try not to let 
it overwhelm me, if I feel 
fatigued, I select an activity 
I can do based on that.  
 
None reported 
Best and worst 
parts of the 
intervention 
Best: Providing more focus on 
what was causing low mood 
which gives an opportunity to 
try and improve that. 
 
Worst: Trying to fit the time in 
to do the therapy. Day is already 
quite full so trying to put extra 
things into my day was not easy, 
as there is not a lot I can cut out.  
Best: Skyping with the 
researcher and being 
able to talk. 
 
Worst: Initially, doing 
the diaries so regularly 
on the sheets, I found 
that time consuming.  
Best: It has 
highlighted the life I 
lead and what could be 
better  
 
Worst: The ideas that 
were suggested to me 
weren’t of value 
because I can’t do 
what others as 
‘normal’ people can 
do. 
 
It has highlighted that I 
have to put up with 
how others do 
activities for me and I 
cannot control that and 
what my MS is like. 
 
Best: Understanding that I 
am not alone and there are 
things that I can do without 
feeling alone and that there 
are places I can go to if I 
need support.  
 
Worst: Looking at mood 
and scoring. It seemed 
important but not that 
important to me. The part 
about values was hard to 
get my head around, I 
started to get it, but it took 
longer. 
Best: It has helped 
me, and I hope it can 






change or lack of 
change 
My MS symptoms have stopped 
change, although it has been a 
useful experience despite not 
Not being able to do 
what I want to do in 
comparison to my 
health before. I 
Having secondary 
progressive MS would 
likely give me a 
different experience to 
I started a new medication 
for pain about the same 
time as the study which 
may have helped a little as 
None reported 
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Question Participant 1 - unchanged Participant 3 - 
unchanged 
Participant 4 - 
unchanged 
Participant 5 - recovered Participant 6 - 
recovered 
making a difference to changing 
my life.  
sometimes want to do 
more than I can. 
 
Mum being unwell 
really had an impact.  
relapse remitting 
because things are 
going to get worse no 
matter what anybody 
does.  
it eased my pain. Although 
it was making me sleepy 
and I think the diaries, 
intervention, and 
medication all worked 
together, maybe it was a 
little bit of everything that 
has helped change. I 
couldn’t say. 
  
Ideas for the 
future 
It is possible that because 
everybody’s MS is different it 
may not work for people. If you 
don’t understand how the 
condition affects them, it can’t 
be tailored. So, it is a bit general 
but that may be difficult to 
change for everyone individual. 
 
Changes to the diary to 
make them less 
focused on hour-to-
hour but morning, 
afternoon, and 
evening. 
I think spending more 
time thinking about 
goals.  
None reported None reported 
 562 
Note. Participant descriptions reflect reliable and clinically significant change categories for Hospital Anxiety and Depression – depression 563 
subscale. Categories include deteriorated, unchanged, improved, and recovered. 564 
 565 
 566 
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Discussion 567 
Behavioural activation has long been considered helpful (Cuijpers et al., 2007) 568 
though there have been no studies focusing on secondary progressive MS, where 569 
physical health and cognition declines. As such, we believe this study makes a useful 570 
contribution to the literature.22 Our findings are comparable to behavioural activation 571 
approaches used with individuals with other neurological conditions to reduce 572 
depression (Oates et al., 2019).23 When considering that the treatment approach was 573 
predominantly self-directed and short-term in nature, the intervention is promising for 574 
those with secondary progressive MS. We hypothesised that an increase in positively 575 
reinforcing activating behaviour would reduce depression which was the case in three of 576 
five participants. Depression scores reduced as activation increased, upon the 577 
introduction of the intervention, which supports the theory that increasing positively 578 
reinforcing behaviours reduces depression. Further, in those that did not increase 579 
activation behaviours a reduction in depression was not observed.  580 
 Based on the results using both conservative dual-criterion and reliable change 581 
indices, the criteria to satisfy replicability allows us to conclude that the processes are 582 
demonstratable across cases, but with caution (Kratochwill et al., 2010). Caution is 583 
suggested because, for the three participants who demonstrated change by one criterion, 584 
other change-criteria were not met and there was a desynchrony across markers of 585 
change. For example, participant 06 demonstrated systematic improvement using the 586 
conservative dual-criterion on the HADS – depression subscale, and demonstrated 587 
reliable and clinically significant change on the HADS – depression subscale but did not 588 
demonstrate systematic improvement using the conservative dual-criterion between 589 
 
22 See Extended Discussion 4.1 for further discussion about effectiveness 
23 See Extended Discussion 4.2 for further discussion about findings in context of previous theory 
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baseline and intervention for activation on the BADS-SF. In the case of participant 06 590 
the trend from baseline assumed increasing activating behaviours which coincided with 591 
reduction in depressive symptoms.  592 
When considering effect sizes using percentage exceeding the median the 593 
intervention ranged in effectiveness across all participants from 0.75 to 1 on HADS – 594 
depression subscale, which is moderate to highly effective.  595 
   596 
Effectiveness of behavioural activation on depression 597 
We hypothesised that behavioural activation would reduce depression, which 598 
was arguably seen in participants who reported increased engagement with positively 599 
reinforcing behaviours.  600 
Visual analysis suggested that changes occurred gradually and, in most cases, 601 
coincided with increased activation on the BADS-SF. One participant remained at the 602 
clinical cut off on the HADS- depression subscale. It is possible that some latent effects 603 
exist using the HADS. For example, there are some items (e.g., “I feel as if I am slowed 604 
down”) that may be insensitive to change in people with secondary progressive MS, 605 
because they are likely confounded by physical health states and disability in this 606 
population (which could be relatively static or deteriorative), this is despite the fact that 607 
the HADS was designed to omit somatic markers of distress/to be apt for use in the 608 
context of physical health conditions. However, the inclusion of the HADS was 609 
important because the measure has good usage in MS research which allows us to 610 
consider changes in respect to other studies (Watson et al., 2014).  611 
We used the suggested cut off for the HADS because it has been used in several 612 
MS studies. Alternative cut offs have been suggested for people with MS (such as 11; 613 
Watson et al., 2014). Future large-scale studies would be better suited to complete 614 
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additional analyses on changes on the HADS-depression subscale when alternative cut-615 
offs are used.  616 
 For those that did not demonstrate change, it would be important to understand 617 
what, if any, benefits there are to maintain their current state. For some individuals, 618 
there may be disincentives (negative consequences) for reporting improvement (e.g., 619 
loss of access to supports) which could have influenced responding and/or engagement 620 
with the intervention. Ferster (1973) suggested that life events such as reduced social 621 
activity, occupational role, or relationship may account for a reduction in daily activity 622 
levels. The loss of reinforcement can generalise to other behaviours and may also result 623 
in verbal preoccupation which may present as complaints to others about feeling low. 624 
The verbal preoccupation may become positively reinforced through peers or therapists 625 
in expressions of sympathy or support which can lead to an increase in maladaptive 626 
behaviour (Azrin & Besalel, 1981).  627 
 628 
Process measure change 629 
Efforts to understand the possible treatment mechanism(s) contributing to the 630 
effectiveness of behavioural activation included ratings of activation. As predicted, 631 
activation increased where depression reduced. In cases of no change or regression, 632 
activation also decreased or did not change. The results were congruent with the theory 633 
of Lewinsohn et al. (1976), which postulates that by reducing behaviours that maintain 634 
or exacerbate depression and promoting counteracting behaviours depression would 635 
reduce. 636 
Regarding values, we hypothesised that during the intervention participants’ 637 
engaged living scores composed of two subscales (valued living and life fulfilment) 638 
would increase. The intervention encouraged participants to identify values and then 639 
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pick activities that aligned with those values. Some participants reported it being 640 
difficult to identify values whilst others said that they were already aware of them. Six 641 
(of ten) questions asked participants whether they were living full lives, whether 642 
anything could stop them from doing what they wanted, or whether life is as they 643 
intended it to be. It is possible that the nature of their condition resulted in similar pre- 644 
and post-intervention scores with few opportunities to demonstrate reliable or clinically 645 
significant change. Additionally, in the current format the intervention manual may not 646 
have included enough values-directed work to promote values-based activation for 647 
some individuals.  648 
During change interviews participants attributed change to reflecting on activity 649 
and engaging in enjoyable tasks as opposed to making direct links to valued living, 650 
except in one case (PS05) where structuring tasks to values was thought as beneficial.24  651 
 652 
Quality of life  653 
Throughout the intervention, health related QoL was assessed. No changes were 654 
observed in the physical component – which includes physical functioning, pain, 655 
general health, and physical roles. Positively, no worsening was observed in physical 656 
health QoL. Two participants, who reported increased activation and reduced depressive 657 
symptoms demonstrated reliable change on the mental health component, with the third 658 
participant demonstrating an increase but it did not fulfil the criteria for reliable change. 659 
Whilst depressive symptoms reduced, the intervention did not directly target other 660 
factors which can be associated with mental health distress, which may explain the lack 661 
of clinically significant change.  662 
 663 
 
24 See Extended Discussion 4.3 for further discussion about values 
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Fatigue 664 
Contrary to concerns that behavioural activation may adversely impact fatigue 665 
(Sharp et al., 2015), there was no observed impact of behavioural activation (promoting 666 
activity) on fatigue in the present study. During the intervention, no changes were 667 
reported in fatigue: thus, activation scores (levels of engagement in positively 668 
reinforcing behaviour) appeared to vary independently of fatigue.  669 
Evaluating fatigue in individuals with depression and secondary progressive MS 670 
is not straight forward. For example, fatigue is commonly associated with both 671 
depression and secondary progressive MS. A difficulty of studying depression in 672 
individuals with secondary progressive MS is that the presence of fatigue in both 673 
conditions makes it difficult to attribute the symptom to the disease or depression 674 
(Thomas et al., 2006). It is possible that the reduction of fatigue identified in the Proctor 675 
et al. (2018) review may be a result of depression related fatigue in early disease 676 
formats rather than fatigue which results from the condition.   677 
Perhaps positively then, the lack of increased fatigue in participants who 678 
increased their activities supports the idea that individuals can increase positively 679 
reinforcing behaviours without exacerbating difficulties associated with their condition. 680 
Fatigue may contribute to the development, maintenance, and exacerbation of 681 
depression by reducing contact with contingencies that were previously reinforcing 682 
(Motl et al., 2009), yet with guided self-help some participants were able to identify 683 
activities and engage despite the presence of on-going high levels of fatigue.25  684 
 685 
  686 
 
25 See Extended Discussion 4.4 for further discussion about fatigue 
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Feasibility 687 
During change interviews participants confirmed the acceptability of the 688 
materials, measures and sessions. Overall the behavioural activation intervention and 689 
methods used in the study were feasible. 690 
 Regarding recruitment, we were able to screen and recruit participants who 691 
were interested in the intervention. Regarding intervention acceptability, no sessions 692 
were missed throughout the study. In terms of participant retention one participant 693 
withdrew from the study prior to scheduling activities. Regarding outcome measures, 694 
across all participants only four weekly questionnaires were not completed by three 695 
participants, and five baseline questionnaires were not completed by three 696 
participants.26  697 
  698 
Strengths and limitations 699 
The study was designed with patient and public involvement (PPI) to investigate 700 
suitable interventions to ameliorate depression in secondary progressive MS. PPI input 701 
improved the selection of measures, the approach used to complete measures, the 702 
acceptability of the language used in the BATD-R, and need for the research. 703 
The design of the study allowed for an investigation of processes that may be 704 
associated with therapy. We were able to track changes associated with behavioural 705 
activation and the weekly impact on depression. Further, the analysis used triangulation 706 
to consider variables and effectiveness. By using visual analysis paired with 707 
conservative dual-criterion, percentage exceeding the median, and reliable and clinically 708 
significant change indices, we were able to draw conclusions without overstating 709 
effectiveness (i.e., reducing Type I and II errors). Using qualitative feedback also 710 
 
26 See Extended Discussion 4.5 for further discussion about feasibility 
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provided explanatory power and added context to data, such as understanding barriers to 711 
engaging in positively reinforcing activities and maintaining distress in the face of 712 
increasing life stressors.  713 
However, the inclusion of multiple measures with repeated application increases 714 
the risk of a Type I error. Further, the repeated administration of measures and the 715 
changes to the represented timeframe during the baseline may have compromised the 716 
psychometric properties of the measures. As the research was of a preliminary nature, 717 
the timeline changes and number of measures were needed to provide an overview of 718 
processes and outcomes for behavioural activation on depression in secondary 719 
progressive MS.  720 
Additionally, during the baseline phase participants were regularly asked to 721 
consider their behaviour and their engagement in positively reinforcing activities. It is 722 
possible that behaviour change therefore occurred prior to planning activates and during 723 
the activity monitoring phase. The regular support sessions, and every-other-day and 724 
weekly outcome measures which were used to strengthen study rigour may have 725 
inadvertently impacted validity.  726 
Finally, the intervention used a guided self-help approach. Participants planned 727 
and engaged in activities which they reported that they believed would be positively 728 
reinforcing in their own time. It is unknown beyond self-report how much someone 729 
engaged in their planned tasks. It is possible that demand characteristics led to 730 
perceived favourable reporting for behaviour. However, to mitigate this, a positive 731 
approach was taken to understanding why non-completion of tasks may have occurred – 732 
with the view that all outcomes were positive as they provided new information for the 733 
researcher and participant to evaluate.27    734 
 
27 See Extended Discussion 4.6 for further discussion about strengths and weaknesses 
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 735 
Clinical implications and future research 736 
It is too soon to conclude that behavioural activation is an efficacious approach 737 
to the treatment of depression for individuals with secondary progressive MS. However, 738 
there is potential for behavioural activation to offer alleviation of depression in the face 739 
of competing physical symptoms of MS in a manualised and structured time limited 740 
intervention that is comparable to IAPT services.  741 
Based on beneficial findings for some participants, further investigation is 742 
warranted. There is evidence that – despite declining MS symptomology – individuals 743 
with secondary progressive MS can identify and engage in positively reinforcing 744 
activities, which may then reduce depressive symptomology.  745 
This study satisfies Medical Research Council guidance for process evaluation 746 
in developing and evaluating complex interventions (Moore et al., 2015). The next stage 747 
would be to answer feasibility questions in a trial such as randomising, testing 748 
procedures, estimating recruitment and retention, and determining sample size (Craig et 749 
al., 2008). 750 
Identifying accessible psychological interventions in those with long-term 751 
neurological problems is important. Behavioural activation is an acceptable intervention 752 
for people with secondary progressive MS, which reduces low mood when engagement 753 
in positive reinforcement occurs. Despite increasing activities to engage in positive 754 
reinforcement there were no adverse effects to individuals’ mental or physical health.  755 
The outcomes support the use in clinical practice and warrants further investigation in 756 
large groups.28  757 
 
28 See Extended Discussion 4.7 for further discussion about implications for clinical practice and future 
research 
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1. Extended introduction 
1.1 Neurological conditions 
 
Neurological conditions are diseases of the central and peripheral 
nervous system, which can affect the brain, autonomic nervous 
system, cranial nerves, peripheral nerves, nerve roots, spinal cord, 
neuromuscular junction, and muscles (World Health Organization, 
2016). In total there are over 600 types of neurological conditions, 
which have been categorised into sudden onset (e.g., brain or spinal 
cord injury), progressive (e.g., late stage multiple sclerosis [MS], 
Parkinson’s, or motor neuron disease), intermittent and unpredictable 
(e.g., epilepsy, migraine, early stage MS, or myalgic 
encephalomyelitis), and stable neurological conditions (e.g., post-polio 
syndrome; NHS England, n.d.), which may be a result of illness or 
injury (Neurological Alliance, 2003; World Health Organization, 2006). 
In literature, neurological conditions have been reported individually 
(as their own classification) and sub-categorised as part of the larger 
umbrella term of long-term conditions (Kings Fund, 2012; National 
Collaborating Centre for Mental Health & National Institute for Health 
Clinical Excellence, 2010; NHS England, n.d). The use of individual and 
sub-categorisation can present difficulties when attempting to 
synthesise existing literature, which impacts our ability to further 
develop our understanding of the associated difficulties people 
experience because data are often amalgamated. Further, the impact 
of this wider grouping means that policy guidance and impact reports 
contain an array of symptoms and experiences making understanding 
individual conditions, or types of conditions difficult.  
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1.1.2 Prevalence and impact of neurological conditions  
 
In England, in 2012, the prevalence of individuals who have one or 
more long-term condition (inclusive of neurological conditions) was 
reported to be more than 15 million people (30% of the population; 
Kings Fund, 2012). However, in 2014, estimates for people living with 
a neurological condition that has a significant impact on their lives in 
the UK, were reported to be as high as 12.5 million. It is estimated in 
England that over 800,000 people have Alzheimer’s/dementia (Prince 
et al., 2014), 135,000 people have a brain injury (McMillan & 
Greenwood, 1991), 300,000 people have epilepsy (Hart et al., 1990), 
127,000 people have MS (MS Society, 2018a), 215,000 people have 
myalgic encephalomyelitis (National Institute for Health and Care 
Excellence, 2007), 120,000 people have Parkinson’s disease 
(Parkinson’s UK, 2018), and 300,000 people have had a stroke 
(Geddes et al., 1996; Oxfordshire Community Stroke Project, 1983). 
The figures demonstrate the increasing incidence of people living with 
a neurological condition and the difficulties associated with prevalence 
estimates. 
 
1.2 Multiple Sclerosis 
 
MS is a chronic neurological condition that affects the central nervous 
system. MS affects over 100,000 people in the UK (MS Society, 2018a). 
The majority of individuals are diagnosed between 30 and 40-years of 
age, with a higher prevalence in females than males (Mackenzie et al., 
2014). 
 
MS is caused by the demyelination of axons; damage to the protective 
layer, known as the myelin sheath, that surrounds nerves. 
Demyelination results in scar tissue on the axons which causes nerve 
damage known as lesions or plaques (Smith & McDonald, 1999). 
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The aetiology of MS and the demyelination of axons is unknown (Smith 
& McDonald, 1999), but several risk factors have been identified such 
as genetics, infection, vitamin D deficiency, smoking, exposure to 
certain solvents, and obesity (Gilden, 2005; MS Trust, 2018). However, 
the risk factors for MS are very common, with thousands of individuals 
exposed to them daily, yet only a small number of people develop MS. 
It is likely that a combination of factors are needed for the development 
of MS (MS Trust, 2018). It is widely theorised that MS is an 
autoimmune disorder, where the body’s immune system attacks the 
individual’s tissues rather than germs.  
 
Four subtypes of MS exist. They are relapse remitting, primary 
progressive, secondary progressive, and benign. Individuals with 
benign MS show no symptoms and have minimal disability over a 
period of many years; typically, individuals are symptomless for over 
15-years (Lassmann et al., 2001). The remaining subtypes are 
categorised by the course of the disease and symptom presentation. 
Around 85% of individuals are initially diagnosed with relapse remitting 
MS (Rejdak et al., 2010). Relapse remitting MS is characterised by the 
sudden onset of symptoms which last on average two to six weeks 
before symptoms completely remit (Rejdak et al., 2010). 
 
Primary progressive MS describes the trajectory of the disease; in 
which symptoms are present and progressively worsen from the onset 
of the disease. Contrastingly, in the later years those with relapse 
remitting MS experience episodes of symptom presentation that do not 
retreat; leading neurologists to confirm transition to secondary 
progressive MS. Individuals have a variety of symptoms that may 
include difficulties with vision, balance, fatigue, pain, and cognition 
(Rejdak et al., 2010). The symptoms experienced by individuals with 
MS vary; based upon the areas of the nervous system that are affected 
and the type of MS (Jones et al., 2008). MS can also have a number of 
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effects on psychological wellbeing (Wilkinson & das Nair, 2013), 
presenting individuals with a need for psychotherapy, that is both 
effective and accessible considering the physiological impact of the 
disease.  
 
1.2.1 Secondary Progressive Multiple Sclerosis 
 
In the UK the prevalence of individuals with secondary progressive MS 
is estimated to be 57.8/100,000 (40.9–74.6/100,000; Khurana et al., 
2018). Individuals with secondary progressive MS experience gradually 
worsening symptoms that can include increased weakness, difficulties 
with coordination, muscle stiffness, bowel and bladder problems and 
troubles with fatigue, depression, and cognition (Compston & Coles, 
2008). 
 
Individuals with secondary progressive MS who experience cognitive 
symptoms can have difficulties with short-term memory, word finding, 
concentration, and processing (MS Trust, 2018). Fatigue is another 
common symptom for individuals with secondary progressive MS. 
Individuals experience fatigue as exhaustion which is disproportionally 
related to a task that the person has engaged in and presents as both 
physical and mental tiredness (MS Trust, 2018). The symptoms that 
individuals experience depend on the location of the lesions located on 
their brain and spinal cord (MS Trust, 2018), meaning individuals can 
have unique symptom presentation. 
 
Secondary progressive MS is characterised at different time points as 
either active, with relapses/or evidence of new MRI activity, or not 
active. Additionally, time points are with progression (worsening 
disease, with or without relapses) or without progression (National 
Multiple Sclerosis Society, n.d) as seen in Figure 5. 
 
   
         Page 100 of 362 
 
Figure 5 
Secondary progressive multiple sclerosis disability progression 
 
 
Note. This figure details an example of disability over time in 
secondary progressive multiple sclerosis. Increased disability is 
represented by increased distance from 0 on the y axis. 
aSecondary progressive multiple sclerosis progression. (Lublin et al., 
2014) 
bRRMS, relapse remitting multiple sclerosis; MRI, Magnetic Resonance 
Imaging. 
 
To manage symptoms, individuals maintain a pharmacological regimen 
therefore identifying psychological interventions to manage mood 
rather than using medication may be of benefit, as it reduces the 




Depression is a disorder characterised by low mood and/or loss of 
pleasure in activities accompanied by a range of physical, emotional, 
cognitive, and behavioural symptoms (National Institute for Health and 
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Care Excellence, 2015). The Diagnostic and Statistical Manual of Mental 
Disorders, fifth edition (DSM-5) defines depression as the presence of 
five of nine symptoms present for two weeks.  
 
The DSM-5 is used to diagnose major depressive disorder by asking 
questions about two core symptoms, feeling down, depressed, or 
hopeless during the last month, and having little interest or pleasure 
in doing things. If the individual has had the presence of the symptoms 
most days for at least two weeks other typical symptoms are 
investigated. Symptoms include fatigue/loss of energy; 
worthlessness/excessive or inappropriate guilt; recurrent thoughts of 
death, suicidal thoughts, or actual suicide attempts; diminished ability 
to think/concentrate or indecisiveness; psychomotor agitation or 
retardation; insomnia/hypersomnia; and significant appetite and/or 
weight loss. 
 
The lifetime prevalence of depression is estimated to be 16% (Kessler, 
Berglund, et al., 2005) and single year prevalence is 4% (Kessler, Chiu, 
et al., 2005). Approximately 25% of individuals with two or more 
chronic health problems have depression compared to 3% of 
individuals who are physically healthy (Moussavi et al., 2007). 
Additionally, stressful life events and low socioeconomic status are 
associated with increased risk of depression (Monroe et al., 1999). 
Treatment for depression is sought by one in four women and one in 
ten men during their lifetimes (National Institute for Health and Care 
Excellence, 2015). However, the increased rates of depression in 
females versus males may be the result of differences in reporting 
(Kessler et al., 2003). 
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1.3.1 Theories of depression 
There are a number of theories for the onset and maintenance of 
depression. Indeed, within certain schools often more than one theory 
exists. For example, early psychodynamic theories of depression posit 
that depression is the result of intrapsychic conflict of conscious and 
subconscious (Freud, 1992). More recently, object relations theory 
posits that depression is caused by difficulties individuals have with the 
development of their representations of healthy relationships. 
Depression results due to a conflict that individuals endure when 
attempting to maintain contact with desired objects (Greenberg & 
Mitchell, 1983).  
Cognitive theorists posit that depression is the result of faulty thinking 
processes (Beck, 1963, 1964) and that thoughts, feelings, and 
behaviour are interrelated and influence each other bidirectionally 
(Center for Substance Abuse Treatment, 1999). Individuals’ emotions 
and behaviours are affected by cognitive factors including perceptions, 
attitudes, beliefs, cognitive schema (Kibler, 2011), and attributions 
(Clore & Huntsinger, 2007). The cognitive factors are used as a 
template to appraise events. Beck (1967) proposed that three 
mechanisms are responsible for the development of depression, the 
cognitive triad of negative automatic thoughts, errors in logic, and 
negative self-schemas. Within the mechanisms, individuals with 
depression hold negative views of themselves, the world, and the 
future (Beck, 1967) resulting in negative self-schemas. The negative 
self-schemas result in individuals misperceiving events as they process 
information from events in a distorted and negatively biased fashion. 
Individuals also ruminate on negative elements of their lives then the 
self-defeating interpretations of events maintain the cognitive triad 
(Beck, 1967). The development of the negative self-schemas can result 
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from a number of experiences such as rejection, loss, abuse, or 
criticism. However, the presence of the negative self-schema 
predisposes an individual to depression, but the cognitive triad and 
schema are activated only in the face of a stressful life event (Beck et 
al., 1979). 
Systemic theorists posit that psychological distress is the result of 
interpersonal relationships (Vetere & Dallos, 2003), therefore 
psychological distress does not result from an individual’s psychology, 
but, is the result of an intricate iterative process that is best understood 
as relationship dynamics at several levels (Vetere & Dallos, 2003).  
 
Systems theory underpins systemic approaches to psychological 
distress and provided a conceptual shift in the understanding of human 
behaviour; moving from linear to circular causation (Vetere & Dallos, 
2003). Circularity describes how feedback loops explain the 
maintenance of anxiety, stress, or distress within a system (Tomm, 
1987a, 1987b, 1988). Further, circularity describes how changes in 
symptoms effect the system (Gar & Hudson, 2009). Over half of people 
with depression experience problematic and stressful family 
functioning (Coyne et al., 2002) and access to social support is 
correlated with depression (Harandi et al., 2017). 
 
1.3.1.2 Behavioural theory  
  
Behaviourism is a psychological approach which uses scientific and 
objective methods for investigating phenomena (Watson, 1913). 
Behavioural theory posits that all behaviours are acquired through 
conditioning through a person’s interactions with their environment. 
Therefore, a person’s actions are influenced by their responses to 
environmental stimuli (Stout, 2003).  
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Traditionally, behaviourism was primarily concerned with observable 
behaviour, as opposed to internal events like thinking and emotion 
(methodological behaviourism associated with J Watson). However, 
radical behaviourism – most notably associated with B.F. Skinner – 
argues that internal events (thoughts) should be explained in the 
analysis of behaviour (Dawson et al., 2015). Behavioural analysis is 
concerned with conditioned behaviour. There are two major types of 
conditioning, classical and operant.  
 
Classical conditioning which is a theory of learning and describes the 
acquisition of a behaviour has been tested and demonstrated in 
laboratory settings (Pavlov, 1902). Within an individual’s environment 
certain environmental stimuli can produce a reflexive response (i.e., 
unconditioned stimulus results in an unconditioned response). The 
reflexive response can be elicited by pairing the unconditioned stimulus 
to a neutral stimulus (Gottlieb & Begej, 2014). Following repetition, it 
is possible to use the neutral stimulus to elicit the reflexive response 
in the absence of the unconditioned stimulus; through paired 
association. The paired association results in the unconditioned 
response becoming a conditioned response. 
  
Operant conditioning describes the maintenance of a behaviour. 
Specifically, that the frequency of a behaviour is controlled by its 
consequences (Skinner, 1953). Factors such as the prominence of the 
stimulus or the timing of the presentation effect the speed in which an 
association is made (Skinner, 1948). Skinner (1974) stated that 
psychology should be used as an experimental science that should aim 
to predict and control behaviour by exploring functional relationships 
that exist between control variables and behaviours. Skinner defined 
behaviour as anything that an individual does; including internal events 
such as thought (Skinner, 1974). Operant conditioning experiments 
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demonstrated that behaviour is influenced by both what happens 
before (classical conditioning) and what happens after an event.  
 
Skinner describes four consequences following an event that alter the 
frequency of a behaviour. The consequences fall in to two categories; 
reinforcement or punishment (Murphy & Lupfer, 2014).  
 
When the consequence of a behaviour increases its frequency, it is 
known as reinforcement, which can either be positive or negative. 
Positive reinforcement occurs when a rewarding stimulus is presented 
following a behaviour that increases the frequency of the behaviour 
(Murphy & Lupfer, 2014). Negative reinforcement occurs when a 
stimulus is not presented or removed following a behaviour that 
increases the frequency of the behaviour (Murphy & Lupfer, 2014). 
Positive and negative reinforcement occur naturally within the 
environment (Skinner, 1953) and the timing and pattern of 
reinforcement impacts both the speed of acquisition and the time it 
takes for a behaviour to become extinct, in the absence of 
reinforcement (Skinner, 1948).   
  
The second type of consequence, punishment, can also be positive or 
negative. Punishment occurs when a stimulus decreases a behaviour. 
A positive punishment is when the presence of a stimulus reduces 
behaviour and negative punishment occurs when the removal of a 
stimulus decreases behaviour (Murphy & Lupfer, 2014).  
 
Another factor that influences behaviour is the timing of reinforcement, 
known as schedules of reinforcement. Four types of schedules exist, 
continuous, intermittent, ratio (fixed and variable), and interval (fixed 
and variable; Ferster & Skinner, 1957). Continuous reinforcement is 
when a behaviour is reinforced every time it occurs. Intermittent 
reinforcement is when a behaviour is reinforced on some occasions and 
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not others; intermittent reinforcement can be at fixed-ratio (set after 
a specified number of occurrences) and variable-ratio (unpredictable 
pattern). 
 
Extinction (ending a behaviour) happens when the association between 
stimuli ends which causes the behaviour to weaken or stop. The rate 
of extinction is affected by the original response, for example, the 
longer a response has been conditioned the longer it can take for the 
behaviour to become extinct (Skinner, 1948). In depression, operant 
conditioning explains the maintenance of behaviour (including 
avoidance) as a result of maladaptive coping strategies. 
 
1.3.1.3 Behaviourism and depression 
 
Ferster (1973) theorised that the reduced levels of activity observed in 
individuals with depression was the result of a lack of reinforcement in 
those activities/behaviours. A number of factors can lead to the 
reduction in reinforcement, such as loss of a relationship or occupation 
which reduces social activity and results in the removal of positive 
reinforcement for both social behaviours and the behaviours that 
precede the activity, such as leaving the house or contacting friends. 
Individuals with MS experience a number of changes which may further 
impact opportunities for positive reinforcement such as reducing 
mobility and reduction in cognitive functioning that may exclude them 
from previously reinforcing activities. The loss of reinforcement can 
generalise to further behaviours, for example, by reducing social 
behaviours, a reduction in behaviours such as eating which has 
physiological reinforcers may occur. The behaviour can be affected due 
to the often intrinsically social aspect of eating. 
 
An association between the severity of depression and rate of positive 
reinforcement supports the idea that a reduction in positive 
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reinforcement can lead to worsening depression (Lewinsohn & Libet, 
1972). However, the study was unable to prove causality and it is 
feasible that the findings highlight what is known; depressed 
individuals engage in less activities than non-depressed individuals and 
reduce their contact with social activities.  
 
Once an individual’s behaviour has changed and they lose contact with 
their activities the person may develop a verbal preoccupation with 
their loss. The verbal preoccupation may present in the shape of crying, 
complaining to others, or expressing suicidal ideation. The verbal 
behaviour may be positively reinforced by individuals around the 
depressed person as the system offer sympathy, leading to an increase 
in the unhelpful behaviour (Azrin & Besalel, 1981). Over time, 
individuals experience reduced opportunity for reinforcement from 
helpful behaviours and experience increased opportunity for 
reinforcement of maladaptive behaviours. The maladaptive behaviours 
become the individual’s chief means of accessing reinforcement. 
 
Negative reinforcement occurs when individuals engage in avoidant 
behaviours because aversive emotions are removed. For example, 
avoiding a friend who tells them “just cheer up, it can’t be all that bad” 
or a critical friend who appears blaming means that the shame or guilt 
that an individual may experience is removed, therefore the avoidant 
behaviour is negatively reinforced and increases the likelihood of 
further avoidance (Lewinsohn, 1974). 
 
1.3.2 Depression and multiple sclerosis 
 
People who have neurological conditions can experience difficulties that 
can weaken or disable them for periods of time (NHS England, n.d). 
Specifically, people can experience problems with fatigue, memory, 
mobility, apathy, cognition, anxiety, and depression (National 
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Collaborating Centre for Mental Health & National Institute for Health 
Clinical Excellence, 2010; National Institute for Health and Care 
Excellence, 2009). People with a long-term and/or neurological 
condition are two to three times more likely to experience mental 
health problems, than those without a long-term and/or neurological 
condition, and there is an independent association between physical 
illness and emotional distress (Kings Fund, 2012). In individuals with 
neurological conditions depression is frequently underdiagnosed. For 
example, depression is underdiagnosed and undertreated in individuals 
with Parkinson’s disease (Quelhas & Costa, 2009), MS (Skokou et al., 
2012), Alzheimer’s disease (Starkstein & Mizrahi, 2006), and epilepsy 
(Trivedi & Kurian, 2007). The underdiagnosis in people with 
neurological conditions might be explained by difficulties in 
distinguishing between neurological and depressive symptoms, which 
may be further exacerbated by communication difficulties experienced 
by individuals with neurological impairment, which makes ordinary 
screening methods less effective (Rickards, 2006).  
  
As a result of diagnosis difficulties, the estimated prevalence of 
depression in specific neurological conditions vary greatly (Thielscher 
et al., 2013). For example, lifetime risk of depression in people with 
MS has been reported to be between 40-60% (Sadovnick et al., 1996), 
in Parkinson’s disease 7-76% (Veazey et al., 2005), in Alzheimer’s 30-
50% (Holtzer et al., 2005), in epilepsy 9-58% (Harden, 2002), and 33-
61% in brain injury (Jorge et al., 2004; Kim et al., 2007). It is possible 
that estimates vary so widely due to the wide range of psychometrics 
and variability in assessments, differences in diagnostic criteria, and 
the overlap with co-morbid symptoms of the condition itself such as 
fatigue (Boyle, 2007). In addition, the known presence or discovery of 
a chronic physical health problem can result in the physician’s attention 
being focused on the individual’s physical condition, leading to 
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depression being overlooked (Thompson et al., 2009; Tiemens et al., 
1999). 
 
Overlooking depression is problematic because depression is a 
common co-morbidity in people with MS. Psychological difficulties and 
psychosocial problems are highly prevalent in individuals with MS and 
can result from factors such as fatigue, physical disability, cognitive 
changes, pain, and difficulties with receiving support from others (Khan 
et al., 2007). Indeed, prevalence rates of depression in people with MS 
are higher than in that of other conditions and the general public 
(Galeazzi et al., 2005; Patten et al., 2003). Further complications 
associated with depression in MS include breakdown in employment, 
medication adherence, increased risk of self-harm, and suicide and 
depression (Hind et al., 2014).  
 
When considering the aetiologies of depression described above and 
the physiological experience of those with MS, additional theories 
warrant consideration in individuals with MS. Depression may be a 
result of MS specific immune dysregulation, iatrogenic effects of MS 
medication, or neurological damage (Mohr & Cox, 2001). It has been 
hypothesised that depression may be an effect independent of the 
disease but may be maintained by the MS (Galeazzi et al., 2005). 
Further, additional factors such as prolonged periods of uncertainty, 
loss of social support, and reduction in daily functioning contribute to 
the ongoing maintenance of depression (Barnwell & Kavanagh, 1997; 
Mullins et al., 2001).  
 
One difficulty in the study of MS and depression is the presence of 
mutual symptoms. For example, fatigue is a symptom of both MS and 
depression which makes it difficult for researchers to attribute the 
presence or on-going presence of a symptom to either MS or 
depression (Thomas et al., 2006).  
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1.3.3 The maintenance and impact of co-morbidity 
 
Depression may be maintained in individuals with MS due to a 
reduction in an individual’s social and leisure activities (Hakim et al., 
2000; Motl et al., 2009). It is important that depression is recognised 
and treated in individuals with MS because the presence of depression 
is associated with poorer self-management of the individual’s 
condition, which reduces quality of life (Katon, 2003). Further, when 
people experience depression in addition to their neurological 
condition, co-morbidity has an adverse effect on an individual’s 
frequency of hospital admissions, duration of hospital stays, 
engagement in treatment, and treatment outcomes (Price et al., 
2011). Co-morbid mental health problems and neurological conditions 
are also associated with increased mortality rates (Kings Fund, 2012). 
The resulting difficulties that individuals experience with self-
management (i.e., medication and appointment adherence) and the 
on-going presence of depression, also has a huge impact on the costs 
that healthcare services have to bear (Kings Fund, 2012).  
 
1.3.4 Impact of depression in people with multiple sclerosis 
 
In 2015, the UK per-subject cost per year for people with MS was 
categorised as severe by the Expanded Disability Status Scale at 
around £40,000 (Kobelt et al., 2017). The costs include direct 
healthcare, disease modifying treatment, services, informal care, and 
production losses, however, individual breakdowns for mental health 
costs are not provided. There is debate amongst researchers about the 
relationship between functional disability and depression, with some 
studies reporting a relationship between depression and greater 
disability and others claiming depressive episodes are independent of 
symptom severity (Chwastiak et al., 2002; Millefiorini et al., 1992).  
   
         Page 111 of 362 
 
People with MS reduce their social and leisure time activities following 
a diagnosis of MS (Hakim et al., 2000), which is unfortunate because 
these activities are known to improve mood (Motl et al., 2009). 
Reduction in activities may be because of mood problems, or other 
disabilities caused by MS, but there is a cyclical effect: low mood to 
fewer activities to low mood. People with MS are unable to engage in 
activities they previously did and may struggle to find new activities to 
replace them (Motl et al., 2009). Whether the cause of reduced 
pleasurable activity results from fatigue and disability, or mood-related 
loss of interest, the lack of activity can theoretically contribute to the 
development, maintenance, and exacerbation of low mood (through 
loss of contact with contingencies that were previously reinforcing and 
mood-enhancing). 
 
People with MS also experience cognitive dysfunction which affects 
between 40-70% of people with MS (Benedict et al., 2006; Strober et 
al., 2014). Cognitive dysfunction may be exacerbated by depression as 
depression can cause significant changes in behaviour which can 
influence the indices of cognitive reserve. Therefore, successfully 
treating depression may lead to a more active lifestyle thereby off-
setting in part the cognitive burden of disease. 
 
When considering the increased cost to services, impact on patient 
outcomes, and decreased quality of life it is important to understand 
the most appropriate treatment for depression.  
 
1.4 Psychological interventions in people with neurological 
conditions 
 
When depression is present with reduced or declining physical abilities 
(common in many neurological conditions), individuals find it difficult 
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to identify with and engage in activities that have pleasurable or 
reinforcing consequences (Kanter et al., 2006). 
 
In the UK, National Institute of Health and Clinical Excellence 
recommends the use of cognitive behavioural therapy (CBT) for 
treating depression in individuals with chronic physical health problems 
(including neurological conditions; National Collaborating Centre for 
Mental Health & National Institute for Health Clinical Excellence, 2010).  
CBT is a short-term, often time-limited, psychotherapy aimed at 
problem solving by reappraising negative thinking that is impacting on 
emotions and behaviours (Beck, 1964). However, CBT is not best 
suited for people with chronic health difficulties (Hind et al., 2010), 
because many have cognitive difficulties that may make accessing and 
engaging with CBT difficult (Hind et al., 2014). Therefore, adapting 
psychological therapies to better consider the interaction of co-morbid 
psychological and physical conditions may be more acceptable to 
people with neurological/physical health conditions (Cully et al., 2009).  
 
Due to the nature of the condition (MS) accessing face-to-face therapy 
can be difficult and expensive (Fletcher et al., 2006; National Institute 
for Health and Care Excellence, 2006) which has led to studies 
investigating the effectiveness of CBT using technology-based formats 
(Hind et al., 2010); following National Institute for Health and Care 
Excellence (NICE) recommendations for computerised CBT or 
telephone interventions for mild to moderate depression. In MS the 
presence of chronic physical illness can make psychological 
interventions difficult, but not without success (Cooper et al., 2011; 
Mohr et al., 2000).  
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1.4.1 Psychological interventions in people with multiple 
sclerosis 
 
The NICE guidance for the treatment of depression for people with MS 
refers clinicians to the NICE guideline on depression in adults with a 
chronic physical health problem (National Institute for Health and Care 
Excellence, 2014). Whilst the MS guidance does not recommend 
specific interventions it highlights the need for, and potential benefits 
of, providing emotional support (National Institute for Health and Care 
Excellence, 2014).  
 
To improve accessibility to help individuals access the potential 
benefits of emotional support, CBT should be adapted to consider 
frequency and length, duration of sessions, and to incorporate physical 
health care with mental health care (National Collaborating Centre for 
Mental Health & National Institute for Health Clinical Excellence, 2010).  
 
CBT has been shown to improve depression in individuals with chronic 
physical health problems. Effect sizes favour CBT over standard care, 
with small-to-moderate effects observed when CBT is delivered as an 
individual intervention (.20-.55) and moderate effects when delivered 
as a group intervention (.58; Farrand & Woodford, 2015; Rizzo et al., 
2011; van Straten et al., 2010). One purported reason for the small to 
medium effect sizes is that standardised CBT interventions are not best 
suited for people with chronic health difficulties (Hind et al., 2010). In 
addition, many individuals with neurological conditions have cognitive 
difficulties which may make accessing and engaging in CBT and the 
materials difficult (Hind et al., 2014). Indeed, when individuals have 
difficulty engaging in materials rates of attrition are increased 
(Fitzpatrick et al., 2010). Therefore, adapting psychological therapies 
to better consider the interaction of co-morbid psychological and 
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physical conditions may be more acceptable to people with 
neurological/chronic physical ill health conditions (Cully et al., 2009). 
As a result, there may be opportunity for an evaluation of effective 
psychological treatments for depression in people with neurological 
conditions. 
 
As secondary progressive MS is a progressive disease and an 
individual’s disability worsens over time understanding the 
effectiveness of interventions at various disease stages is important; 
as, favourable approaches may only be helpful for individuals with 
minor disability issues. A review of psychological interventions for 
people with MS organised the findings in to four sub-groups: people 
with cognitive impairments, people with moderate to severe disability, 
people with MS (no other criteria), and people with depression (Thomas 
et al., 2006). The authors of the review found 16 psychological 
intervention studies for people with MS on outcomes for depression, 
anxiety, disability, cognitive functioning, self-esteem, and self-efficacy. 
The evidence suggested the use of CBT showed improvements for 
people with depression (Thomas et al., 2006). However, the studies in 
the review had small sample sizes increasing the risk of a type 2 error. 
Further, the review found only three trials for participants (n=80) with 
moderate to severe disability and only one trial reported favourable 
outcomes for psychotherapy for depression.  
 
An alternative approach to CBT may be behavioural activation. NICE 
recommended that behavioural activation be compared with 
antidepressant medication for treating depression for people who have 
chronic physical illness, to investigate the clinical and cost 
effectiveness of behavioural activation (National Collaborating Centre 
for Mental Health & National Institute for Health Clinical Excellence, 
2010). The importance of future research in this area is a result of 
limited existing evidence for the effectiveness of high-intensity 
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psychological interventions, in this population, to treat moderate to 
severe depression. Currently, the most substantial evidence base for 
the treatment of depression in this population is CBT, however there 
have been recent studies that suggest behavioural activation may be 
effective (National Collaborating Centre for Mental Health & National 
Institute for Health Clinical Excellence, 2010). 
 
1.5 Telephone based interventions 
 
Due to the costs of psychotherapy, lack of services for individuals who 
live in rural areas, and the complications that physical difficulties or 
fatigue can create for individuals travelling to appointments, modalities 
other than face-to-face warrant investigation. Telephone can be used 
for a number of health care activities, including diagnosis, emotional 
support, medication and symptom management, and physical and 
mental health interventions. Telephone-psychotherapy allows an 
individual to access psychological therapies from their own homes and 
reduces travel costs incurred by some community-based therapists.  
 
Telephone-psychotherapy works in the same way as face-to-face 
therapy; however, telephone-psychotherapy may have lower attrition 
rates than face-to-face therapy (Mohr et al., 2008). Individuals are 
often satisfied and accepting of telephone-psychotherapy (Bee et al., 
2008), however, clinical experience tells us that some individuals 
dislike telephone-psychotherapy due to not being able to see who they 
are talking to; making it difficult to engage emotionally. Despite the 
differing user experience of telephone-psychotherapy several reviews 
have indicated the potential effectiveness of telephone-psychotherapy 
in individuals with a range of physical and mental health difficulties 
(Hailey et al., 2011; Leach & Christensen, 2006), including those who 
have had a stroke (Johansson & Wild, 2011).  
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In a systematic review and meta-analysis of telephone psychotherapy 
for people with MS positive treatment effects were found for outcomes 
of depression, physical activity, quality of life, fatigue, MS symptoms, 
and medication adherence (Proctor et al., 2018). The authors of the 
review identified 11 randomised-controlled trials, with 1104 
participants, assessing the effectiveness of telephone-psychotherapy 
for people with MS compared to no care, treatment as usual, and other 
controls. Ten studies were included in the meta-analysis and a 
moderate effect size was found for depression favouring the 
intervention (SMD = 0.47, 95% CI 0.21- 0.73). However, the studies 
included in the review were of poor methodological quality. The 
included studies were predominantly CBT and whilst immediate post-
intervention benefits were observed they were not sustained in the 
long-term. 
 
In addition to telephone-psychotherapy a number of computerised CBT 
interventions have been investigated. In a recent narrative review 
(Ratajska et al., 2019), authors conclude that despite difficulties in 
recruitment and high dropouts, in interventions without human 
support, (Richards & Richardson, 2012) that computerised 
interventions have the potential to benefit patients. However, the 
review has a number of methodological issues, such as not outlining a 
search strategy or assessing included studies’ quality meaning that an 
assessment of effectiveness should be made with caution.  
 
Like much of the research published on interventions for people with 
MS there is a sparsity of investigations into the effects of telephone-
psychotherapy for people with secondary progressive MS.  
 
1.5.1 Mechanisms of change in internet/telephone therapies 
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Approaches used in telephone-psychotherapy are thought to engender 
change in the same way that face-to-face psychotherapy. Telephone-
psychotherapy uses psychoeducation, techniques specific to the 
therapy modality, and therapeutic rapport (Wampold & Imel, 2015). 
Strong therapeutic rapport has been found to improve outcomes in 
telephone-psychotherapy for people with MS (Beckner et al., 2007) 
however the study design was unable to demonstrate mechanisms of 
change.  
 
1.5.2 Face-to-face vs technology-based communication therapy 
 
When compared to face-to-face interventions, telephone-
psychotherapy interventions are equally comparable (Brenes et al., 
2011). Telephone-psychotherapy appears to offer increased 
opportunity to access therapy as attrition is lower in telephone-
psychotherapy than face-to-face interventions in individuals with 
depression (Mohr et al., 2008). 
 
1.5.3 Rationale for telephone internet-calling in multiple 
sclerosis 
 
The application of telephone-psychotherapy and mechanisms for 
change utilises similar methods to face-to-face interventions. There is 
growing evidence for the effectiveness of telephone-based approaches; 
despite methodological issues which affected the quality of the studies 
included in reviews. In a recent meta-analysis investigating the 
effectiveness of telephone-psychotherapy in people with MS small to 
moderate effects were identified (Proctor et al., 2018) but higher 
quality studies were needed. Telephone-psychotherapy offers a 
practical solution to overcoming physical difficulties that people with 
secondary progressive MS experience. For individuals who are unable 
to travel to appointments due to their symptoms such as fatigue, 
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telephone-psychotherapy supports individuals to continue to access 
support when most needed.    
 
1.5.4 Guided self-help 
Guided self-help is a NICE recommended treatment for depression and 
anxiety. Guided self-help is usually short-term, supported with 
materials, and delivered by individuals with training in delivering 
psychotherapies. The aim of guided self-help is to support an individual 
to make changes to make positive changes to mood. The approach 
encourages individuals to develop a collection of resources in order to 
enable them to be their own ‘therapist’ in the future. The approach 
aims to improve an individual’s sense of agency, as individuals are able 
to make their own changes, thus, encouraging them to draw on the 
resources they acquired in any future occurrences of psychological 
difficulties.  
In the general population the evidence for the effectiveness of self-help 
versus face-to-face interventions is varied. For example, no significant 
difference was found between face-to-face and self-help interventions 
for depression or anxiety (Cuijpers et al., 2010). Whilst the findings 
were not significant a small effect size was identified favouring guided 
self-help. Contrastingly, in a review investigating the efficacy and 
acceptability of self-help interventions for anxiety, face-to-face 
interventions were more effective than telephone-psychotherapy. 
However, the review did highlight a significant effect size (.84) in 
favour of self-help versus wait list controls. The review also highlighted 
a significant effect size for the use of supported self-help versus no 
guidance (.34), indicating that the addition of someone to give 
guidance or web-based interventions improved treatment outcomes.  
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1.5.4.1 Guided self-help in multiple sclerosis 
 
Guided self-help interventions have been researched in individuals with 
MS and findings have demonstrated the effectiveness of the approach. 
For example, when compared to usual care, an eight-week, guided, 
telephone CBT intervention showed a reduction in pre- and post-
intervention scores for depression (F(1, 21) = 15.37, p < .001; Mohr 
et al., 2000). There were only 32 participants in the intervention group 
so further higher-powered research is required, however, the findings 
indicate the potential utility of combining telephone-psychotherapy, 
guided by clinicians and making use of homework tasks and materials. 
Mohr et al. (2000) also indicate that the utilisation of telephone-
psychotherapy is a more beneficial approach than face-to-face 
interventions for individuals who have difficulties to attend regular 
appointments due to symptoms that result from their condition such 
as fatigue.  
 
More recently, a randomised-controlled trial using cognitive-
behavioural telephone-psychotherapy for people with MS compared 
intervention group to an educational control group (Ehde et al., 2015). 
The educational control group consisted of symptom education and 
management. The control intervention was developed to account for 
therapeutic rapport, participating in a manualised intervention, and 
treatment dosing. The research showed that all participants 
significantly improved on depression, pain, and fatigue measures from 
pre- to post-intervention. The researchers had hypothesised that there 
would be a significant difference between the two groups, however, 
none was found. However, individuals in the cognitive-behavioural 
telephone-psychotherapy group had significantly higher levels of 
treatment satisfaction, mood, social roles, and activation which were 
maintained at long-term follow up. 
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In a recent review of the effectiveness of self-management 
interventions in individuals with MS for depression, anxiety, and quality 
of life, three of five studies reported reduction in depression (Kidd et 
al., 2017). However, only one of the three studies reported a significant 
difference to a control group. The Ehde et al. (2015) study was also 
included in the review and showed significant improvements in 
depression at six- and twelve-months post-intervention.  
 
1.5.4.2 Rationale for guided self-help  
 
The MS Society have a top ten list of research priorities. The list is the 
result of consultation with people with MS, their families, and 
healthcare professionals. Listed in their priorities is research on “How 
can people with MS be best supported to self-manage their condition?” 
(MS Society, 2018b). Guided self-help would allow people with MS to 
use self-management for their condition. Additionally, research on the 
effectiveness of interventions for self-management of the condition 
contributes to the MS Society’s research priorities.  
 
NICE (2017), recommend self-help interventions as a first line 
intervention. Using guided self-help makes access to treatment largely 
accessible to a large number of individuals with potentially small costs 
to the NHS. Indeed, research on guided self-help for people with 
psychological distress has promising indications despite some 
limitations in the quality of assessed studies. Unfortunately, the 
acceptability of self-help interventions by individuals is unclear. In a 
systematic review where 31 studies were identified none of the studies 
assessed individual’s acceptability of self-help interventions (Lewis et 
al., 2012). However, when individuals engage, the effectiveness for the 
treatment of depression and attrition rates are comparable to face-to-
face interventions (Cuijpers et al., 2010). 
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1.6 Behavioural activation 
 
Behavioural activation is a type of psychological therapy that 
encourages individuals with depression to engage in activities they 
have been avoiding in which individuals define goals and activity 
schedules (Veale, 2008).  
 
Behavioural activation is a structured psychotherapeutic approach 
which aims to (a) increase engagement in activities associated with 
pleasure or mastery, (b) decrease engagement in activities that 
maintain depression, and (c) problem solve barriers limiting access to 
reward or maintain aversive control (Dimidjian et al., 2011). 
Behavioural activation is a relatively simple, easy to understand, 
intervention that does not require a highly trained therapist or complex 
skills from the patient (Lejuez et al., 2011), and may be suitable for 
individuals with cognitive and physical difficulties. Behavioural 
activation is based on the behavioural model of depression (Lewinsohn 
& Shaffer, 1971). Specifically, that depression is a result of reduced 
positive reinforcement, particularly in social relationships. Social 
relationships are considered important by Lewinsohn and Shaffer 
(1971) in preventing and overcoming depression. Behavioural 
activation aims to reduce depressive symptoms by implementing a 
schedule of positive reinforcement by altering an individual’s behaviour 
and/or their environment. As, in certain environmental contexts, 
behaviours that reduce depression will continue to occur through 
reinforcement and those that increase depression will decrease over 
time (Roane et al., 2016).  
 
The origin of behavioural activation can be seen in Lewinsohn and 
Libet’s (1972) seminal paper on pleasant events scheduling, several 
treatments developed in the 1970s (Kanter, Manos, et al., 2010), and 
its use as a component of cognitive therapy (Beck et al., 1979). 
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Lewinsohn et al. (1976) developed an intervention manual based on a 
collection of earlier intervention studies. The manual outlines that 
individuals should engage in activity scheduling to overcome deficits in 
environmental positive reinforcement and social skills to overcome 
behavioural deficits in acquiring and maintaining reinforcement. A 
number of interventions were evaluated based on Lewinsohn et al.’s 
(1976) manual. At the same time, alternative models were being 
developed based on varying behavioural models. For example, one 
approach emphasised training in behavioural, interpersonal, and 
cognitive skills (McLean, 1976). One approach used self-control 
therapy which utilised Lewinsohn’s interventions and included 
techniques from Kanfer’s (1970) behavioural model of self-control such 
as cognitive techniques (Rehm, 1977). Despite empirical support 
building throughout the 1970s, the utilisation of behavioural 
approaches declined in the late 1970s and early 1980s (Kanter, Manos, 
et al., 2010). The changes were in part the result of a study that 
indicated that cognitive therapy was superior to behavioural 
interventions (Shaw, 1977) and a second study that completed a 
component analysis that showed no difference in the effectiveness of 
activity scheduling, cognitive techniques, or skills training (Zeiss et al., 
1979). Following the studies, Lewinsohn began integrating cognitive 
and behavioural techniques (Lewinsohn et al., 1986) and the 
integration of cognitive and behavioural approaches gained momentum 
which led to CBT being the most researched form of psychotherapy 
(David et al., 2018).  
 
A later component analysis of cognitive therapy also found no 
difference in the effectiveness between cognitive and behavioural 
approaches (Jacobson et al., 1996). The design of the study meant 
that cognitive techniques were added to behavioural techniques which 
led to the conclusion that adding cognitive techniques did not improve 
outcomes. Further, Jacobson concluded that based on the equal 
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efficacy but improved efficiency and ease of training that behavioural 
activation techniques were superior to cognitive techniques.  
 
1.6.1 Theoretical underpinnings of behavioural activation  
 
Ferster (1973) posited that depression is characterised by an increase 
in certain behaviours and a decrease in other types. Ferster stated that 
an increase in escape and avoidance behaviours of depressed 
individuals meant that people receive fewer rewards from their 
activities. The decrease in reward is the result of individuals not 
engaging in productive activities often enough, which reduces the 
effectiveness of the reinforcement of those activities. Further, 
depressed individuals engage in behaviours to escape aversive feelings 
which prevented positively reinforced behaviour. Avoiding aversive 
feelings results in depressed individuals’ behaviour being negatively 
reinforced rather than positively reinforced. Specifically, behaviour 
serves to reduce aversive states instead of allowing an individual to 
engage in their environment where behaviour is naturally rewarded 
and positively reinforced.  
 
Lewinsohn (1974) used behavioural theory to posit that depression is 
a function of low rates of response-contingent positive reinforcement 
and inadequate social skill. Behavioural activation manuals aim to 
decrease behaviours that sustain or exacerbate depression by 
promoting counteracting behaviours (Martell et al., 2001). Behaviours 
are counteracted by using techniques such as activity monitoring and 
scheduling (Jacobson et al., 1996), which address environmental 
deficits in positive reinforcement and difficulties in acquiring and 
maintaining reinforcement (Kanter, Santiago-Rivera, et al., 2010).  
 
Response-contingent is defined as “reinforcement that is dependent on 
an individual’s actions” (Martell et al., 2010, p.7). For example, if a 
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person attempts to speak to a friend to arrange to meet and the friend 
ignores the attempt (i.e., does not provide response-contingent 
reinforcement) or rebukes the invite as “clingy” (i.e., punishes), 
eventually the individual will cease attempts to converse and they will 
feel sad about the friendship. Over time conversation behaviours may 
extinguish, reducing positive reinforcement and behaviours that 
typically result in reward which can maintain depression.  
 
Reduced rates of response-contingent positive reinforcement not only 
occur in upsetting or negative events. Lewinsohn (1974) explained that 
events such as job promotions can lead to a loss of social reinforcement 
because individuals can lose peers in the transition to management.  
 
As described earlier, operant conditioning describes the maintenance 
of depression. The efficacy of behavioural activation supports the 
operant conditioning account of depression (Veale, 2008). As, 
behavioural activation interventions promote engagement in avoided 
activities and a functional analysis of avoidance-based cognitive 
processes. By raising an individual’s level of activity whilst 
simultaneously reducing avoidant behaviours there is increased 
opportunity for environmental reinforcement and a greater 
engagement in a range of behaviours.  
 
As highlighted, when compared to cognitive interventions, behavioural 
activation was found to be as effective which provides support that the 
behavioural theory of depression is comprehensive enough to inform 
the development of treatments (Ekers et al., 2011). Yet many 
approaches include a functional analysis of the cognitive factors that 
maintain avoidant behaviour (Veale, 2008), meaning that using 
behavioural accounts in isolation may be reductionist.  
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Indeed, whilst depressed cognitions are considered to be behaviours 
associated with dysphoria due to a lack of response-contingent 
reinforcement, operant conditioning fails to account for individuals 
without depression experiencing similar thoughts as those reported by 
individuals with depression. Contrastingly, cognitive theorists posit 
that cognitions have a causal role in depression and are not merely a 
product of depression (Beck, 1967; Beck et al., 1979). 
 
Whilst it has been argued that behavioural theory fails to account for 
common group factors of depression, behavioural activation was 
developed to be a flexible intervention that is tailored to the individual 
receiving treatment. The behavioural activation model is not intended 
to assume that specific classes of behaviours are reinforcing for an 
individual. Instead, behavioural activation uses functional analysis to 
increase behaviours with the highest potential for an individual to 
interact with their environment that provides positively reinforcing 
antidepressant behaviour (Martell et al., 2010). 
  
1.6.2 Behavioural activation components  
 
Kanter, Manos, et al. (2010) reviewed three meta-analyses to identify 
the component techniques used in behavioural activation studies. Of 
the 32 identified trials six behavioural activation manuals were 
frequently referenced (Beck et al., 1979; Gallagher et al., 1981; Lejuez 
et al., 2001; Martell et al., 2001; McLean, 1976; Rehm, 1977). The six 
manuals and the earlier manual, Lewinsohn et al. (1976), shared 
several components. All seven manuals include activity monitoring, 
and activity scheduling; five manuals include skills training, 
contingency management, and procedures targeting verbal behaviour; 
three manuals include values and goals assessment; two manuals 
include relaxation; and one manual includes procedures targeting 
avoidance. In addition to these eight overarching categories of 
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behavioural activation interventions, a variety of ancillary techniques 
were also identified. The ancillary techniques include procedures 
considered common to all psychotherapies such as developing 
therapeutic rapport and a treatment rationale (Kanter, Manos, et al., 
2010). Additional techniques included homework, setting agendas, and 
relapse prevention.  
 
1.6.2.1 Activity monitoring 
 
Activity monitoring is used to provide baseline information of an 
individual’s activity levels and mood to inform future activation 
assignments. Activity monitoring is also used to support the rationale 
of behavioural activation to clients by demonstrating a relationship 
between activity levels and mood. An activity chart can be used to 
identify an individual’s current behaviours that they enjoy and 
unhelpful behaviours. Further, activity charts can be used to highlight 
avoidance behaviours, experiences of mastery and pleasure, restriction 
of activity, and consistency with values (Martell et al., 2001). Activity 
charts are used to reduce and replace activities that maintain an 
individual’s low mood (Dimidjian et al., 2011; Dimidjian et al., 2006).   
 
Initially, activity monitoring was not envisioned as an intervention to 
change behaviour itself, instead, it was conceptualised as a necessary 
precursor to change. However, it is reported that the process of activity 
monitoring positively impacts outcomes as a standalone intervention 
and has reduced smoking behaviour (McFall, 1970), ruminating 
(Frederiksen, 1975), and binge eating (Latner & Wilson, 2002). Yet, 
combining activity scheduling with activity monitoring is more effective 
than monitoring alone (Graf, 1977). 
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1.6.2.2 Values and goals assessment 
 
Many psychotherapies begin with an assessment of an individual’s 
goals for therapy. Some variants of behavioural activation also include 
an assessment of goals and values to inform activation assignments. 
For example, Lejuez et al. (2001) assess an individual’s values in a 
simplified form of Acceptance and Commitment Therapy (Hayes et al., 
1999) and the values are used to develop specific goals for activation.  
 
Some argue that values are an issue of cognition and not behaviour 
(Kanter, Manos, et al., 2010), however, behavioural theory views 
values functionally as reinforcers. Specifically, that the process of 
identifying and verbalising values orientates an individual toward 
ideographical defined positive reinforcers (Bonow & Follette, 2009). For 
example, the value of “being a good husband” is not a specific 
behaviour, however, it suggests a number of behaviours that can be 
associated with “being a good husband” which could be reinforcing if 
engaged in. Further, it is possible that the process of stating a value 
may serve as a reinforcing consequence for value associated 
behaviour. For example, saying “I am a good husband” may solidify 
certain behaviours as reinforcing as they are verbally evaluated to be 
consistent with being a good husband, even in the absence of 
environmental support for the behaviour (Kanter, Manos, et al., 2010). 
The use of values may motivate and sustain behaviour when 
environmental reinforcers are not expected to be immediately present 
(Kanter et al., 2009). Using values-based interventions may be 
beneficial in circumstances where activation behaviours result in 
immediate aversive states that could result in future avoidance in the 
absence of immediate reinforcement (Plumb et al., 2009). Therefore, 
if values are strongly held by an individual, as verbally-derived 
reinforcement, the value may maintain behaviour in the face of 
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competing, aversive consequences that would extinguish behaviour 
(Kanter et al., 2009). In individuals with secondary progressive MS 
values also provide an opportunity to continue to access environmental 
reinforcement when increasing physical disability may remove the 
opportunity for engagement with activation events.  
 
1.6.2.3 Activity scheduling 
 
The purpose of activity scheduling is for an individual to increase 
contact with environmental positive reinforcement. Individuals and 
their clinician usually collaborate to set homework tasks to engage in 
activities to increase contact with positively reinforcing behaviours. 
Early interventions focused on pleasant events scheduling. More 
recently, the scheduling of activities has moved to encouraging 
individuals to focus on pleasure and mastery ratings of completed 
activities (Beck et al., 1979). Many approaches also grade task 
assignment; using hierarchy to engage in activities that individuals feel 
most able to expose themselves to, based on their mood and perceived 
resources. Activity scheduling is used as stimulus control to produce 
prompts in the environment to improve behaviour or remove 
problematic behaviour. 
 
1.6.2.4 Skills training 
 
Skills training is a label for a collection of interventions including social 
skills such as assertiveness, communication, or interpersonal skills, 
and non-social skills such as problem solving (Kanter, Manos, et al., 
2010). Skills training has been used when individuals do not know how 
to engage in effective behaviour that results in environmental 
reinforcement. It was thought that depressed individuals may lack the 
social skills to engage in activities, which ultimately may mean that 
scheduling activities will fail because the individual is not able to obtain 
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or maintain contact with reinforcing behaviours (Kanter, Manos, et al., 
2010). Techniques such as role plays, and modelling are employed in 
an attempt to develop skills within the therapy room and then test the 
acquired learning as part of the homework task in the individual’s 




Relaxation techniques have been integrated into some behavioural 
activation treatment manuals. Relaxation techniques have been used 
to target sleep difficulties and to enhance the experience of enjoyable 
activities (Kanter, Manos, et al., 2010). It has been suggested that the 
use of relaxation techniques is beneficial for the treatment of 
depression due to the overlapping symptoms between depression and 
anxiety (Morgan & Jorm, 2008). 
 
1.6.2.6 Contingency management 
 
Contingency management aims to address situations where efforts 
toward engaging in helpful behaviour is punished or not rewarded by 
the environment, or, when unhelpful behaviours are maintained by 
positive or negative environmental reinforcement (Kanter, Manos, et 
al., 2010). Contingency management is used when immediate 
environmental reinforcement is not available. Contingency 
management is used by using self-reinforcement on targeted positive 
behaviours. The aim is that by taking control of reinforcement and 
rewarding at close temporal proximity to the target behaviour that the 
intended behaviour will increase (Petry, 2011).  
 
1.6.2.7 Procedures targeting verbal behaviour 
 
Despite the critique made by many that behavioural interventions fail 
to address cognitive mediators of depression and that cognitive content 
is not addressed, a number of behavioural interventions specifically 
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target verbal behaviour. For example, Lewinsohn (1974) addressed 
negative cognitive content by discussion and other behavioural 
activation interventions target covert verbal behaviour. Behavioural 
interventions differ from cognitive approaches as they do not aim to 
restructure cognitions, but, focus on the frequency. By focusing on the 
frequency individuals aim to decrease the frequency of negative covert 
verbal behaviours and increase the frequency of positive covert verbal 
behaviours (Kanter, Manos, et al., 2010). Early interventions used 
thought suppression, rehearsing positive thoughts, and substituting 
negative thoughts with positive thoughts (McLean, 1976). More 
recently, behaviourists have begun to view thoughts contextually and 
consider thought suppression or replacement as futile (Kanter, Manos, 
et al., 2010). Rather than reducing the frequency of negative verbal 
behaviour a functional approach is used to explore the context in which 
negative thought behaviour occurs and the consequences that 
maintain the behaviour (Martell et al., 2001).  
 
1.6.2.8 Procedures targeting avoidance 
 
Only one of the behavioural activation manuals uses procedures to 
target avoidance (Martell et al., 2001). The process was developed 
using the behavioural theory of depression and the behavioural theory 
of anxiety. Behavioural techniques for the treatment of depression 
focused on deficits in positive reinforcement, whereas, the behavioural 
theory of anxiety focused on excessive negative reinforcement. Yet, it 
was posited that they were interrelated (Ferster, 1973) and techniques 
were developed to support individuals to identify avoidant behaviour 
and activate target behaviours in the face of competing avoidance 
tendencies (Martell et al., 2001). 
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1.6.3 Research on behavioural activation 
 
Over the years a number of meta-analyses have been conducted and 
demonstrated the efficacy of behavioural activation (Cuijpers et al., 
2007; Ekers et al., 2008; Mazzucchelli et al., 2009). In the Ekers et al. 
(2008) meta-analysis 17 randomised-controlled trials with 1109 
participants were identified. Post-treatment depression scores were 
superior to controls (standardised mean difference [SMD] -0.70, 95% 
CI -1.00 to 0.39), brief psychotherapy (SMD -0.56, 95% CI -1.0 to -
0.12), supportive therapy (SMD -0.75, 95% CI -1.37 to -0.14), and 
equal to CBT (SMD 0.08, 95% CI -0.14 to 0.30). The Mazzucchelli et 
al. (2009) meta-analysis identified 34 randomised-controlled trials with 
2055 participants. The pooled effect size for post-treatment depression 
when compared to controls was significant with an effect size of 0.78 
(95% CI 0.58 to 0.97) favouring intervention; using 16 studies and 
453 participants. Again, no significant difference was found between 
behavioural activation and cognitive therapy.   
 
Behavioural activation was evaluated against the standards for the 
promotion and dissemination of psychological procedures, the authors 
concluded that behavioural activation should be designated a well-
established and empirically validated treatment (Mazzucchelli et al., 
2009; Task Force on Promotion and Dissemination of Psychological 
Procedures, 1995). 
 
In non-neurological populations, the behavioural activation component 
of CBT is as effective alone, compared to when used in combination 
with cognitive aspects (Jacobson et al., 1996) – and has been found to 
be as effective as antidepressant medication (Dimidjian et al., 2006). 
Both behavioural activation and antidepressant medication were 
significantly more effective than cognitive therapy (Dimidjian et al., 
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2006). This demonstrates the potential use of behavioural activation 
as a parsimonious intervention. Comparable therapies are important 
as engagement in CBT may be difficult for people with neurological 
conditions because they can experience fatigue and cognitive 
difficulties (Motl et al., 2009), which may limit their effectiveness. 
Behavioural activation may represent a less burdensome intervention 
versus CBT. 
 
A meta-analysis of activity scheduling (a type of behavioural 
activation) interventions for the treatment of depression found a 
pooled effect size of 0.87, favouring activity scheduling over waitlist or 
placebo controls or alternative psychological therapies (95% CI: 
0.60~1.15) and heterogeneity was low (Cuijpers et al., 2007). The 
authors conclude that future research using behavioural activation in 
difficult populations is needed. Specifically, when considering the 
advantages of activity scheduling: a simple, easy to understand 
treatment, which does not require complex skills from therapists, it 
would be beneficial to examine if activity scheduling can be applied in 
difficult populations which cannot be treated with complex 
interventions. Also, whether activity scheduling could replace more 
complex psychological interventions, which require greater intellectual 
capabilities from patients (Cuijpers et al., 2007). 
 
In an updated meta-analysis of the effectiveness of behavioural 
activation for depression by Ekers et al. (2014) 26 randomised-
controlled trials, with 1524 participants, showed behavioural activation 
was superior to controls for post-treatment scores on depression (SMD 
−0.74 CI −0.91 to −0.56) and medication (SMD −0.42 CI −0.83 to -
0.00). Study quality was low in most of the studies and the authors 
reported that follow-up periods were short.  
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Behavioural activation is also considered cost-effective (Richards et al., 
2016). In individuals without neurological conditions behavioural 
activation was delivered by junior mental health workers, who received 
less costly or intensive training than psychologists, with effectiveness 
as equal as CBT (Richards et al., 2016). Behavioural activation 
represents a parsimonious alternative to CBT which may increase 
individual’s self-efficacy, reduce functional disability, and increase self-
management reducing overall costs. 
 
1.6.4 Behavioural activation and multiple sclerosis 
There are no published trials for the use of behavioural activation for 
individuals with MS as evidenced by a recent systematic review 
investigating behavioural activation for depression in individuals with 
neurological conditions (Oates et al., 2019). However, the authors of 
the review identified ten studies that used behavioural activation for 
the treatment of depression in neurological conditions including 
dementia (n=4), stroke (n=3), epilepsy (n=1), brain injury (n=1) and 
Parkinson’s disease (n=1). Seven of the ten studies were randomised-
controlled trials but none of the studies compared behavioural 
activation to an alternative psychotherapy. Eight of the ten studies 
reported a reduction in depression post-treatment favouring 
behavioural activation with effect size ranging from small to large (d = 
0.24–1.7). However, the methodological quality of the studies varied 
with higher quality studies needed. Many of the included studies had 
small sample sizes and level of disability not often reported. Some 
studies detailed adaptations that were made to support the delivery of 
the intervention such as using the telephone to conduct sessions, 
delivering interventions directly to carers, or giving psychoeducation to 
carers. The reported efficacy of behavioural activation in individuals 
with neurological conditions is comparable to pooled effect sizes 
reported in meta-analyses in populations without neurological 
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conditions. However, the results should be treated with caution due to 
the sub-optimal quality of the included studies. None of the studies 
were able to demonstrate mediators of change and future studies 
would benefit from improved quality.  
1.6.5 Brief Behavioural Activation Treatment for Depression: 
Revised treatment manual (BATD-R) 
 
Following the component analysis of cognitive therapy by Jacobson et 
al. (1996), Lejuez et al. (2001) developed the Brief Behavioural 
Activation Treatment for Depression (BATD) manual, the manual was 
described as such because it used a fewer number of sessions than  
Jacobson et al.’s (1996) manual which used 20 sessions. The manual 
used behavioural theory to target contextual factors impacting 
behaviour and matching law (Herrnstein, 1970).  Matching law 
suggests that when multiple schedules of reinforcement are available 
at the same time for different behaviours, individual’s behaviour 
typically follows the proportions of reinforcement provided by different 
response options, whilst also describing conditions where behaviour 
may deviate in allocation due to over or under matching. In other 
words, depression is a function of both decreased reinforcement for 
non-depressive behaviours and increased reinforcement for depressive 
behaviours (Kanter, Manos, et al., 2010). The BATD is a 12-session 
protocol and includes activity monitoring, goals and values 
assessment, activity scheduling, and contingency management. The 
manual was used in a number of trials and found improved depressive 
symptoms (Hopko et al., 2003). 
 
The manual was revised ten years after initial publication. The BATD-
R had modifications that simplified and clarified treatment elements 
and procedures. The modifications included: (a) greater emphasis on 
treatment rationale, including therapeutic alliance; (b) greater clarity 
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regarding life areas, values, and activities; (c) simplified (and fewer) 
treatment forms; (d) enhanced procedural details, including 
troubleshooting and concept reviews; and (e)  availability of a modified 
daily monitoring form to accommodate low literacy patients (Lejuez et 
al., 2011). The manual was streamlined and includes five unique 
sessions and five additional sessions to allow for concept review. The 
BATD-R has been modified to include fewer sessions and showed 
significant reductions in depression using six to eight sessions 
(Daughters et al., 2008; MacPherson et al., 2010) and benefits have 
been seen in a single session (Gawrysiak et al., 2009). 
 
1.7 Rationale for behavioural activation in secondary 
progressive multiple sclerosis 
 
NICE recommended that research should investigate behavioural 
activation in people who have chronic illness (National Collaborating 
Centre for Mental Health & National Institute for Health Clinical 
Excellence, 2010). When considering that outcomes in the general 
population have been as comparable to CBT, in an increasingly strained 
national healthcare service, identifying, viable cost-effective 
interventions is becoming increasingly necessary. Further, if individuals 
with neurological conditions, such as MS, are experiencing increasing 
fatigue, worsening symptoms, and difficulties accessing therapies, 
behavioural activation may offer the most accessible intervention.  
 
For people with neurological conditions, such as MS, depression may 
be a result of declining physical health which may make it increasingly 
difficult to engage in activities that individuals previously found 
enjoyable or positively reinforcing. Behavioural activation aims to 
support individuals to identify and increase their access to positive 
reinforcement within their environment and reduce sources of negative 
reinforcement. As behavioural activation focuses on increasing 
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rewarding activities and not changing cognitions, behavioural 
activation may be an acceptable intervention for people with secondary 
progressive MS. 
 
Behavioural activation is a parsimonious intervention. Jacobson et al. 
(1996) argued that behavioural activation alone can be used as a 
streamlined intervention, which can achieve maximal impact for 
minimal burden. When considering that depression is a problem for 
people with secondary progressive MS and that we do not know the 
best way to intervene, using values as a means for identifying activities 
for contingent reinforcement may be of benefit. There is an existing 
evidence-base for the use of the BATD-R and its adaptability more 
broadly. However, evidence is limited in its examination of individual-
level moderators and mediators of change, which is important for 
refining our theoretical understanding of therapeutic mechanisms and 
when tailoring/implementing such interventions with people with MS in 
practice.  
 
The inclusion of values within the treatment manual may be important 
for people with secondary progressive MS, due to their on-going 
increasing difficulties. By exploring activities that people with 
secondary progressive MS enjoy or previously enjoyed an exploration 
of the components of joy can be made. New activities can then be 
sought that contain the same components. Lejuez et al. (2011) suggest 
by understanding an individual’s values associated with an activity can 
provide positive reinforcement over time, due to activities being linked 
to values rather than being arbitrarily selected. This may increase their 
access to positive reinforcement in several areas of their lives, rather 
than fewer specific that may narrow the opportunities for success 
(Lejuez et al., 2011). 
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When considering the increased cost to services, impact on patient 
outcomes, and decreased quality of life it is important to understand 
the most appropriate treatments for depression. Adapting 
psychological therapies to better consider the interaction of co-morbid 
psychological and physical conditions may be more acceptable to 
people with neurological/physical health conditions (Cully et al., 2009).  
 
Importantly, using behavioural activation may represent a simpler, 
cost-effective, intervention that represents a parsimonious option for 
psychotherapy. If outcomes on depression are equivalent to other 
psychotherapies but represent a smaller dose of psychotherapy 
services may be able to increase their efficiency and be able to support 
a greater number of individuals.  
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2. Extended methods 
 
2.1 Epistemological position  
 
The aims of the study lend themselves to a critical realist framework. 
Critical realism posits that a world exists independent of an individual’s 
understanding, language, and beliefs, but  subjective interpretations 
impact the way it is experienced (Edwards et al., 2014). In the study, 
individuals’ experiences, history, beliefs, and the context in which they 
live impact their expectations; however, there is an objective reality 
that exists beyond the individual that will have an influence on the 
findings. Outhwaite (1987) highlights that science is not simply a 
deductive process of detecting causal relationships, but one that seeks 





The Medical Research Council framework for the development and 
evaluation of complex interventions (Craig et al., 2008) state 
interventions should be developed systematically, using available 
evidence and theory. Interventions should be tested using a phased 
approach, beginning with a series of pilot studies targeting 
uncertainties in the design. The aims of the study were closely aligned 
with the ‘development’ phase of the framework and were achieved 
using mixed-methods. 
 
One method of investigating person-to-person variability and 
mechanisms of change in clinical interventions, is the single-case 
experimental design (Craig et al., 2008). Where randomised-controlled 
trials aim to demonstrate change in outcomes between two-time 
points, single-case experimental designs aim to understand whether 
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intervention processes are accountable for change (Craig et al., 2008). 
By exploring mechanisms through which interventions introduce 
change, researchers can investigate theoretical mediators of that 
change (Moore et al., 2015). This is crucial in understanding how these 




Ethical approval for the study was granted by the East Midlands – 
Nottingham 2 ethics committee (ref: 19/EM/0013; ethical approval 
process can be seen in appendices B to D). Informed consent was 
obtained from each participant by the study researcher (LLO). The 
study was registered on ClinicalTrials.gov (reference NCT03935529). 
 
2.3.1 Ethical considerations 
 
The study was conducted in accordance with guidelines set out by the 
British Psychological Society (British Psychological Society, 2010) and 
adhered to the Good Clinical Practice guidelines (NIHR, 2016). 
  
Individuals scoring highly on the Hospital Anxiety and Depression Scale 
(HADS) at screening were not excluded from the study but were 
encouraged to seek support from their GP. If a participant sought 
further support from their GP, the information was recorded within the 
participant’s contact notes and discussed during analysis. Additionally, 
if the measures identified that a participant’s mood was deteriorating 
during the intervention, the individual was advised to seek support 
from their GP.  
 
The risks of suicide and suicidal intent are characteristic of the 
condition being investigated, for the purposes of the study they were 
classed as adverse events. Good Clinical Practice guidelines were 
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followed by monitoring mood changes through measures and contact. 
Where any risk was identified the risk protocol for Nottingham 
University Hospitals Trust was followed. Serious adverse events were 
documented and discussed with supervisors and the trust, in line with 
the HRA (2018) safety reporting guidelines.  
 
During study design the researchers outlined that the study would be 
terminated if concerns were identified, following discussions with 
supervisors. Participants would be informed of the termination and 
provided with guidance on seeking further support, such as accessing 




Informed written consent (Appendix E) was obtained from all 
participants. Individuals were given at least one week to decide if they 
would like to take part, before being contacted by the researcher. The 
field supervisor assessed the participant’s capacity to consent and 
informed the researcher. If a participant was deemed to lose capacity 
to consent during the study, their involvement was terminated. Any 
concerns about capacity were discussed in research supervision. No 
plans were made to include individuals deemed to lack capacity due to 
the nature of the materials and intervention and the resulting 
engagement difficulties.  
 
2.3.3 Participant withdrawal 
Participants were informed of their right to withdraw from the study at 
any time point, without impact on their clinical care. Participants were 
invited to provide feedback, at interview, but were under no obligation 
to do so. Data collected up to the point of withdrawal was used within 
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the analysis, participants were informed of the analysis when 
consenting to take part. 
2.3.4 Data management 
 
In accordance with General Data Protection Regulations (The European 
Parliament & The Council of The European Union, 2016), research data, 
personal data, and the linking code were stored separately. 
Electronically stored data was password protected and encrypted, to 
ensure it was kept secure. Hard copies, such as consent forms, were 
kept in a locked filing cabinet at the university. 
 
Upon study completion, personal data was stored for only as long as 
necessary, so that the researcher could provide a research summary. 
Research data will be kept in locked safe storage at the University of 
Lincoln, for a period of seven years, before it will be destroyed. 
Published results were anonymised and did not contain participant 
identifiable information. 
 
2.3.5 Logistical considerations 
 
Participants were remunerated with a £20 Amazon voucher. Gifting 
was in line with INVOLVE guidelines (NIHR, 2012). Whilst payment of 
participants can lead to concerns of result bias, this gift was made 
following the interview, and was a nominal thank you for participant’s 
time.  
 
If a participant failed to comply with the protocol, they were not 
excluded from the study, but they were asked if they were willing to 
take part in the interview to gather feasibility information.  
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2.4 Participants and recruitment 
 
2.4.1 Sample size 
A minimum of three replications, across successive cases, are required 
in single-case experimental design research, to meet standards for 
assumed intervention related change (Smith, 2012). Six participants 
are suggested for attrition (Smith, 2012).  
 
2.4.2 Recruitment 
Participants were recruited from Nottingham University Hospitals 
Trust, by the MS clinical care team, who provided participants with the 
study advertisement (Appendix F). Participants also self-referred, 
using information from study-related advertisements placed in the MS 
clinics, MS Society local branch newsletters and social media.  
 
Within the Nottingham University Hospitals Trust MS clinic, 750 
individuals with secondary progressive MS are regularly seen, on 
average 50 per month (Evangelou, personal communication, February 
2018). Chwastiak et al. (2002) report depression prevalence in people 
with MS of 41.8%, with higher levels in people with more advanced 
disease. Therefore, we anticipated having an estimated population of 
300 to sample from, of which 20 per month may be experiencing low 
mood.  
 
Participants received a screening and information pack, containing a 
consent form (Appendix E), participant information sheet (Appendix 
G), and HADS (Appendix H). A telephone call from the researcher 
provided opportunity for further questions. If the participant did not 
meet the inclusion criterion (Table 6), they were excluded and provided 
an information sheet for managing emotions (Appendix I). Consenting 
participants’ GP were sent a letter detailing their involvement in the 
study (Appendix J).   
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Table 6 
Inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria 
Neurologist confirmed diagnosis 
of secondary progressive 
multiple sclerosis 
 
People undergoing psychological 





Aged over 18 years 
 
 
Able and willing to give consent  
 
 
Have a telephone, access to the 








Note. This table demonstrates the inclusion and exclusion criteria for 
the study.  
a HADS; Hospital Anxiety and Depression Scale. 
b Exclusion criteria was based on self-report. 
 
2.4.3 Data collection and assessment 
Demographic and clinical data were collected through self-report 
(Appendix K). The data allowed exploration of wider factors, beyond 
the intervention, to be included in any change analysis, and allowed 
for future replicability. 
 
Feasibility data were collected in regard to recruitment, session 
attendance, attrition, questionnaire adherence, follow-up, additional 
support, interviews and acceptability, presented in Table 7.  
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Table 7  
Feasibility questions 
Feasibility information How measured 
Recruitment Number of people given 
information by the multiple 
sclerosis team.  
Number of people screened 
using Hospital Anxiety and 
Depression Scale. 
Number of people meeting cut-
off and consenting. 
Number of people not meeting 
cut-off on Hospital Anxiety and 
Depression Scale. 
Session attendance Data on overall percentage of 
sessions attended. 
Attrition Number of participants dropping 
out. 
Questionnaire adherence Record of missing data reported. 
Follow-up Number of participants 
completing follow-up measures.  
Additional support Number of participants directed 
to seek additional support from 
their GP. 
Interviews Number of participants 
completing the change 
interviews. 
Acceptability of the materials, 
measures, and sessions 
Qualitative feedback via 
interviews. 
Note. This table demonstrates the feasibility questions answered in the 
study and how each element of feasibility information was measured.  
 
2.5 Measures 
This section describes screening, baseline, process, and outcome 
measures. Psychometric properties, method, and point of 
administration are reported in Table 8. As shown in Table 8, where 
possible, measures previously used in MS research were selected. The 
measures were used to screen, establish a baseline, investigate 
process, and outcomes. 
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2.5.1 Screening 
The HADS (Zigmond & Snaith, 1983) was used to screen participants 
for inclusion (scoring ≥8 on the depression subscale).  
 
2.5.2 Baseline 
The Patient Health Questionnaire 2 (PHQ2; Kroenke et al., 2003; 
Appendix L) was used to establish a baseline. The PHQ2 was 
administered every-other-day, during the baseline phase, to establish 
a baseline for the primary outcome variable of interest (depression). 
As no higher frequency measure exists, questions were adapted to ask, 
‘over the last two days.’ To overcome the impact of adapting the 
measure, outcome measures, such as the HADS, were used on a 
weekly basis. Internal consistency: ⍺ = .83 (Löwe et al., 2005). 
Sensitivity (82.9%) and specificity (90.0%) indicating a 38.4 positive 
predictive value (Kroenke et al., 2003). Sensitivity (99%) and 
specificity (87%) and positive predictive value (72%) have been 
investigated in a MS population. 
 
2.5.3 Process measures 
The Engaged Living Scale (ELS; Trompetter et al., 2013; Appendix M) 
was used to identify alignment to values, to allow us to understand the 
impact of values-based action. Internal consistency: ⍺ = .92. Subscales 
range from ⍺ = .62 to .89. Test–retest: r= .66 (p< .0001; Knirsch, 
2015). Good construct validity has been reported (Trompetter et al., 
2013). 
 
The Behavioural Activation for Depression Scale Short Form (BADS-SF; 
Manos et al., 2011; Appendix N) was used to track participant 
engagement in behavioural activation. Good item characteristics and 
acceptable internal consistency are reported (Manos et al., 2011). 
Acceptable construct validity, and predictive validity (Kanter et al., 
2012). The BADS-SF was used to track weekly changes in behaviours 
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that underlie depression and that are specifically targeted for change 
by behavioural activation. 
 
2.5.4 Primary outcome 
In line with study aims, the HADS was used to investigate change in 
depression. 
 
2.5.5 Secondary outcomes 
Levels of fatigue were investigated using the Modified Fatigue Impact 
Scale (MFSIS-SF; Vickrey et al., 1995; Appendix O). Internal 
consistency: ⍺ = .80 (Vickrey et al., 1995). The questionnaire has high 
face validity due to use in MS research (Vickrey et al., 1995). 
 
Changes to participant’s quality of life, were investigated using the 
Short Form-12 version 2 (SF-12v2; Ware et al., 1996; Appendix P).  
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Table 8  

























0 - 21 
Anxiety subscale internal 
consistency: ⍺ = .83 (mean) 
Depression subscale internal 
consistency:  ⍺ = .82 (mean) 
(Bjelland et al., 2002) 
Sensitivity: 90%, Specificity: 87% (Hind et 
al., 2016). High sensitivity and specificity 
have been reported versus clinical interview 
and other measures, in people with multiple 
sclerosis (Honarmand & Feinstein, 2009). In 
2016, a systematic review comparing mood 
measures used with people with multiple 
sclerosis Hind et al. (2016). The authors 
reported the HADS had a sensitivity of 90%, 
which was the highest of the compared 
mood measures in the review 
   










and score range 
Reliability Validity 
SF-12v2 











Range 0 - 100 
 
Internal consistency ⍺ = >.8  




The questionnaire was populated from the 
full version which has high face validity due 
to use in multiple sclerosis research (Vickrey 
et al., 1995). Additionally, the SF-12v2 has 

















Internal consistency: ⍺ = .80 
(Vickrey et al., 1995) 
The questionnaire has high face validity due 
to use in multiple sclerosis research (Vickrey 










Internal consistency: ⍺ = .91 
(Trompetter et al., 2013). 
Subscales range from ⍺ = .62 to 
.89 
Good construct validity has been reported 
(Trompetter et al., 2013) 
   














range 16 – 80 
 
Valued living 
range 10 – 50 
 
Life fulfilment 
range 6 - 30 




al., 2003)6  
Depression  2 items 






Internal consistency: ⍺ = .83 
(Löwe et al., 2005) 
Sensitivity (82.9%) and Specificity (90.0%) 
indicating a 38.4 positive predictive value 
(Kroenke et al., 2003). Sensitivity (99%) 
and specificity (87%) and positive predictive 
value (72%) have been investigated in a 
multiple sclerosis population 
 
   
















Activation 9 items 
 





Range 0 - 54  
Internal consistency: ⍺ = .82 Good 
item characteristics and acceptable 
internal consistency are reported 
(Manos et al., 2011)  
Acceptable construct validity, and predictive 
validity (Kanter et al., 2012) 
 
Note. The online database was facilitated by a software known as Qualtrics. The software sends a link and a 
reminder to participants to complete questionnaires via their phone or computer. 
 
a The reflective period represents how questions are phrased, such as “how often over the last week, have you…” 
b HADS, The Hospital Anxiety and Depression Scale; SF-12v2, Short Form-12 version 2; MFIS-SF, Modified Fatigue 
Impact Scale-Short Form; ELS, Engaged Living Scale; PHQ2, Patient Health Questionnaire 2; BADS-SF, 
Behavioural Activation for Depression Scale Short Form. 
c Time point administered: 1, Screening; 2, Pre-intervention; 3, Mid-intervention; 4, Post-intervention; 5, Weekly; 
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2.6 Design method 
2.6.1 Intervention manual 
The BATD-R was adapted for supported self-help use for people with 
secondary progressive MS (author permission, Appendix Q). The 
supported self-help format involved participants receiving five sessions 
delivered by the researcher.  
 
• The script was condensed into a five-session format using the 
five core sessions (Appendix R). 
• A resource pack for participants, including psychoeducation 
materials (depression, behavioural activation, values) was 
organised (Appendix S). 
• A session fidelity framework was identified (Appendix T). 
 
In addition, the protocol was updated to use a combination of face-to-
face and telephone/internet calls. The duration of sessions was 
changed and included an up to two-hour initial session followed by 
sessions lasting up to one-hour. The existing session material was 




The BATD-R manual consists of ten sessions, consisting of five unique 
and five additional sessions; for concept review and post-treatment 
planning. The manual has been previously modified to include fewer 
sessions (six-to-eight) and the abbreviated format significantly 
reduced depression in participants (Daughters et al., 2008; 
MacPherson et al., 2010). Indeed, beneficial effects have been reported 
from receiving one or two sessions (Armento et al., 2012; Gawrysiak 
et al., 2009). Therefore, the intervention content was focused into five, 
fortnightly sessions, using the unique sessions, allowing time to engage 
in activities. It was considered that fewer sessions could be beneficial, 
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as demonstrating change in a fewer number of sessions would have 
clinically relevant implications by representing a lesser demand on 
resources, whilst promoting self-management for people with MS. 
Further, it would be comparable to existing services such as IAPT.   
 
As the manual is written in American English, the manual and 
materials, including values identification worksheets and diaries were 
adapted. 
 
As people with secondary progressive MS experience physical 
difficulties, which can impact their ability to attend appointments, 
internet-video communication (e.g., Skype) and telephone calls were 
used to conduct sessions.  
 
2.6.3 Acceptability of the manual 
The adapted materials were checked for acceptability, against the 
original manual, in a project team meeting. Materials were sent to an 
existing patient and public involvement (PPI) panel, consisting of 
people with MS, some of whom have secondary progressive MS, who 
were available to consult on research projects. PPI can help define what 
is acceptable to participants and provide insight into potential barriers 
to engagement (National Institute for Health Research, 2014; NIHR). 
Feedback was requested on the structure and duration of sessions and 
suitability of materials. As these activities are conducted under the 
auspices of PPI, Health Research Authority guidance suggest ethical 
approval was not required (Health Research Authority, 2017). 
 
2.6.4 Intervention 
The delivery of the intervention was facilitated by the researcher. To 
investigate changes to mood and whether/how behavioural activation 
processes can account for any observed change, a multiple single-case 
experimental design (MSCED) was used.  
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2.6.5 MSCED 
Craig et al. (2008) state that in the development and evaluation of 
interventions, it is important to first understand whether the 
intervention is effective in everyday practice and second, to understand 
how the intervention works. A feasibility randomised-controlled trial 
can assess the average effect of an intervention within a group. 
However, this design is unable to investigate theoretically predicted 
mediators of change between and within individuals, needed to explore 
how an intervention works (Craig et al., 2008).  
 
In comparison, MSCEDs investigate the effectiveness of psychological 
interventions, by examining behaviour and interpersonal processes 
(Smith, 2012). Single-case experimental designs are an approach to 
investigate treatment efficacy (Rassafiani & Sahaf, 2010). Therefore, 
using MSCED leant itself to the study aims. MSCEDs are experimental 
by design, capable of providing a rigorous, methodologically sound 
method of evaluation (Smith, 2012). Manipulating the independent 
variable, by implementing and removing it at selected time-points, 
allows researchers to examine causal effects and test hypothesised 
contingencies (Barlow et al., 2008). Single-case experimental designs 
differ from comparative group studies by focusing on individual 
differences, rather than group differences. Using MSCED allows 
researchers to examine cause and effect if any change is identified in 
participants (Backman et al., 1997). The method used in MSCED 
reduces the potential that confounding variables are attributed to 
change on the dependent variable, because, researchers are able to 
use time series data to investigate association of change (Rassafiani & 
Sahaf, 2010). Rich data sets in MSCEDs are beneficial for investigating 
the aims of the study because it allowed exploration of the impact of 
behavioural change. 
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Typically, an ABA design would see participants go from no-
intervention (A), intervention (B), back to no-intervention. However, 
as the intervention involved learning, it cannot be unlearned, therefore 
the effect of the intervention (or component phases) cannot be readily 
taken away. The study used an AB design, where A was baseline and 
B was the intervention.  
 
Using an AB design each participant became their own control, as prior 
to intervention, we understood their usual responding for the target 
variable. Data were then tested for changes in the target variable 
(over-and-above the usual responding) once the intervention was 
introduced. Therefore, any behaviour change during the treatment 
phase can be attributed to the intervention. To establish a stable 
baseline, baselines must have at least three data points, to sufficiently 
establish baseline trend, level, and stability, against which to test 
intervention-phase changes (Smith, 2012).  
 
Randomised controlled-trials (RCT) are frequently used to examine the 
efficacy of interventions. However, RCTs do not examine individual 
outcomes meaning that participants who are in a group that 
demonstrated change but encountered opposite effects are not 
understood (Davies et al., 2007). By investigating individuals, MSCEDs 
provide an important role in clinical psychology as they provide 
practitioners with evidenced-based clinical practice (Bloom et al., 
2003). As participants receive repeated measurement on target 
variables, MSCED examines both whether change occurs, but also 
whether the change is significant, stable, and what caused the change 
(Davies et al., 2007). 
 
2.6.6 Interviews 
Post-intervention, one-to-one interviews were conducted to inform 
feasibility aims (acceptability of the intervention and research 
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procedures). Interviews were conducted by CM (Trainee Clinical 
Psychologist) who was not otherwise involved in the study. All 
interviews were audio recorded. The interview schedule (Appendix U) 
was based on Elliott and Timulak’s (2005) change interview. 
Participants provided feedback about their experiences of the study to 
elicit an understanding of their lifestyle during the intervention, to 
consider any potential extraneous variables that may impact the 
findings and what participants attribute change to. The framework has 
been used in psychological intervention studies to provide qualitative 
information on positive and negative changes. Further, the framework 
asks participants to theorise which, if any, aspect of the intervention 
they would attribute to changes (Castonguay, 2011; Clarke et al., 
2004; Klein & Elliott, 2006). This allowed for triangulation of the 
results; using outcome data and verbal feedback (Morse, 1991). 
 
Based on guidelines (Srivastava & Thomson, 2009) change interview 
data were evaluated by considering contextual, diagnostic, evaluative, 
and strategic categories in terms of the following questions: was any 
positive or negative impact described, what was the context 
surrounding the intervention like and could change be attributed to 
environmental factors, what factors underlie the participants 




This section outlines the participant journey. The procedure flowchart 
is reported in Figure 6.  
 
  
   
         Page 156 of 362 
 
Figure 6 





Following recruitment, participants were sent instructions for installing 
video communication software (Skype). The researcher contacted the 
participant to complete pre-intervention measures and collect 
MS Clinical Care team 
provide information 
about the study. 
Researcher phones to discuss 
the project and sends 
screening pack. 
Potential participant 
emails researcher after 
seeing advert. 
Individuals who did not 
consent or meet inclusion 
criteria, were provided 
with MS Society booklet for 
managing emotions and 
signposted to their GP. 
Researcher contacts one week 
later to answer final questions 
and complete the screening 
questionnaire. 
Baseline: no other contact, 




behavioural activation sessions 
(plus an additional optional 
troubleshooting session), and 
a final review. 
Change interview  
Participants who withdrew 
from the study were 
provided with the MS 
Society booklet for 
managing emotions, and 
advice on seeking further 
support. Participants were 
invited to the change 
interview, to discuss any 
potential issues with the 
intervention. 
Consent forms returned. 
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demographic and clinical information. Following the contact, 
participants completed the PHQ2 every-other-day to establish a 
baseline. Participants completed measures using Qualtrics (a data 
management service). Qualtrics allowed participants to upload their 
responses to an online database using their phone or computer. 
Intervention and measures timeline are reported in Figure 7. 
 
Figure 7 
Intervention and measures timeline 
 
2.7.2 Intervention 
An overview of the sessions delivered by the researcher can be seen in 
Table 9. The contacts were guided by the five unique sessions of the 
BATD-R, which were:  
 
Treatment planning 
Participants received a single face-to-face session at their home, 
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Psychoeducation and behavioural activation 
Participants received a single psychoeducation session, followed by 
three, fortnightly, behavioural activation sessions. In addition, 
participants were offered an optional support session for 
troubleshooting. Participants opted-in to the session, by responding to 
a question via Qualtrics. Sessions lasted up to one-hour and contact 
was made using internet video software or telephone. 
 
Treatment evaluation 
Participants received a review session lasting up to one-hour, contact 
was made using internet video software or telephone. 
 
2.7.3 Post-intervention 
Participants were contacted by a fellow Trainee Clinical Psychologist to 
take part in a 30-minute, one-to-one, audio recorded phone interview. 
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Table 9 
Session plan outlining content, delivery method, homework, and overview 

















including a discussion 








The face-to-face session lasted between one and two 
hours and provided an opportunity to develop a 
therapeutic rapport. The researcher’s role as a support 
aid was explained, before conducting a focused 
assessment. The assessment explored the participant’s 
current difficulties and the resulting impact of their 
condition and low mood. The session began with a brief 
discussion about depression. The content included 
information on depression prevalence, functional 
impact, potential symptoms, and changing behaviours 
in the face of depression. The introduction of 


















The session focused on exploring the participant’s 
important life areas, to begin considering and 
highlighting their values. The participant was 
introduced to the homework form and given an 
opportunity to ask any questions.   
 
   
         Page 160 of 362 
 






Daily monitoring form 
review. 
Activity selection. 










This session reviewed the daily monitoring form. 
Attention was given to activities which the participant 
was doing and whether the activities are enjoyable, 
important, gave a sense of achievement or neither. By 
then introducing the activity ranking and selection task, 
the participant was supported with planning activities 
that they believed were not too difficult to engage in, 
between the sessions. This included increasing the 
identified enjoyable activities the participant 
















This optional session was used for problem solving. 
Reasons for introducing the session included difficulties 
in engaging activities, problems with the homework 






Daily monitoring form 
review. 
Activity planning. 










This session reviewed the daily monitoring form and 
the planned activities. The review focused on 
enjoyment, importance, and achievement of activities. 
The session addressed any difficulties the participant 
had completing certain activities and how this can be 
overcome. The session explored activities in relation to 
the participant’s values and that they seem consistent 
with those values.  
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Daily monitoring form 
review. 
Activity planning 










This session reviewed the daily monitoring form and 
the planned activities. The session addressed any 
difficulties the participant had completing certain 
activities and how this can be overcome. The session 
explored the activities in relation to the participant’s 






Daily monitoring form 
review. 





None This session reviewed the daily monitoring form and 
the planned activities. The session then focused on 
reviewing the work completed during the intervention 
and how the participant can continue to apply the skills 
they had learned.  
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2.8 Analysis 
Online data (from Qualtrics.com) was transferred by LLO to Microsoft 
Excel, which was used to develop all charts for analysis. 
 
2.8.1 Demographic and feasibility data 
Descriptive statistics were used to present participant demographics, 
including age, gender, relationship status, care support and type (paid 
/unpaid carers, hours per week), ethnicity, education level, and 
employment status. Descriptive statistics were used to present 
information on disease duration and progression.  
 
Data on session length, and feasibility data were analysed using 
descriptive statistics. Feasibility data described includes recruitment, 
session attendance, attrition, questionnaire adherence, follow-up, 
additional support, interviews and acceptability. 
 
2.8.2 MSCED 
Visual analysis is the established and recommended approach to 
analyse single-case experimental design data (Morgan & Morgan, 
2008). The analysis identifies any phase-related changes in process 
and outcome variables. The analysis provided a visual representation 
of the covariation between process and outcome measures, to explore 
whether/how the intervention had a positive impact on mood and 
activation. By using visual analysis in time-series data, responses to 
measures can be used to assess the dependent variable, as it varies 
over time in response to the independent variable (Barlow et al., 
2008). The collected time-series data were examined using 
conservative dual-criterion (Fisher et al., 2003). In addition, to 
calculate treatment effects, the percentage exceeding the median was 
used (Ma, 2006).  
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2.8.2.1 Conservative dual-criterion and percentage exceeding 
the median 
Calculating effect sizes has become an increasingly common practice 
to supplement visual analysis in order to support clinical decisions 
about treatment effects (Morley, 2018), however no consensus exists 
on which method should be used with each having relative strengths 
and weaknesses (Lenz, 2013). The conservative dual-criterion was 
developed by Fisher et al. (2003) in order to improve on analysis 
methods such as the split-middle technique and the percentage of 
nonoverlapping data (Swoboda et al., 2010) to increase inter-rater 
reliability. A strength of the analysis is that both baseline data and 
projected trend are used and is reported to have low rates of Type I 
and Type II errors, which makes the analysis rigorous for single-case 
experimental design analysis.  
 
To apply the conservative dual-criterion a line for level and a line for 
trend is drawn on the treatment graph using baseline data. The method 
aims to control the rate of Type I errors, the level and trend line are 
set 0.25 standard deviations in the direction of the predicted treatment 
effect. The method has four steps (Swoboda et al., 2010): 
 
1. Sum the number of data points in the treatment phase. 
2. Use the total to identify the number of points in predicted 
direction needed to conclude that there is systematic change 
(Table 10). 
3. Sum the number of points in the treatment phase that are above 
both lines where treatment aims for increase, or the number 
below both lines if treatment aims to reduce. 
4. If the number of data points from Step 3 is equal to or greater 
than the number required by Step 2, conclude that systematic 
change occurred from baseline to treatment. If not, conclude that 
there is not sufficient evidence of systematic change. 
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Table 10 
Criteria for concluding that the treatment-phase change is systematic 
Number of points in 
treatment phase 
Number of points in predicted direction 













Adapted from “Visual Aids and Structured Criteria for Improving Visual 
Inspection and Interpretation of Single-Case Designs” by Fisher et al. 
(2003). 
  
In addition to conservative dual-criterion, treatment effect size were 
calculated using the percentage exceeding the median (Ma, 2006). The 
percentage exceeding the median is based on the assumption that if 
there was no effect then treatment phase data points will fluctuate 
50/50 below and above the median of the baseline phase. The 
percentage exceeding the median is calculated by stretching the 
median from baseline across the treatment phase and counting the 
number of points that fall above or below the line (if decrease denotes 
positive change). The number of points exceeding are then compared 
to the total number of possible to gain a percentage. The percentage 
is then changed into a score ranging from 0 to 1, by moving the decimal 
place two places to the left. Scores ≥ .9 indicate ‘highly effective 
treatment’, scores between .7 and .9 indicate ‘moderately effective’, 
and scores < .7 indicate ‘questionable or not effective’ treatment (Ma, 
2006).  
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A strength of using percentage exceeding the median is that the 
approach is less vulnerable to Type II errors as it uses all baseline data 
which accounts for potential outliers in data sets which may negatively 
influence the evaluation of an intervention (Lenz, 2013). However, 
percentage exceeding the median has been criticised for producing 
inflated effect sizes and Type 1 errors by not detecting changes, or lack 
of, across phases (Wolery et al., 2010), hence the pairing with 
conservative dual-criterion.  
 
2.8.2.2 Establishing a baseline 
To present depression data for each participant, scores for the PHQ2 
collected during baseline were converted to HADS equivalent to track 
change using a trendline. By calculating the trendline of the PHQ2 
during baseline we calculated the value at the intercept at 0 (one 
observation before baseline: i.e., the pre-intervention datapoint). We 
then changed the value at intercept to the pre-baseline HADS score 
and used the trendline to approximate values of HADS depression 
during baseline. Then, to approximate the intervals used during the 
intervention phase, we transposed the pre-intervention plus baseline 
points into three datapoints coinciding with (a) Pre-intervention, (b) 
Baseline 3, and (c) Baseline 6; this which allowed us to treat datapoints 
as equidistant and on the same scale (an example of this process can 
be seen in results 3.4.1). 
 
2.8.3 Clinically significant and reliable change 
Visual analysis is supplemented with use of reliable and clinically 
significant change indices, to provide quantitative decision criteria for 
identifying the statistical robustness and practical importance of any 
visually-apparent shifts over time. Jacobson and Truax (1991) 
developed the clinical significance and reliable change index to assess 
whether the observed change on pre-to-post questionnaires is large 
enough to be deemed clinically meaningful and reliable. By referring to 
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the manipulation of the independent variable and clinically significant 
and reliable change, an interpretive context for understanding changes 
is provided (Jacobson & Truax, 1991); this is important when 
considering the development of larger feasibility studies. Using 
clinically significant and reliable change allowed investigation across 
individual participants and an evaluation of each of the single-case 
data. 
 
Following an intervention, it is important to assess whether an 
individual experienced meaningful change as a result of that 
intervention (Jacobson & Truax, 1991). We need to know whether the 
individual experienced reliable change and, if so, whether the change 
was clinically significant. The reliable change index is used to determine 
if change in an individual’s pre- and post-intervention score is 
statistically significant (Jacobson & Truax, 1991). Reliable change 
indices estimate if change is greater than measurement unreliability 
and therefore a result of intervention. Reliable change is calculated 
using the standard deviation and the reliability of a measure. If the 
change was reliable, we can then assess whether it is clinically 
significant, which is demonstrated when an individual’s score moves 
from a ‘clinical’ to a ‘non-clinical’ range.  
 
Reliable change is calculated by dividing the change in an individual’s 
pre-intervention to post-intervention score by the standard error of 
change. Standard error of change is calculated using the following 




The calculation indicates the amount by which an individual’s score 
must change to reliably state that change is not due to chance. 
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Clinically significant change is assessed and achieved in the following 
three different ways (Jacobson & Truax, 1991).  
 
• Criterion a: an individual’s post-intervention score is more than 
two standard deviations from the mean score of a clinical group. 
 
• Criterion b: an individual’s post-intervention score is within two 
standard deviations of the mean score of a non-clinical group.  
 
• Criterion c: an individual’s post-intervention score is closer to the 
mean of the non-clinical group than the mean of the clinical 
group.  
 
Reference data used for reliable change indices and clinically significant 
analyses can be seen in Tables 11 and 12. 
 
HADS. Reliable change indices were calculated using the depression 
score for all participants with MS (n = 4379) mean score (7.6, SD = 
4.2, SE = .06) and using the reliability score of 0.82 for the depression 
subscale (Bjelland et al., 2002). The standard error of change given 
these values is 2.52. The reliable change criterion is 1.96 times this, 
i.e., 4.94. 
 
BADS-SF. Reliable change indices were calculated using norms from 
student (n = 28) participants who completed the BADS-SF and using 
the reliability score of .82. At first assessment the mean score was 
25.68 (SD 8.21; Manos et al., 2011). The standard error of change 
given these values is 4.93. The reliable change criterion is 1.96 times 
this, i.e., 9.65. 
 
ELS. Reliable change indices were calculated using data from a sample 
of 439 participants and using the reliability score of .90. The mean 
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score was 60.80 (SD 7.83; Trompetter et al., 2013). The standard error 
of change given these values is 3.50. The reliable change criterion is 
1.96 times this, i.e., 6.86. 
 
MFIS-SF. Reliable change indices were initially explored from Smith et 
al. (2018) who used data from two studies of MS participants (n = 168) 
and the reliability score of .761. The mean score was 9.78 (SD 5.11; 
Smith et al., 2018). The standard error of change given these values 
is 3.54. The reliable change criterion is 1.96 times this, i.e., 6.93. As 
two standard deviations from the mean would have resulted in a 
negative score the mean from the sample was used. The mean score 
was 14.88 (SD 4.45). The standard error of change given these values 
is 3.08. The reliable change criterion is 1.96 times this, i.e., 5.98. 
 
SF-12v2. In normative data the mean is 50, scores >50 indicate better 
physical or mental health than the mean. Scores <50 indicate worse 
physical or mental health than the mean. Reliable change indices were 
calculated using data from a study of change in health-related quality 
of life in a MS population (n=3516; Janzen et al., 2013) and the 
reliability score of 0.80. The physical health subscale mean was 39.88 
(SE .17) and mental health subscale mean was 51.78 (SE .16). 
Standard deviation was obtained by multiplying by the square root of 
the sample size (59.30). The physical subscale standard deviation is 
10.08. The standard error of change given these values is 6.38. The 
reliable change criterion is 1.96 times this, i.e., 12.50. The mental 
health subscale standard deviation is 9.49. The standard error of 
change given these values is 6.00. The reliable change criterion is 1.96 
times this, i.e., 11.76. 
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Table 11 
Reference data used for reliable change indices and clinically 
significant analyses  








































Note. This table demonstrates the reference data and clinically 
significant change criterion for the study as outlined by Jacobson and 
Truax (1991). 
a HADS, Hospital Anxiety and Depression Scale; BADS-SF, Behavioural 
Activation Scale-Short Form; ELS, Engaged Living Scale; MFIS-SF, 
Modified Fatigue Impact Scale-Short Form; SF12v2 PH, Short Form-
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Table 12 
Reliable change indices values and clinically significant change cut-off 
scores  




BADS SF 9.65 9.26 
ELS 6.86 45.14 







Note. This table demonstrates the calculated values for reliable change 
indices (RCI) and clinically significant change (CSC) cut offs. 
a HADS, Hospital Anxiety and Depression Scale; BADS-SF, Behavioural 
Activation Scale-Short Form; ELS, Engaged Living Scale; MFIS-SF, 
Modified Fatigue Impact Scale-Short Form; SF12v2 PH, Short Form-
12v2 Physical Health; Short Form-12v2 Mental Health 
 
2.8.4 Interviews 
To meet the aim of understanding the participants’ experience of the 
intervention, a method with explicit focus on experience is necessary. 
Interpretative Phenomenological Analysis (Smith et al., 2009) aims to 
understand people’s experience of a phenomenon and how they make 
sense and ascribe meaning to the experience. However, this process is 
driven by data of rich narratives (Smith et al., 2009). The mixed-design 
of this study better aligned to a framework analysis (Gale et al., 2013). 
A framework analysis emphasises how both a priori issue, and 
emergent data driven themes guide development of an analytic 
framework (Parkinson et al., 2016). This study had predefined areas 
we wished to explore, and framework analysis explores participant 
experience, whilst remaining open to discovering the unexpected 
(Parkinson et al., 2016). Framework analysis has been used to analyse 
semi-structured interviews in health research (Gale et al., 2013) which 
is comparable to the present study. Themes used to generate codes 
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were developed from the research question. Codes were applied to 
participant’s responses and were analysed for patterns. Codes were 
arranged into a matrix to correlate themes to participant codes. 
 
2.8.5 Intervention fidelity 
Intervention sessions were audio recorded and evaluated by an 
independent researcher. Fidelity was investigated using a set 
framework, to investigate alliance, and content delivery adherence. In 
total, 19% of audio recordings were audited to ensure accuracy. 
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3. Extended results 
3.1 Demographics 
Demographic information for the participants who did not establish a 
baseline in the study can be seen in Table 13. 
 
Table 13 
Demographic information for participants who did not establish a 
baseline 
Demographic PS07 PS08 
Age 42 63 
Gender Female Male 
Relationship Married Married 
Care Paid (14hrs) Unpaid 
(10 hrs) 
Unpaid (35 hrs) 
Education University School 
Employment Unemployed Retired 
Diagnosis duration 10 years 10 years 
SPMS duration 4 years 5 years 
Note. Both participants were of white British ethnicity. 
 
3.2 Feasibility  
Feasibility data can be seen in Table 14. 
Table 14 
Feasibility data 
Feasibility information Data 
Recruitment Number of people responded from MS 
Society advert:7 
Number of people given information by the 
multiple sclerosis team: 4 
Number of people identified via word of 
mouth: 3 
Other identification: 3 
Total number of people study discussed 
with: 17 
Number of people screened using Hospital 
Anxiety and Depression Scale: 11 
Number of people meeting cut-off and 
consenting: 8 
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Feasibility information Data 
Number of people not meeting cut-off on 
Hospital Anxiety and Depression Scale 
depression sub-scale: 3 
 
Session attendance Data on overall percentage of sessions 
attended: 100% of scheduled sessions 
were attended 
 




Number of questionnaires not completed: 
5 during baseline (7.8%) 
0 pre/mid/end (0%) 
4 weekly (7.3%) 
 





Note. This table demonstrates the data and information pertaining to 
feasibility questions in the study. 
 
Of the six individuals who were identified and not screened, one 
declined, two did not respond after being sent the information pack, 
two did not have secondary progressive MS, and one did not have a 
computer.  
 
Of the weekly questionnaires, participant 1 did not complete two and 
participants 2 and 3 did not complete one. Of the baseline 
questionnaires, participant 8 did not complete one, participant 4 did 
not complete one, and participant 5 did not complete three. 
 
3.3 Attrition 
One participant withdrew from the study after the second session. The 
participant completed the change interview. 
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3.4 Baseline data 
3.4.1 Example conversion of baseline PHQ2 data to HADS 
equivalent 
The data presented in Figure 8 shows the baseline data for participant 
1. Over 6 datapoints participant 1 scored: 4, 2, 2, 2, 2, 3. The resulting 
trendline equation was y = -0.1429x + 3. 
Figure 8 
Baseline data for participant 1 
 
Note. Lower scores indicate reduced depression.  
 
By using the value of the intercept at 0 (i.e., 3) and changing the value 
to participant 1’s HADS depression score pre-intervention (14) it was 
possible to use the trendline to approximate the values of HADS 
depression during baseline: 
Pre-intervention (T0) Depression score (y) = (-0.1429*0) + 14 = 14 
Baseline 1 (T1) Depression score (y) = (-0.1429*1) + 14 = 13.9 
Baseline 2 (T2) Depression score (y) = (-0.1429*2) + 14 = 13.7 
… 
Baseline 6 (T6) Depression score (y) = (-0.1429*6) + 14 = 13.1 
   
         Page 175 of 362 
 
Then, to approximate the intervals used during the intervention phase, 
the pre-intervention score was used, and the baseline was transposed 
in to three datapoints: (1) Pre-intervention (HADS 14), (2) Baseline 3 
(HADS 13.6), and (3) Baseline 6 (HADS 13.1). 
 
3.4.2 Baseline trends 
In total, two participants (PS07 and PS08) trended to notable 
improvement during the baseline phase. The responses on the every-
other-day measures indicated that they had not been experiencing 
difficulties with low mood or little interest or pleasure in doing 
activities. The baseline periods were extended from two to three weeks 
for participant 4 and the baseline periods were extended from two to 
four weeks for participants 3, 7, and 8. 
 
3.5 Sessions 
Session one lasted between 90 and 120 minutes. Sessions two to six 
lasted between 38 and 60 minutes. Participants 1,2,3, and 5 requested 
the additional problem-solving session. Participant 6 did not request 
the problem-solving session. No sessions were cancelled or missed 
during the intervention. 
 
3.6 Process measure - values 
 
3.6.1 Participant 1  
Participant 1’s ELS scores can be seen in Figure 9. Participant 1’s total 
ELS score at pre-intervention was 53 and post-intervention was 49. 
Participant 1 started within the non-clinical range and at the study end 
was still non-clinical.  Participant 1 did not achieve reliable or clinically 
significant change. Participant 1’s valued living score pre-intervention 
was 42 and post-intervention was 31 and represented a deterioration 
in valued living. Participant 1’s life fulfilment score pre-intervention 
was 11 and post-intervention was 18 and represented an increase in 
life fulfilment.  
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Figure 9 
Engaged living score for participant 1 
 
Note. This figure shows participant scores for the Engaged Living Scale, 
including total score and subscales valued living and life fulfilment. 
Higher scores indicate closer alignment to values, valued living, and 
life fulfilment.  
 
3.6.2 Participant 2  
Participant 2’s ELS scores can be seen in Figure 10. Participant 2’s total 
ELS score at pre-intervention was 19 and post-intervention was 16. 
Participant 2 did not achieve reliable or clinically significant change. 
Participant 2’s valued living score pre-intervention was 11 and post-
intervention was 10 and represented a deterioration in valued living. 
Participant 2’s life fulfilment score pre-intervention was 8 and post-





















Total score Valued living score Life fulfillment score
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Figure 10 
Engaged living score for participant 2 
 
Note. This figure shows participant scores for the Engaged Living Scale, 
including total score and subscales valued living and life fulfilment. 
Higher scores indicate closer alignment to values, valued living, and 
life fulfilment.  
 
3.6.3 Participant 3  
Participant 3’s ELS scores can be seen in Figure 11. Participant 3’s total 
ELS score at pre-intervention was 65 and post-intervention was 56. 
Participant 3 started within the non-clinical range and at the study end 
was still non-clinical. Participant 3 had reliable deterioration. 
Participant 3’s valued living score pre-intervention was 37 and post-
intervention was 38. Participant 3’s life fulfilment score pre-
intervention was 28 and post-intervention was 18 and represented a 
deterioration in life fulfilment which was more notable than any change 





















Total score Valued living score Life fulfillment score
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Figure 11 
Engaged living score for participant 3 
 
Note. This figure shows participant scores for the Engaged Living Scale, 
including total score and subscales valued living and life fulfilment. 
Higher scores indicate closer alignment to values, valued living, and 
life fulfilment.   
 
3.6.4 Participant 4  
Participant 4’s ELS scores can be seen in Figure 12. Participant 4’s total 
ELS score at pre-intervention was 50 and at the time of withdrawal was 
57. There was reliable improvement but participant 4 started within 
the non-clinical range. Participant 4’s valued living score pre-
intervention was 40 and post-intervention was 46 and represented an 
improvement in valued living. Participant 4’s life fulfilment score pre-






















Total score Valued living score Life fulfillment score
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Figure 12 
Engaged living score for participant 4 
 
 
Note. This figure shows participant scores for the Engaged Living Scale, 
including total score and subscales valued living and life fulfilment. 
Higher scores indicate closer alignment to values, valued living, and 
life fulfilment.  
 
3.6.5 Participant 5  
Participant 5’s ELS scores can be seen in Figure 13. Participant 5’s total 
ELS score at pre-intervention was 35 and post-intervention was 56. 
Participant 5 achieved reliable and clinically significant change. 
Participant 5’s valued living score pre-intervention was 23 and post-
intervention was 37 and represented an improvement in valued living. 
Participant 5’s life fulfilment score pre-intervention was 12 and post-






















Total score Valued living score Life fulfillment score
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Figure 13 
Engaged living score for participant 5  
 
Note. This figure shows participant scores for the Engaged Living Scale, 
including total score and subscales valued living and life fulfilment. 
Higher scores indicate closer alignment to values, valued living, and 
life fulfilment.  
 
3.6.6 Participant 6 
Participant 6’s ELS scores can be seen in Figure 14. Participant 6’s total 
ELS score at pre-intervention was 44 and post-intervention was 51. 
Participant 6 achieved reliable and clinically significant change. 
Participant 6’s valued living score pre-intervention was 32 and post-
intervention was 37 and represented an improvement in valued living. 
Participant 6’s life fulfilment score pre-intervention was 12 and post-






















Total score Valued living score Life fulfillment score
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Figure 14 
Engaged living score for participant 6 
 
Note. This figure shows participant scores for the Engaged Living Scale, 
including total score and subscales valued living and life fulfilment. 
Higher scores indicate closer alignment to values, valued living, and 
life fulfilment.  
  
3.6.7 Synthesis 
Overall, changes over time were observed in three participants, with 
two showing reliable and clinically significant improvement and one 
showing reliable deterioration. Two participants started in the non-
clinical range, including the participant who demonstrated reliable 
deterioration and at study end four participants were in the non-clinical 
range, including the participant with reliable deterioration. Within the 
subscales three participants demonstrated an improvement in valued 
living and three participants demonstrated an improvement in life 
fulfilment. Conversely, two participants demonstrated a reduction in 






















Total score Valued living score Life fulfillment score
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3.7 Secondary outcome - fatigue  
With the exception of participant 4 (pre-intervention score = 5), fatigue 
scores ranged from 15 to 19 pre-intervention and 12 to 18 post-
intervention in all other participants. The largest change in score was 
a reduction of three (PS01 & PS06), with no participants having an 
increasing score in fatigue. Of those where activation increased, no 
consistent changes were observed in relation to fatigue. Pre-, mid- and 
post-intervention comparisons for participants can be seen in figure 
15. 
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Figure 15 





Note. This figure demonstrates participants’ fatigue scores pre-, mid- 
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3.8 Change interviews 
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3.8.1 Synthesis 
Reports varied between those who experienced change and those that 
did not. In cases of those who did not experience change or withdrew, 
participants reported not having high expectations of the intervention 
and that they could not anticipate changing their lifestyle. 
Comparatively, those that experienced change found the intervention 
interesting and very good. They reflected on the benefits of being able 
to use diaries to review their weeks and focus on their mood and how 
changes came about. They said it was good to be able to take an active 
role in therapy and still have someone to talk too, rather than just 
offloading. On occasions the participants found the structure of the 
diaries (i.e., frequency of recording) laborious, yet, in spite of the time 
taken to complete diaries participants commented on their usefulness. 
Even the participants who did not experience change indicated a 
heightened awareness of their difficulties and having some ideas for 
solutions, but their perception was that the solutions would have been 
too hard to put in place.  
 
Participants who experienced change commented on the rapport 
developed with the researcher which was seen as positive. Participants 
said that they felt more positive post-intervention than before the 
sessions and that they were placing things in perspective by reviewing 
their diaries, which they found helpful as it allowed more emotional 
capacity to make changes. One participant even highlighted that 
engaging in therapy had been a platform to improve communication 
between the participant and their spouse, which had led to additional 
support from the spouse to help the participant introduce behavioural 
change by identifying antecedents. In one participant where change 
was not identified, they commented that they did not think that they 
were depressed and that they were only experiencing low mood on 
occasion.  
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Changes attributed to therapy were linked to diary usage and having 
space to talk, although initially opening up was hard. Few external 
attributions were described beyond one participant who reported 
improved communication which they credited the therapy process to. 
Lack of changes external to therapy were attributed to identifying 
mood related difficulties and some potential solutions but they did not 
know how to implement them and that they did not anticipate any 
change due to being ‘set in their ways.’ External factors associated to 
non-change and barriers to change were the participant’s MS 
symptoms. They reported being able to highlight difficulties associated 
to low mood and think about some solutions but commented that the 
amount of additional time it takes to complete activities (e.g., activities 
of daily living) meant that they had less time to implement new 
activities. A number of stressors were reported across all participants 
including MS symptoms, reliance on others, not having time, and ill 
health amongst loved ones.  
 
The flexibility of the researcher and sessions, and the questionnaires 
being online were reported as helpful. Overall, the intervention 
appeared to increase self-reflection, problem solving, and an increased 
awareness of shared experiences, with the biggest barrier to change 
being ill-health.   
 
3.9 Fidelity 
From the BATD-R checklist, the following competencies were assessed, 
Session one: (a) Confidentiality; (b) Discussion of depression; (c) 
Treatment rationale; (d) Daily monitoring form (importance, 
enjoyment, and achievement ratings, and when should you complete 
the form; (e) Important things about the structure of the treatment. 
Session two: (a) Daily monitoring, review homework and troubleshoot; 
(b) Treatment rationale review; (c) Values identification and forms. 
Session three: (a) Daily monitoring, review homework and 
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troubleshoot; (b) Values identification and forms review; (c) Activity 
selection and ranking; (d) Daily monitoring with activity planning. 
Session four: (a) Daily monitoring, review homework and 
troubleshoot; (b) Daily monitoring with activity planning. Session five: 
(a) Daily monitoring, review homework and troubleshoot; (b) Values 
identification and forms review; (c) Daily monitoring with activity 
planning. Evaluation session: (a) Daily monitoring, review; and (b) 
planning for the future.  
 
Recordings were selected such that each of the five sessions in the 
intervention plan and evaluation session were represented at least 
once, and no two sessions were from the same participant (i.e., 
maximising variation across sessions and participants). Sampled 
sessions were: PS01S1, PS02S3, PS03S4, PS04S2, PS05Evaluation, 
and PS06S5. 
 
3.10 Participant summaries 
Participant 1 attended all sessions and took part in the change 
interview. No reliable change was found in depression, activation, 
engaged living, fatigue, or health related quality of life. Visual analysis 
showed a slight trend to improvement in depression, though 
participant 1 did not move to clinically significant improvement or 
demonstrate systematic change using dual-criterion. Visual analysis 
showed no trend to improvement or deterioration in any other 
outcome. Effect size for percentage exceeding the median was highly 
effective for depression on the HADS depression subscale and 
moderately effective on activation on the BADS-SF. Participant 1 
reported in sessions that they could not try many new activities due to 
their MS. Additionally, they reported that the amount of additional time 
that it takes to complete daily activities makes it hard to find time to 
implement solutions to difficulties that had been identified during 
sessions. Homework adherence was poor with in session reporting 
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noting that diaries or activities were not planned. At treatment end 
Participant 1 did not want an onward referral. 
 
Participant 2 attended all sessions. No reliable change was found in 
depression, activation, engaged living, fatigue, or health related quality 
of life. Visual analysis showed no trend to improvement or deterioration 
in any outcome, although on conservative dual-criterion they were one 
observation off showing systematic change on the HADS depression 
subscale. Effect size for percentage exceeding the median was 
moderately effective for depression on the HADS depression subscale 
and questionable or non-effective on activation on the BADS-SF. 
Participant 2 reported a relapse in symptoms which coincided with a 
levelling off in measures. Participant 2 was particularly worried about 
the effect of their symptoms on their speech and requested not to take 
part in the change interview. Participant 2 regularly completed 
homework and self-opted to email their diaries ready for sessions. 
Participant 2 reported an increase in activity and enjoyment, 
achievement, and importance in the activities but when completing the 
outcome measures, he reported not engaging in activity and little 
improvement in mood. Of note, participant 2 found discussing values 
very difficult and that the time spent on highlighting their values 
instead highlighted a lack of values and valued living which participant 
2 found distressing. Participant 2 requested an onward referral to 
therapy after taking part in the study commenting that there were a 
number of difficulties they wanted to explore in therapy. 
 
Participant 3 attended all sessions. No reliable or clinically significant 
change was found in depression, activation, fatigue, or health related 
quality of life. Reliable deterioration was found in engaged living, but 
the participant started and remained within the non-clinical range pre- 
and post-intervention. Participant 3 was at clinical cut off for non-
clinical depression at the end of intervention. Effect size for percentage 
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exceeding the median was highly effective for depression on the HADS 
depression subscale and activation on the BADS-SF. Participant 3 
reported being unwell and spent a brief period in hospital during the 
first few weeks. They indicated that the illness and made them feel 
increasingly fatigued. Additionally, participant 3’s mother was very 
unwell throughout the intervention, during the sessions participant 3 
became tearful on a number of occasions when discussing this. Further, 
participant 3 reported a number of friends had died during the 
intervention which had been particularly upsetting. Despite the 
external stressors, visual analysis showed a trend to improvement in 
depression and activation. Participant 3 regularly completed homework 
tasks and completed the change interview. Participant 3 reported that 
having the space to talk and to be able to reflect on behaviours using 
their diaries was helpful. Participant 3 declined an onward referral.  
 
Participant 4 attended two sessions and then withdrew. Participant 4 
agreed to take part in the change interview. Participant 4 stated that 
it was not worth trying new activities because nothing would change 
and that any planned activities, he could predict what score he would 
rate enjoyment, importance, and achievement before doing them. 
Participant 4 said that no number of questionnaires would change his 
mood because his MS is a condition, that he has all the time.  
 
Participant 5 attended all sessions. Improved reliable and clinically 
significant change was found in depression and engaged living. Reliable 
change was seen in activation and mental health related quality of life 
to improvement. Visual analysis showed an improvement in activation 
from baseline. Systematic improvement was not seen in depression 
scores but were one observation away from meeting criteria. Effect size 
for percentage exceeding the median was moderately effective for 
depression on the HADS depression subscale and highly effective on 
activation on the BADS-SF. Participant 5 took part in the change 
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interview, completed homework and at evaluation reported feeling 
better and did not wish to be given any additional information for on-
going psychological support. Participant 5 reported finding the process 
of scheduling activities very helpful and attributed positive changes 
to mood.   
 
Participant 6 attended all sessions, the length of the time in the study 
was longer than other participants because the participant did not wish 
to have a session during the Christmas and New Year holidays. 
Participant 6 completed outcome measures during those two weeks. 
Reliable and clinically significant change was found in depression and 
engaged living. Reliable improvement was found on the mental health 
related quality of life. Visual analysis showed a trend to improvement 
in depression. Effect size for percentage exceeding the median was 
highly effective for depression on the HADS depression subscale and 
moderately effective on activation on the BADS-SF. Participant 6 
completed homework and took part in the change interview. At 
evaluation they reported feeling better in mood and declined an onward 
referral. They reported positive improvements in communication with 
their spouse and receiving support to identify antecedents to low mood 
to change behaviour. The participant used the diaries to identify 
patterns of behaviour that maintained low mood and used the diaries 
day-to-day to help support changes when they were feeling low. The 
participant also began to evaluate behaviour by asking themselves 
what they would say to a friend who was experiencing similar distress 
or changes in behaviour.    
 
Participant 7 showed a trend to improvement during the baseline 
phase. When discussing changes at debrief they indicated that they 
were feeling much better in mood and declined any information for 
seeking psychological support. 
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Participant 8 showed a trend to improvement during the baseline 
phase. When discussing changes at debrief they indicated that they 
thought that the increase was likely the result of it being Christmas. 
They believed it would be a temporary improvement and they 
requested information to self-refer to psychological therapy. 
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4. Extended discussion 
 
We aimed to (a) examine preliminary efficacy of a behavioural 
activation intervention, for people with secondary progressive MS 
experiencing low mood, (b) understand the feasibility of recruiting, 
retaining, and delivering the intervention, (c) explore whether/how the 
intervention has a positive impact on mood, fatigue, and quality of life 
using process measures, and (d) understand participants’ experience 
of the intervention. 
4.1 Effectiveness 
What works clearing house reports that single-case designs aim to 
assess causal questions such as: “Is this intervention more effective 
than the current “baseline” or “business-as-usual” condition?” 
(Kratochwill et al., 2010, pg3). More specifically, does the introduction 
of an independent variable have a causal relationship with a change on 
the dependent variable. In the case of this study we wanted to 
understand whether the introduction of behavioural activation 
(independent variable) had a change on depression (dependent 
variable) in individuals with on-going and declining physical health 
difficulties. Secondly, to understand mediators and moderators we 
wanted to understand whether behavioural activation increased 
engagement in positively reinforcing behaviours and a decrease in 
maintaining behaviours of depression. If so, does increased 
engagement in positively reinforcing behaviour coincide with the 
introduction of therapy sessions focusing on behavioural activation 
which then has a positive effect on depression. Single-case designs are 
particularly fitting to the pursual of research questions in applied and 
clinical settings (Kratochwill et al., 2010).  
 
It is important to consider whether effectiveness can be observed in 
populations where prevalence is considered lower than general 
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population studies because high powered group studies can be difficult 
to conduct (Kratochwill et al., 2010). When only group designs are 
considered it is not possible to understand the minutiae of who 
responded to an intervention and outcomes can be obscured when only 
reporting effect sizes and/or group means. Helpfully, the design of the 
study allows us to consider the characteristics of those participants that 
did change and those that did not experience change which is 
important when considering effectiveness and future research or 
application.  
 
Effectiveness in single-case experimental designs is typically 
considered as replication. That is, “in most cases experimental control 
is demonstrated when the design documents three demonstrations of 
the experimental effect at three different points… or across different 
cases” (Horner & Spaulding, 2010). Further, experimental effect is 
demonstrated when there is a covariation with the manipulation of the 
independent variable and predicted changes in the dependent variable, 
but there is no formal basis for three demonstrations rather it is just a 
conceptual norm (Kratochwill et al., 2010). It is also difficult to draw 
valid causal influence from AB designs due to the lack of replication 
which means it is harder to rule out alternative explanations for 
changes that are observed (Kratochwill et al., 2010). However, as 
therapeutic learning cannot be taken away introducing later phases is 
not possible. In an attempt to overcome some of the difficulties in 
exploring causality, baselines were established in this study, which in 
some cases meant differing lengths of baseline.  
 
During the baseline one participant was observed to be increasing their 
activation, based on their reporting on the BADS-SF. It is possible that 
expectancy effects were occurring. Expectancy effect occurs when an 
individual begins to react unconsciously because they expect a given 
result. The expectations that are unconsciously responded to occur 
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naturally and can be introduced by the process of giving individuals 
specific information prior to therapy and may contribute to therapeutic 
outcomes (Tambling, 2012). In an attempt to mitigate any expectancy 
effects that may have occurred from responding to measures asking 
about activity levels every-other-day, minimal information was given 
about the process of behavioural activation. Further, the analysis 
method incorporated the use of baseline trends and stability 
(conservative dual-criterion). However, participants were aware that 
the study aimed to reduce low mood by increasing activity levels.   
 
Visual analysis is used to investigate replication effects but each of 
these differ (discussed earlier), in this study conservative dual-criterion 
was used along with percentage exceeding the median. Data were 
supplemented with reliable change indices. When using conservative 
dual-criterion method, the intervention failed to demonstrate three 
replications, but when considering percentage exceeding the median 
analysis the condition is satisfied. When using analyses to triangulate, 
the criteria are satisfied but the variation in scores across measures 
made interpretation difficult and as such considering the criteria 
satisfied should be used with caution. It does however provide a basis 
to consider group effects.  
 
Where no change was observed in low mood scores nor was any 
change in activation scores, which when paired with the evidence that 
increased activation scores led to a reduction in depression, the 
behavioural theory that increasing environmental positive 
reinforcement and reducing maintaining behaviours has a positive 
effect on depression is demonstrated. Whilst in some participants the 
sessions led to increased engagement in activation, the question 
remains as to why this was not observed with all participants. Potential 
theories to explain this observation are discussed in the next sections.  
 
   
         Page 195 of 362 
 
There is an association with poor physical health and decreased mood 
(Kings Fund, 2012). In secondary progressive MS individuals’ 
symptoms do not remit and continue to worsen. Using the baseline 
trajectories for some participants may lend some support that a lack 
of reduction in depression scores may still be a positive outcome. For 
example, where trajectories were increasing for worsening mood, if we 
assume that physical health continues to be poor or declining does a 
levelling off of mood represent a positive change. Certainly, in the case 
of participant 3 they reported benefits from the intervention to their 
mood despite having been ill and experiencing external destressing 
stressors. Whilst the idea that a levelling off of mood scores in the face 
of external stressors/physical health decrease warrants further 
exploration, we are still left with the question of why in some cases 
improved mood observed?  
 
Using repeated measurement strategy and the BADS-SF means we can 
be somewhat confident that the intervention was effective; at least 
when activation was increased. However, there were cases where 
improvements in activation did not occur. For participant 2 there 
appeared to be a slight change in activation and mood when the activity 
planning sessions started but following a relapse in MS symptoms 
activation reduced and mood increased, which is congruent with the 
theory around positively reinforcing activities and mood. Of particular 
interest with participant 2 was self-reporting during the intervention. 
Participant 2 emailed his activity diaries for each session and talked 
through them, commenting on a number of activities that he was 
engaging in, enjoying, and deriving a sense of achievement. Despite 
these reports when completing post-session measures, he repeatedly 
scored indicating that he was avoidant of activities and was not 
enjoying. It is possible that demand characteristics led him to comment 
on enjoying activities, but the session were structured to cover ‘what 
we did not do, did not enjoy, and to think about obstacles.’ If the 
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sessions had only focused on discussing positive activities it is possible 
there would have been an increased pressure to then find and discuss 
enjoyable activities, but as time was spent (as highlighted in fidelity 
assessments) on identifying and focusing on negative behaviours this 
was less likely the case. During the intervention participant 2 found 
discussing and identifying values difficult. Participant 2 often discussed 
childhood experiences and wished to explore childhood further, 
commenting that he had bought a compassion focused therapy book 
and identified with many of the examples and could relate to the 
approach. He discussed being hopeful that post-intervention that I 
would support him to make a referral to work with a psychologist using 
compassion focused therapy. It is possible that secondary gains were 
occurring, and he thought that he needed to score high for distress so 
that an onward referral would be discussed post-intervention. During 
the session recordings he discussed a number of things that he found 
helpful about the approach, including having someone to discuss his 
distress with, but as his symptoms relapsed, he was particularly 
worried about his speech and that he was embarrassed that CM 
(interviewer) would not understand him. He had agreed to take part in 




Only one participant withdrew during the study. The participant 
withdrew after the baseline and after session two, which was prior to 
any activity scheduling activities and only during the activity 
monitoring period. The point in which the participant withdrew did not 
occur at a critical time, which if they had, might compromise the 
study’s internal validity and render any causal inferences invalid 
(Kratochwill et al., 2010). The participant’s scores were similar at 
baseline to those that remained in the study. There were no apparent 
differences about this participant versus those that completed the 
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intervention. Baseline had achieved stability and there were no visually 
apparent differences compared to completers. The participant reported 
that they did not see how their mood could change because their MS 
would always be present. It is possible that completing the 
questionnaires and diary sheets highlighted to the participant the 
difficulties in planning behaviour. Certainly, they talked about their 
dependence on others to help enable them and give them access to 
activities. It is possible that the participant was experiencing learned 
helplessness (Seligman, 1972; Seligman & Maier, 1967) discussed 
below. 
 
4.2 Findings in context of previous research and theory  
4.2.1 Behavioural theory and behavioural activation 
 
Behaviourism is founded in the use of scientific and objective methods 
to investigate occurrences (Watson, 1913). By using single-case 
experimental design we were able to explore behavioural responses to 
the introduction of intervention in phases.  
 
In the first phase (baseline) we were able to investigate the 
behavioural responses of depression, as such we were able to observe 
conditioned behaviours through the participant’s interactions with their 
environment before change was introduced; allowing us to see how 
people’s actions are influenced by environmental stimuli (Stout, 2003). 
At the start of the second phase (intervention) participants were asked 
to make a diary of their activities and rate behaviour in order to gather 
evidence for how their mood was impacted by environmental stimuli. 
However, a level continuation of low mood was not observed as 
expected; it had been assumed that change in mood would likely occur 
at the point of scheduling activities (after several sessions). It is 
important to note that giving participants questionnaires and diaries to 
keep is an introduction of a behaviour change. As, participants were 
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able to think about their activity levels, values, and use their diaries to 
note when their mood was better or worse which may have led to 
behaviour change.  
 
Thus, the process of observation in itself may have led to change, 
which may explain the increasing activation baseline scores for 
participant 6 for positively reinforcing behaviour. Behavioural theory 
posits that depression is maintained due to schedules of reinforcement 
(Skinner, 1953). We know that the prominence of a stimulus affects 
the strength of association in behaviour, perhaps when participants 
were observing their mood and behaviour, and answering 
questionnaires which are designed to make them think about enjoyable 
activities there were unintended consequences. Specifically, that some 
behaviours were changed or put on an extinction schedule.   
 
The improvement in mood coinciding with positively reinforcing 
activities as the intervention went on may be a demonstration 
extinction schedules in effect. The gradual changes observed may be 
a demonstration of the association between stimuli weakening and 
then stopping. Skinner (1948) lends support to the notion of 
weakening stimuli as he reported that the rate of extinction is affected 
by the original response, i.e., the longer a behaviour has been 
conditioned the longer it can take for the behaviour to become extinct. 
In the participants, delayed extinction was seen as maladaptive coping 
strategies and avoiding activities.    
 
Despite extinction being observed in some participants other 
participants did not demonstrate any change in mood or positively 
reinforcing behaviour. It is important to consider the lack of change in 
behaviour from a theoretical perspective. In depressed individuals 
reduced activity is the result of a lack of reinforcement in activities that 
were previously reinforcing (Ferster, 1973). The loss of reinforcement 
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may be explained by factors such as relational, occupational, or social 
activity reduction, thereby removing positive reinforcement for an 
activity and for behaviours that precede the activity. Certainly, based 
on the participants that did not change they commented on their 
dependence on others (paid carers) and the reduced time that they 
had to try and place in new activities to bring about change because of 
their MS symptoms. Comparatively, participants 5 and 6 reported 
receiving increased support from significant others to help with their 
engagement in activities which were thought to provide access to 
environmental reinforcement. Therefore, receiving additional support 
or the perception of how much control one has may influence 
extinction.  
 
When depression occurs with declining physical abilities, individuals 
find it difficult to identify and engage in new activities that have 
pleasurable or reinforcing consequences, which has been 
demonstrated in people with MS (Motl et al., 2009). Despite the finding 
by Motl et al. (2009), with guidance, participants were able to identify 
new activities and in cases also engage in them to have a positive 
impact on their mood. Identifying and engaging in activities that 
provide environmental reinforcement is congruent with Lewinsohn’s 
(1974) theory of depression and the results of the study are supportive 
of the theory. Further, by using techniques such as activity monitoring 
and scheduling (Jacobson et al., 1996), which aims to address 
environmental deficits in positive reinforcement, behavioural activation 
decreased depression.  
 
4.2.2 Behavioural activation and neurological conditions 
 
Over the years a number of meta-analyses have been conducted and 
demonstrated the efficacy of behavioural activation (Cuijpers et al., 
2007; Ekers et al., 2008; Mazzucchelli et al., 2009). Further, in a 
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systematic review of behavioural activation for depression in 
individuals with neurological conditions (Oates et al., 2019), eight of 
the ten studies reported a positive outcome for behavioural activation. 
Similar adaptations were made in the present study such as the use of 
telephone-psychotherapy and the effect sizes were comparable to the 
studies reported in the systematic review. There are still a number of 
differences worth considering in regard to the populations studied in 
the systematic review. For example, individuals with secondary 
progressive MS have declining physical health and cognition. In the 
systematic review, benefits were reported using behavioural activation 
for depression in stroke, epilepsy, and brain injury populations, where 
typically, continued deterioration is not observed. Support for 
behavioural activation for depression was found with people with 
dementia, but study adaptations frequently used carers or family 
members to introduce behaviour change and report perceived mood. 
In this study, using guided self-help participants were able to observe 
and engage in activity despite declining physical health and cognition. 
 
4.2.3 Theory of planned behaviour 
 
The theory of planned behaviour (Ajzen, 1991) can provide additional 
understanding to the results from the current study, for both changes 
and non-changes. Help seeking behaviour is contingent on three critical 
factors, they are: attitudes towards help-seeking, intention to seek 
help, and actual help-seeking behaviour (Gulliver et al., 2012). 
Involvement in research does not necessarily mean that an individual 
is planning to make changes to self, instead the primary driver may be 
to engage in research or to help others. Still, each participant was 
aware of the study and the intervention and chose to take part. The 
route in which participants entered the study varied. With some 
participants being provided information by their MS Clinical Care Team 
and others receiving information through the MS Society support 
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branches. It is possible that participants attended their routine clinical 
appointments and were asked about their mental health which led to 
an unplanned discussion and being provided with study information. 
Therefore, the individual may not have had the intention of seeking 
support for mental health but further understanding of what drew each 
participant to the study is needed.  
 
As mentioned, each participant was aware of the study and the 
intervention when they agreed to take part, so if opportunistic 
conversations of presentations removed intention to seek in help-
seeking theory, continued engagement in the study is not explained. 
Only one participant withdrew, and no sessions were missed, which 
may suggest that help-seeking attitudes for mental health are 
considered positive. Understanding subjective needs can further 
explain engagement because individuals seek support to solve their 
problems and having an awareness of one’s subjective needs 
influences decisions on whether or not to seek help (Gross & McMullen, 
1983). 
 
The theory of planned behaviour (an extension of theory of reasoned 
action) posits that the best predictor of behaviour is the intention to 
act. Intention is an individual’s attitude toward behaviour, subjective 
norms, and perceived behavioural control. Therefore, if an individual 
evaluates a behaviour as positive (attitude), and they believe that 
other individuals, such as family or professionals, want them to engage 
in the behaviour (subjective norm) then the individual’s motivation is 
higher, and they are more likely to engage in the behaviour (Ajzen, 
1991). Later, an additional factor was added to the likelihood of 
intention and behaviour which was the perceived ease or difficulty that 
the individual can carry out the behaviour. In the case of the 
participants, those without immediate familial support and who were 
dependent on paid carers either did not demonstrate change or 
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withdrew. It is possible that without subjective norms belief in 
behaviour change was less. Or in behavioural theory terms there was 
a lack of environmental contingent reinforcement from family or friends 
commenting on change or providing praise.   
 
4.2.4 Learned helplessness 
 
Learned helplessness is a phenomenon that occurs when an individual 
has been subject to repeated exposure to aversive stimuli that is 
beyond their control. As such, in cases of depression the individual’s 
real or perceived absence of control of an outcome may account for 
the maintenance of low mood (Seligman, 1975). For participants 1 and 
4 they indicated in their sessions and in the change interviews that 
they cannot change the activities that they do and have less control 
due to their dependence on carers, who may not arrive at set times, 
or because of the additional time activities take to complete. Indeed, 
early research into helplessness posited that an individual’s acceptance 
of powerlessness resulted in learned helplessness. Therefore, attempts 
to escape or avoid aversive stimuli cease even when presented with 
alternatives. Over time, learned helplessness may generalise to other 
situations (Hiroto & Seligman, 1975), as individuals with secondary 
progressive MS have no control over their physical symptoms it may 
be possible that a generalisation occurs to agency for their mental 
health. More recently, studies have indicated that individuals’ default 
state is one of no control and that helpfulness is the state which is 
learned (Maier & Seligman, 2016). As such, introducing the idea of 
helpfulness supports the results of this study where changes were 
observed and gives optimism that helpfulness can be learned with an 
appropriate reinforcement schedule, yet more information is needed 
from the individuals who did not change to better understand where to 
intervene. 
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Whilst the initial studies that led to the observation of helplessness 
were behavioural, the findings on the two-factor theory of avoidance 
learning led to researchers assuming a cognitive role in learning is 
required (Maier & Seligman, 2016). For example, according to Peterson 
and Seligman (1984) how someone interprets an event impacts the 
likelihood of helplessness and subsequent depression. However, 
behavioural theories such as relational frame theory have gone some 
way to provide a behavioural overview of the generalisation of 
behaviour (Hayes et al., 2001). 
 
The presence of helplessness and/or how someone perceives an event 
impacts their physical and mental health. For example, someone who 
perceives events as uncontrollable have worse outcomes on physical 
and mental health and as such are less likely to change unhealthy 
patterns of behaviour (Henry, 2005). There appears to be a 
bidirectional impact on depression and social impact where learned 
helplessness is present. The impact demonstrates the complex 
interactions that are occurring for individuals because without the 
presence of helplessness, depression impacts social activity 
(Lewinsohn, 1974) and lack of social activity impacts depression 
(Wilkinson & das Nair, 2013). Therefore, unpicking the interactions to 
target interventions may be better achieved with a detailed assessment 
rather than a one size fits all manualised approach for all. 
 
In terms of those with secondary progressive MS long-term 
presentation of helplessness may be explained by Abramson et al. 
(1978). Abramson et al. (1978) stated that the inability to escape 
would only result in momentary helplessness. Instead, the attributional 
reformulation that individuals make of what causes their helplessness 
predicted the length and extent of helplessness. When individuals 
attributed helplessness to unsolvable problems, long-term 
helplessness was observed. In the case of those with secondary 
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progressive MS the continued progression of the disease and increasing 




Along with ideas of learned helplessness, processes of attribution may 
be explained by self-efficacy (Bandura, 1982). Self-efficacy is the 
concept of how much ability one has to deal with situations, or simply 
put, one’s agency. When we are able to understand the beliefs that an 
individual has about their power and ability to affect situations, we can 
influence the power an individual has and how they face challenges, 
which is particularly important when considering health related 
behaviours. As reduced self-efficacy is associated with predicted health 
behaviours (Luszczynska & Schwarzer, 2005).  
 
In research and interventions aimed at behaviour change considering 
self-efficacy is important because individuals are likely to avoid tasks 
when self-efficacy is low and engage in tasks when self-efficacy is high 
(Muris, 2002). Where it may not be possible to put behaviours on an 
extinction schedule using reinforcement, interventions may be 
supported by raising self-efficacy in order to increase the likelihood of 
behaviour change. The sooner the environmental reinforcement occurs 
the more likely a behaviour change and maintenance is. However, 
when the avoidance of behaviour does not provide an opportunity for 
reinforcement, we need to understand how best to ensure that a 
behaviour occurs or how to prevent avoidance behaviours. As 
therapists are not present at all times to introduce antecedent control 
it may be that raising self-efficacy may be a way to support people to 
engage in behaviour change or overcome reduced motivation.  
 
Reduced motivation is associated with depression (National Institute 
for Health and Care Excellence, 2015). In behavioural activation 
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individuals are encouraged to, rather than waiting for motivation to 
return, engage in activities and motivation will occur after repeated 
reinforcement (Lejuez et al., 2011). However, if competing 
reinforcement is perpetuating avoidance behaviours and therefore 
starving a participant of positive environmental reinforcement then 
considering an individual’s self-efficacy may be of further benefit as 
those with low self-efficacy are less likely to try or maintain efforts to 
complete tasks than those with high self-efficacy leading to learned 
helplessness. 
 
4.2.6 Secondary gains 
 
During the intervention some participants did not report any changes. 
In particular, one participant reported positive experiences in activities 
and psychological wellbeing in the sessions but on measures reported 
the opposite. It is possible that as an individual loses contact with their 
activities that a verbal preoccupation with the loss can occur (Azrin & 
Besalel, 1981; Ferster, 1973). Verbal preoccupation can present in a 
number of ways such as crying or complaining to others. In the case 
of participant 2 verbal preoccupation presented as repeated 
discussions about not having any values nor having lived a life as such. 
The participant used sessions to often talk about childhood and needing 
guidance to focus back to behavioural activation. As such, it was 
discussed with the participant that further therapy may be of benefit 
and the participant was very keen to explore how to get an onward 
referral post-intervention. It is possible that the incongruence between 
self-report in sessions and measures was linked to a secondary gain of 
receiving future therapy if mood continued to present as low. Verbal 
behaviour may be positively reinforced by individuals around the 
depressed person as the system offer sympathy, leading to an increase 
in the unhelpful behaviour (Azrin & Besalel, 1981). Unfortunately, 
participant 2 did not take part in the change interview, the withdrawal 
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from the change interview coincided with a MS related symptom 
relapse where the participant had difficulties speaking. The participant 
did contact on two occasions post-intervention to discuss onward 
referral and discuss therapy types with the hope to spend time thinking 




This study, in the cases of participants 1 and 2, did not appear to make 
improvements in people moving toward identifying their values and 
engaging in valued activity. Instead, both participants reported 
difficulties identifying values and living a valued life as they compared 
their current capability to their abilities pre-MS diagnosis. The number 
of sessions delivered in the study and the pace of the sessions meant 
that a set amount of time was designated to the establishment of 
values. The number and length of sessions were selected in order to 
keep in line with comparable therapy initiatives like IAPT. However, in 
this study establishing values was difficult and provides an insight into 
the difficulties of rigid manualised interventions as there is an 
assumption that all individuals will progress at the same rate.  
 
The use of the measures may have had unintended consequences, in 
that participants were regularly reminded of their difficulties. In ACT, 
this process is not problematic as reduction in mood is not the desired 
outcome but in behavioural activation reducing depression is 
theoretically aligned to the idea that increasing environmental 
reinforcement reduces depressive behaviour.  
 
4.4 Fatigue 
It was hypothesised that an increase in activity measured by the BADS-
SF would demonstrate favourable effects on fatigue. There appears to 
be cyclical effect of low mood leading to fewer activities and fewer 
activities leading to low mood. In studies of increased activity or 
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exercise in people with chronic fatigue, individuals report reduced 
fatigue and, in some cases, improved psychological wellbeing (Larun 
et al., 2015). Notably, in this study no changes were observed to 
fatigue whether activation increased or remained the same. It is 
possible that in this case participants were selecting positively 
reinforcing activities that did not include exercise or physical activity 
as a component. Despite the lack of change to fatigue, outcomes 
suggest that when individuals are able to support themselves to 
engage in activities fatigue was not a reported barrier and positively 
fatigue did not increase and represent a barrier.  
4.5 Feasibility  
4.5.1 Recruitment 
 
The strategy used in this study for recruitment was feasible. However, 
for a larger trial would need further consideration. More participants 
were identified and recruited from MS Society local groups than the MS 
Clinical Care team. Should the recruitment strategy be expanded 
increased involvement from multisite NHS trusts would be necessary. 
Clinic appointments are often fast paced with both clinicians and 
patients having agendas to cover in the time frame. As patients often 
only see clinicians in the recruiting service six-monthly, considering 
approaches such as contacting patients from a database would be 
beneficial. In some trusts having a database of people interested in 
research and their condition has been achieved as part of routine care 
questions asked at review, with patients opting into communication.   
It is possible that the participants included in this study may be more 
motivated to take part and engage in psychological therapy than those 
who did not. Conducting a feasibility randomised-controlled trial as 
directed as the next step in the MRC framework would provide further 
information on recruitment strategy and attrition.  
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4.5.2 Session delivery  
Sessions were delivered via the telephone or using Skype. No sessions 
were cancelled or missed. However, conducting sessions using 
technology allowed increased flexibility due to participants not needing 
to arrange transport or the clinician not needing to arrange therapy 
rooms. As a result, it was possible to provide increased flexibility to 
session time, dependent on the diary of the clinician which was 
evidenced by moving the time of one or two sessions. Being able to 
move the sessions was beneficial as it allowed people to engage in 
activities which they had planned as part of their activity goals.  
 
The number of sessions was acceptable to participants, however, 
significant changes to values was not observed. Participants reported 
that the concept of values whilst helpful was difficult to grasp. 
Additional time would be needed to facilitate greater support to 
identification of values. However, changes were observed despite 
difficulties to values identification which warrants additional 
investigation into the necessity of values components which could be 
facilitated in a three-arm feasibility trial (control, behavioural activation 




Participants reported that the BATD-R manual was understandable, 
and the worksheets were easy to complete. However, participants 
reported that the time frequency was too high on the diaries, additional 
room needed to be added for those with difficulty writing, and half of 
the participants preferred to complete diaries electronically.  
4.6 Strengths and limitations 
The study contributes a structured design to investigate mediators and 
moderators of behavioural activation for depression in individuals with 
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secondary progressive MS. The study was designed with the aim to 
balance between ecological validity and experimental control. Multiple 
single-case experimental design studies require a critical in-depth 
analysis but often produce a varied picture in terms of effectiveness. 
Whist the results begin to demonstrate that people with secondary 
progressive MS can identify and engage in activities to increase positive 
reinforcement and reduce depressive symptoms, the outcomes among 
all participants was slightly varied and therefore does not provide 
clarity on the efficacy of behavioural activation for people with low 
mood and secondary progressive MS which may have been captured 
by a design such as a randomised-controlled trial.  
This multiple single-case experimental design study is an initial 
approach to examine the effects of behavioural activation on 
depression for people with declining physical health (i.e., secondary 
progressive MS) which used a multimodal, multi-measure approach 
which was a data-intensive design. The design provided the benefit of 
triangulation opportunities (Webb et al., 1966) by collecting relevant 
data that reduced the likelihood of missing important information. 
A number of measures were used to provide detailed information in 
regard to mood, behaviour change, fatigue, values, and quality of life. 
Additionally, there were a good number of data collection points which 
is important in visual analysis and case series data. However, the 
repeat effects of measures can be problematic. As discussed, the 
measures may have contributed to behaviour change due to increased 
awareness of one’s behaviour which threatens internal validity. 
Further, the use of repeated measures could lead to iatrogenic effects. 
For example, participant 2 discussed the difficulties that he had 
identifying values and that he felt he had lived a life without such 
values. The repeated weekly values questionnaire may have served as 
a reminder that his observation on his life had not changed. The 
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measures were selected after careful and critical consideration to 
maximise the understating of behavioural activation for this 
population, which would not have been possible with fewer measures.  
Another strength of the design was establishing a baseline, a short 
questionnaire was used every-other-day to track changes in mood and 
activation. Using a modified short screen meant that baseline data 
points could be collected and established in a shorter period of time 
than using weeks to months of HADS questionnaires, which would have 
meant prolonging intervention. Whilst data points could be collected 
over a shorter period of time the process of adapting measures 
threatens the validity and reliability of the measure. Further, 
converting the data from the PHQ2 using trendlines and intercepts was 
not without difficulty as the sensitivity for change in both the HADS 
and PHQ2 are different. To overcome the changes made to baseline 
data a triangulation of assessment was used including the conservative 
dual-criterion method which takes into account trendline from baseline. 
Therefore, any increase or decrease could still be analysed taking into 
account behaviour observed prior to intervention. 
One potential limitation of the study was the time of year. Several 
participants took part over Christmas. One participant whose baseline 
trended to improvement commented that he thought that things had 
not changed in regard to his mood and that the reported changes on 
measures were likely accounted for by it being Christmas which they 
said often gives people a lift in mood. However, Christmas does not 
always increase people’s mood as it can be a polarising period because 
people with low mood may feel extra pressure to socialise, people may 
think about loss more, or may not have anyone to share Christmas 
with.  
Therapeutic alliance and its potential effects on outcome need to be 
considered (Orlinsky et al., 1994) as change may be due to relational 
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factors. Indeed, variance around common factors can be accredited to 
relational factors (Wampold & Imel, 2015). During the change 
interviews participants commented positively on LLO throughout the 
study, which may be a confounding variable. As a therapeutic 
relationship measure was not used it is not possible to evaluate the 
impact of alliance on outcomes. 
Participants completed the intervention and study procedures such as 
measures with no adverse events. One participant withdrew prior to 
activity scheduling reporting that he did not believe it was possible to 
improve his mood. Overall, the completion and lack of adverse events 
suggests that the intervention was appropriately safe and well 
accepted.  
Finally, it is possible that recall and/or social desirability bias (Van de 
Ven & Huber, 1990) may have occurred. As participants reported their 
ratings for activities and discussed their diaries, they may have felt 
pressured to report completion and or benefits. Additionally, change 
interviews required participants to retrospectively recall their 
experiences which may have resulted in inconsistencies. In order to 
mediate potential bias, all diary discussions (completion or non-
completion) were viewed as learning opportunities with participants, 
and change interviews were conducted within two-weeks of the 
evaluation session.  
4.7 Implications for clinical practice and future research  
Behavioural activation is a well-established intervention; however, it is 
used less frequently in isolation. In terms of identifying parsimonious 
interventions for individuals with degenerative conditions the findings 
of this study support the use of behavioural activation as a guided self-
help approach via telephone-psychotherapy. Benefits of reduced low 
mood were observed in participants where activation increased, with 
no adverse effects observed. The design of the study was structured 
   
         Page 212 of 362 
 
to replicate potential clinical practice using a structured manualised 
approach with worksheets and script to provide guided self-help, which 
increases the ecological validity of the findings. Whist the findings of 
the study are helpful, it is important to not over- or understate the 
effectiveness of the intervention due to the sample size and lack of 
control group to contextualise. The design of the study provides 
insights into mediators and moderators of therapy which is important 
because it is necessary to understand what, if anything, creates 
change. The increase in activities that were positively reinforcing 
reduced mood. The positive impact may be attractive to individuals and 
the NHS as the number of sessions and format are comparable to 
existing services such as IAPT. However, behaviour change was not 
observed in all cases and future research is needed to understand why 
behaviour change does not occur in individuals with degenerative 
conditions and randomised-controlled trials are needed to provide 
comparative data on group effects and therefore whether behavioural 
activation for individuals with secondary progressive MS is efficacious. 
Due to the manualised and scripted approach repeating the 
intervention in a randomised-controlled trial should be harmonious. As 
previously discussed, the use of values within the intervention warrants 
further understanding and would be feasible in a three-arm trial.  
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5. Personal Reflections 
 
This section offers my personal reflections on the research process 
including the reasons for conducting research in this area, reflections 
on the literature, rationale for selecting behavioural activation, 
methodological considerations, and learning points.  
 
Typically, quantitative research projects do not include a reflective 
process nor is it common place to include reflections in a critical realist 
framework. However, as critical realism theorises that a world exists 
independent of an individual’s understanding and that a world exists of 
subjective interpretations that influence the way individuals experience 
it (Edwards et al., 2014) it would be helpful to understand how I 
attempted to balance the perspectives within the study. As I have 
considered the history, beliefs, and context in which participants live it 
seems fitting that I consider my own within the same context. Further, 
clinical psychologists are uniquely placed within the healthcare 
profession as we are encouraged to be reflective in our practice in order 
to promote growth and engage in evidenced based practice (McIntosh, 
2010).  
 
When I started clinical training, I had a number of ideas that I wanted 
to consider for my thesis; which I hoped I would be able to link to my 
previous experiences. I wanted to conduct research with individuals 
who had neurological conditions and hoped to be able to draw on the 
considerable experience of the course staff and field supervisors who 
had expertise in this area. I hoped that continuing to develop my skills 
within this area would help me apply clinical skills post-training. Based 
on my experience of working with people who had Parkinson’s disease 
I was aware that there are individuals who experience a number of 
difficulties in the face of increasing physical difficulty but there was a 
lack of adapted therapeutic approaches available to them. I discovered 
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that the course staff had close links and a growing portfolio of research 
working with people who had MS. I was able to spend time learning 
about the condition and the challenges individuals face and how many 
services are set up to support individuals with cognitively driven 
interventions. The need for the research, and more specifically, 
effective interventions is high when considering the economic 
pressures that the NHS faces. Further, as a move toward integrating 
physical and mental health concepts continues to grow, and research 
shows the bidirectional effects on mental and physical health 
outcomes, completing research in this area is important.  
 
Whilst critically evaluating the literature on mental health prevalence 
in individuals with neurological conditions I found it surprising that 
despite the vast number of neurological conditions and the varying 
difficulties including cognitive, emotional, and behavioural changes, 
there were no specific guidelines relating to supporting mental health 
difficulties in neurological populations. Instead, NICE guidance 
suggests referencing the guidelines for supporting people with mental 
health difficulties who have chronic health difficulties. Despite the lack 
of specific guidelines, NICE did make recommendations that 
behavioural activation approaches needed investigating for their 
effectiveness. 
 
Whilst the study was in its developmental phase I worked with a patient 
and public involvement panel that consisted of people with secondary 
progressive MS and their carers. During this time, I was able to 
consider the applications of a behavioural activation approach and how 
continued physical decline makes long-term engagement in positively 
reinforcing activities difficult. Within my clinical work I align myself with 
the concepts of Acceptance and Commitment Therapy and its 
application to emotional distress in individuals with physical health 
difficulties. When considering longer-term changes in cognition 
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engagement in Acceptance and Commitment Therapy concepts may be 
difficult but behavioural theory and valued living appeared congruent 
in its application to a secondary progressive MS population.  
 
When completing a systematic review on behavioural activation 
approaches for individuals with a neurological condition (Oates et al., 
2019) there appeared to be some limited evidence of effectiveness of 
behavioural activation in reducing depression, though less was known 
about the impact of behavioural activation on progressive conditions.  
 
When designing the research, I considered the most appropriate 
approach to answer my research questions. Whilst randomised-
controlled trials are gold standard for assessing effectiveness, the MRC 
guidance for developing effective strategies (Moore et al., 2015) made 
me consider the importance of demonstrating processes that occur 
during interventions. The evidence base for process in behavioural 
activation research is lacking. Therefore, I concluded that the primary 
importance, was to first show that behavioural activation processes 
account for changes in depression before considering group 
comparison research. 
 
Single-case experimental designs use repeated measurement of the 
process and outcome of interest. Therefore, the measurement strategy 
needed careful consideration to ensure that we could confidently 
attribute change to therapy rather than non-therapeutic variables. 
Initially, I had selected measures with good reliability and validity 
however in the early design iterations the measures were full length 
versions. In the process of trying to ensure rigour I had lost contact 
with the practitioner element of the scientist-practitioner approach, 
and I had not fully considered the burden and fatigue that completing 
the high number of questions and questionnaires would cause. People 
with secondary progressive MS experience fatigue and when people 
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experience depression, we know that engagement in tasks is difficult 
and that lack of motivation is common. Thankfully, being able to work 
with people who have secondary progressive MS and their carers was 
a valuable opportunity to consider the impact that my initial protocol 
would have caused, the process also put me in direct contact with my 
end users and I was able to step back in to a practitioner mindset and 
empathically consider how to strike the balance between strong 
methodological approaches that also had the ability to work in practice.  
 
The selection of the behavioural activation manual was something that 
I reflected on for some time. Eventually, the BATD-R was selected due 
to its use of values-based activities which was congruent with the idea 
that as physical health declined, activities could still be identified that 
were positively reinforcing for them. The literature supporting the use 
of a five-session model and the additional training video and paper to 
use the manual meant that I felt skilled in my ability to apply it to the 
population studied. 
  
I had experience of conducting research within the NHS and completing 
ethical applications. I knew it was important to start early in order to 
ensure enough time was available to complete the research. I had not 
anticipated the amount of time and administration resources that 
would be involved when working as an individual and not a research 
team. The research coincided with changes to data protection as it 
moved to GDPR, also the ethical process changed so that I no longer 
needed to apply for both university ethics and HRA approval. 
Unfortunately, I had already started the process for data protection 
under the old act and applied for university ethics as everything 
changed. The HRA process felt manageable due to having experienced 
the process previously but I had not anticipated the effects of recruiting 
at a site that I did not work for. There was a lack of continuity from 
HRA approval to site set up which created significant delays and I found 
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myself trying to balance increasing anxiety and recruiting enough 
participants.  
 
Based on the literature the recruitment plan seemed sound. The local 
site team provided information to potential participants, but it is not 
clear whether there were less individuals reporting with symptoms of 
low mood and secondary progressive MS or whether promoting the 
study came with challenges. Fortunately, including the local MS Society 
groups was of great benefit, but in the future, I would set up the 
recruitment strategy with the aim to over recruit and use a number of 
sites.  
 
The approach to analysis was well considered because often single-
case experimental designs only use visual analysis with less 
consideration to effect size and reliable and clinically significant 
change. I believed that adding these factors alongside a framework 
analysis provided explanatory power to think about variables and 
potential factors that contribute to change and facilitated more detailed 
interpretation of the data. However, on reflection, without a designated 
primary analysis method the results would have been very difficult to 
interpret due to the variance in findings.  
 
One thing that I noticed was an ambivalence in my motivation to avoid 
attrition. During the study I would often formulate participants’ 
motivation for change because one of the critical skills for a clinical 
psychologist is knowing when to bring about endings. However, as the 
recruitment process had been challenging, I found myself wanting to 
support those in the study which may not have been helpful. 
Specifically, the participant who withdrew frequently sent me emails 
about the process of the research, asking questions about the 
questionnaires, or giving me feedback on the Qualtrics system. When 
I first called him to discuss the study, I called his house phone and it 
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rang out, I then called his mobile phone which also rang out. I followed 
up by emailing and saying that I had been unable to leave a voicemail, 
but I would be happy to call again. The day after I received an email 
where he chastised me for “not appreciating my audience” and that 
whilst he had anticipated my call his anxiety had made it difficult for 
him to answer and that his children can expect the phone to ring 
beyond 20 times before he answers. I felt very guilty but acknowledged 
that it may have been difficult and that it was helpful that he had let 
me know. During his time in the study he said he did not see the point 
in making any changes and that he knew what his outcomes would be. 
He often fixated on certain things, for example, he spent each of the 
sessions retelling one story, which he also told during the change 
interview with CM. After he withdrew from the study, he continued to 
email me about difficulties within his life. I found this very challenging, 
as he had indicated he did not think the sessions could be helpful, but 
he kept emailing me to discuss things that had annoyed or upset him. 
There is a line between being a researcher and clinician and at times I 
found it a hard one to walk. I wanted to support my participant but 
recognised that if he was not in the study, then I was not his therapist. 
I thanked him again for his input into the research and suggested that 
any further support be sought through his GP.  
 
The research process presented a number of opportunities to build on 
my research skills, from writing journal ready papers, the publication 
process, designing and analysing studies, and engaging with the 
administration processes in the NHS. I believe that being able to 
communicate effectively and use my time efficiently meant that I was 
able to pursue hold ups rather than leaving them which would have 
resulted in much longer delays. My confidence has increased in regard 
to synthesising results, particularly in regard to systematic reviews 
where working with my supervisors showed me better ways to 
consolidate results and highlight to a reader what has been found. I 
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have been very appreciative of the MS community for their passion and 
engagement in research projects with them commenting that they 
would like to continue to help support ongoing and upcoming projects 
in this field. Their commitment to engaging in a project and not 
knowing whether it would be effective or not is commendable and 
without their passion this thesis would not have been possible. Despite 
the difficulties in regard to administration and conducting research 
within changing services my enthusiasm to continue to contribute to 
the field is higher than ever.  
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Appendix E 
Participant consent form 
 
CONSENT FORM 
Title of Study: Behavioural Activation for Low mood in Multiple Sclerosis (BALMS) 
IRAS Project ID: 254182 
Name of Researcher: Lloyd Oates         
Participant ID Number: ________________________________________  
 
 
1.  I confirm that I have read the information sheet dated 06/02/19 (version 2) for the 
above study. I have had the opportunity to consider the information, ask questions and 
have had these answered satisfactorily. 
 
2.  I understand that my participation is voluntary and that I am free to withdraw at any 
time without giving any reason, without my medical care or legal rights being affected. 
I understand that should I withdraw then the information collected so far cannot be 
erased and that this information may still be used in the project analysis. 
 
3.  I understand that relevant sections of my medical notes and data collected during the 
study, may be looked at by individuals from the University of Lincoln, from regulatory 
authorities or from the NHS Trust, where it is relevant to my taking part in this research. 
I give permission for these individuals to have access to my records, I understand that 
my personal details will be kept confidential.  
 
4.  I understand that the information collected about me will be used to support 
other research in the future and may be shared anonymously with other researchers.  
 
5.  I agree to my General Practitioner being informed of my participation in the study. 
 
6.  I would like to receive a summary of the results of the study.     YES      NO 
 
7.  I agree to be emailed once a year about remaining on a contact list for involvement 
in potential future studies.      YES      NO 
 
8. I agree to take part in the above study. 
 
______________________       __________       _________________ 
Name of Participant    Date          Signature 
 
 
______________________   __________   ________________ 
Name of Person taking consent  Date          Signature 
 
  
Please initial box 
 
   






Do you have Secondary Progressive MS? 
Have you stopped doing activities you really enjoy? 
Have you noticed your mood has become lower? 
 
If so, a new study may be of benefit to you.  
We would like you to take part in a research project that involves 
identifying activities that link closely to the things that matter to you 
most to improve mood. You would take part in one-to-one sessions, 
that are structured around Behavioural Activation. Behavioural 
activation involves finding activities that you may enjoy or get a 
sense of achievement from and gradually introducing the activities 
into your week.  
During the study a researcher will support you to identify new 
activities and help you consider how to restart old hobbies. The 
sessions will be both face-to-face and through your computer, using a 
video calling programme. You will meet the researcher on five 
occasions and take part in a brief interview after the final session.  
If you would like to know more about the research, then please 
contact me to discuss further and receive a more detailed information 
pack: 16662517@students.lincoln.ac.uk 
Making contact does not commit you to taking part. You will be able 
to ask any questions to learn more about the study, to help you make 
an informed choice. 
This study is being undertaken as part of the qualification for a 
Doctorate in Clinical Psychology and is supervised by:  
Professor Roshan das Nair: Roshan.dasnair@nottingham.ac.uk 
Dr. Nima Moghaddam: NMoghaddam@lincoln.ac.uk 
Dr. Nikolaos Evangelou: Nikos.Evangelou@nottingham.ac.uk 
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Participant Information Sheet 
(Version 2: 06/02/2019) 
IRAS ID: 254182 
 
Title of Study: Behavioural Activation for Low mood in Multiple 
Sclerosis (BALMS) 
Name of Researcher and Supervisors: Lloyd Oates (Researcher), 
Professor Roshan das Nair (Supervisor), Dr. Nima Moghaddam 
(Supervisor), and Dr. Nikolaos Evangelou (Supervisor)   
 
We'd like to invite you to take part in our research study. The study is 
being undertaken as part of the qualification for a Doctorate in 
Clinical Psychology. Joining the study is entirely up to you, before you 
decide we would like you to understand why the research is being 
done and what it would involve for you. One of our team will go 
through this information sheet with you, to help you decide if you 
would like to take part and answer any questions you may have. 
We'd suggest this should take about 15 minutes. Please feel free to 
talk to others about the study if you wish. 
 
What is the purpose of the study? 
Living with Multiple Sclerosis can present many different challenges 
for people. Uncertainty and changing physical abilities may mean that 
people take part less in activities they usually enjoy. People 
diagnosed with secondary progressive Multiple Sclerosis can find it 
difficult to take part in hobbies and interests and it can be hard to 
find new activities to replace them. People can experience low mood 
and fatigue as a result.  
 
Waiting lists for regular NHS psychological therapies can be long and 
often are not specifically tailored for people with secondary 
progressive Multiple Sclerosis. So, we are investigating a 
psychological therapy that has been adapted for people with 
secondary progressive Multiple Sclerosis, across Nottinghamshire. We 
would like to investigate if the therapy helps reduce depression. We 
would also like to understand people’s experiences of the therapy.  
 
Why have I been invited? 
   
         Page 275 of 362 
 
 
You are being invited to take part because you have a diagnosis of 
secondary progressive Multiple Sclerosis and have expressed that you 
have been experiencing low mood. We are inviting ten participants 
like you to take part. 
 
Do I have to take part? 
It is up to you to decide whether to take part. If you decide to take 
part you will be given this information sheet to keep, a short 
questionnaire to complete, and be asked to sign a consent form. If 
you decide to take part, you are still free to withdraw at any time and 
without giving a reason. This would not affect your legal rights. 
 
What will happen to me if I take part? 
 
If you have been informed of the study by the Multiple Sclerosis care 
team or have seen an advertisement for the study in the MS Society 
Nottingham Branch, you have already likely had a discussion with the 
researcher and been sent this information sheet.  
 
Once you have read the information sheet and had any questions 
answered by the researcher, you will be asked to complete a short 
screening questionnaire (Hospital Anxiety and Depression Scale) and 
a consent form. The questionnaire will then be scored. Depending on 
your score, you will be asked if you would like to continue in the 
study. 
 
If you would like to continue you will then be asked to complete an 
online questionnaire. Following this you will be sent a text message 
every two days, to answer eleven brief questions (which form part of 
two questionnaires  - the Patient Health Questionnaire 2 and the 
Behavioural Activation for Depression Scale – Short form). You will 
receive the text messages for a minimum of two weeks and up to 
four weeks. After the fourth week it is possible that taking part may 
come to an end.  
 
If you are asked to continue, the researcher will contact you to 
arrange a visit to your home. During this visit the researcher will ask 
you questions about your interests, hobbies, and the difficulties you 
experience because of your Multiple Sclerosis. You will then be asked 
to complete a pack of questionnaires online and the following 
appointment time will be arranged.  
 
The next four sessions will take place fortnightly using an internet 
video calling system (such as Skype). During these sessions the 
researcher will support you to identify activities you would like to 
complete and to consider any difficulties you may have with this. At 
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the end of the session the researcher will set tasks for the week, such 
as maintaining a diary of your activities. Each week during the 
sessions you will be asked (by text reminder) to answer the 
questionnaires online.  
 
After the fourth session you will be contacted to discuss the activities 
you completed over the last fortnight and asked to complete the 
questionnaires.  
 
Each session will be audio recorded. A random selection of the 
recordings will be listened to by an independent researcher. The 
independent researcher will check that the content of the sessions 
adhered to the manual being used to structure the support. Following 
the review at the end of your involvement in the study, all audio 
recordings will be erased. The recordings may include the use of your 
first name, however, any further identifiable information will be 
removed, prior to review, using audio editing software. The audio 
recordings will not be transcribed.  
 
After the last session you will be contacted by a Trainee Clinical 
Psychologist, who is not involved in the study design, to take part in 
a 30-minute interview over the phone. During the interview you will 
be asked about your opinion of the sessions. Two months after this 
you will be invited to complete the questionnaires one final time.  
 
If at any time you no longer wish to take part, you can contact the 
researcher. You do not need to provide a reason, but, the researcher 
will ask if you would like to take part in the interview. We will ask this 
as it may help us to understand your experience of the therapy 
sessions. 
 
Expenses and payments 
To thank you for your support we would like to give you a £20 
amazon voucher. The voucher will be sent to you after the interview.  
 
What are the possible disadvantages and risks of taking part?  
You need to be aware that you will be asked to complete 
questionnaires every week. It is not expected that the questionnaires 
will take longer than 15-minutes. During the first 2-4 weeks, you will 
be asked to answer questions every two days. These questions are 
not expected to take longer than five minutes.   
 
What are the possible benefits of taking part? 
Whilst it is currently unknown what, if any, direct benefits may occur 
during the study, you will contribute to the ongoing collection of 
knowledge of working psychologically with people with Multiple 
Sclerosis. The hope is to identify potential future benefits.  
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What if there is a problem? 
If you have a concern about any aspect of this study, you should ask 
to speak to the researchers who will do their best to answer your 
questions.  The researchers contact details are given at the end of 
this information sheet. If you remain unhappy and wish to complain 
formally, you can do this by contacting ethics@lincoln.ac.uk. 
 
If you feel that we have let you down in relation to your information 
rights then please contact the Information Compliance team by email 
on compliance@lincoln.ac.uk or by post at Information Compliance, 
Secretariat, University of Lincoln, Brayford Pool, Lincoln, LN6 7TS. 
 
You can also make complaints directly to the Information 
Commissioner’s Office (ICO). The ICO is the independent authority 
upholding information rights for the UK. Their website is ico.org.uk 
and their telephone helpline number is 0303 123 1113. 
 
Will my taking part in the study be kept confidential? 
 
We will follow ethical and legal practice and all information about you 
will be handled in confidence. 
 
If you join the study, some parts of the data collected for the study 
will be looked at by authorised persons from the University of Lincoln 
who are organising this research. They may also be looked at by 
authorised people to check that the study is being carried out 
correctly. All will have a duty of confidentiality to you as a research 
participant and we will do our best to meet this duty.  
 
All information which is collected about you during the research will 
be kept strictly confidential, stored in a secure and locked office, 
and on a password protected database. Your personal details will be 
kept in a separate location to your research details, as guided by 
GDPR (previously Data Protection Act). Any information about you 
which leaves the university will have your name and address 
removed (anonymised) and a unique code will be used so that you 
cannot be recognised from it.   
   
The research data which will have no identifiable information will be 
kept for five years after the end of the study. All research data will be 
kept securely for five years in accordance with university policy. After 
this time your data will be disposed of securely. During this time all 
precautions will be taken by all those involved to maintain your 
confidentiality, only members of the research team will have access 
to your personal data. 
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Although what you say in the sessions or interview is confidential, 
should you disclose anything to us which we feel puts you or anyone 
else at any risk, we may feel it necessary to report this to the 
appropriate persons, but you will be kept informed of this process. 
 
The researchers will collect information from you for this research 
study in accordance with our instructions. 
 
Nottinghamshire University Hospitals NHS Foundation Trust will use 
your name, NHS number and contact details to contact you about the 
research study, and make sure that relevant information about the 
study is recorded for your care, and to oversee the quality of the 
study. Individuals from the University of Lincoln and regulatory 
organisations may look at your medical and research records to check 
the accuracy of the research study. Nottinghamshire University 
Hospitals NHS Foundation Trust will pass these details to the 
University of Lincoln along with the information collected from you 
and your medical records. The only people in the University of Lincoln 
who will have access to information that identifies you will be people 
who need to contact you to enrol you into the study, complete the 
study or audit the data collection process. The people who analyse 
the information will not be able to identify you and will not be able to 
find out your name, NHS number or contact details. 
Nottinghamshire University Hospitals NHS Foundation Trust will keep 
identifiable information about you from this study for five years after 
the study has finished.  
 
 
When you agree to take part in a research study, the information about 
your health and care may be provided to researchers running other 
research studies in this organisation and in other organisations. These 
organisations may be universities, NHS organisations or companies 
involved in health and care research in this country or abroad. Your 
information will only be used by organisations and researchers to 
conduct research in accordance with the UK Policy Framework for 
Health and Social Care Research. 
 
This information will not identify you and will not be combined with 
other information in a way that could identify you. The information will 
only be used for the purpose of health and care research, and cannot 
be used to contact you or to affect your care. It will not be used to 




The University of Lincoln is the sponsor for this study based in the 
United Kingdom. We will be using information from you in order to 
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undertake this study and will act as the data controller for this study. 
This means that we are responsible for looking after your information 
and using it properly. The University of Lincoln will keep identifiable 
information about you for up to 12 months after the study, so we can 
send you a summary. 
Your rights to access, change or move your information are limited, 
as we need to manage your information in specific ways in order for 
the research to be reliable and accurate. If you withdraw from the 
study, we will keep the information about you that we have already 
obtained. To safeguard your rights, we will use the minimum 
personally-identifiable information possible. We will ask if you give 
permission for us to contact you about possible follow-up studies. If 
you give permission, you will be emailed once a year to ask if you 
would like to remain on the contact list.  
 
You can find out more about how we use your information at 
https://ethics.sites.lincoln.ac.uk/research-privacy-notice/ 
 
What will happen if I don’t want to carry on with the study?  
 
Your participation is voluntary, and you are free to withdraw at any 
time without giving any reason and without your legal rights being 
affected. If you withdraw once analysis has begun, then the 
information collected so far cannot be erased and this information 
may still be used in the project analysis.  
 
What will happen to the results of the research study? 
 
The results of the research will be written up as part of the 
researcher’s major thesis for the Doctorate in Clinical Psychology. A 
further paper will be written for publication in a relevant journal and a 
report will be prepared for the MS Society. The results are likely to be 
published mid-2020, if you have requested a copy this will be sent 
you either by email or post (whichever you prefer). You will not be 
identifiable in any publications.   
 
Who is organising and funding the research? 
This research is being organised and funded by the University of 
Lincoln. 
 
Who has reviewed the study? 
All research conducted by the University of Lincoln is looked at by 
independent group of people, called a Research Ethics Committee, to 
protect your interests. This study has been reviewed and given 
favourable opinion by the University of Lincoln Research Ethics 
Committee and East Midlands - Nottingham 2 Research Ethics 
Committee.  
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Further information and contact details 
 
Chief Investigator: 
Dr. Nima Moghaddam: NMoghaddam@lincoln.ac.uk 
  
Primary Investigator: 
Lloyd Oates: 16662517@students.lincoln.ac.uk 
 
Supervised By: 
Professor Roshan das Nair: Roshan.dasnair@nottingham.ac.uk 
Dr. Nima Moghaddam: NMoghaddam@lincoln.ac.uk 
Dr. Nikolaos Evangelou: Nikos.Evangelou@nottingham.ac.uk 
 
Postal Contact Details: 
Doctorate in Clinical Psychology 
School of Psychology 
College of Social Science 
University of Lincoln 
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Appendix H 
Hospital Anxiety and Depression Scale and permission 
 
The University of Nottingham has permission for students to use the 
measure for research purposes.   
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Appendix I 
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Appendix J 
GP information sheet 
 
 
GP Information Sheet 
(Version 2: 06/02/2019) 
IRAS ID: 254182 
 
Title of Study: Behavioural Activation for Low mood in Multiple Sclerosis 
(BALMS) 
Researcher: Lloyd Oates  
Supervisors: Professor Roshan das Nair (Clinical Psychologist), Dr. Nima 










Dear Dr X, 
 
Re: client details: Name, D/O/B, address 
 
Your patient, named above, has given their consent to take part in the behavioural 
activation for low mood in Multiple Sclerosis study. This is a multiple single-case 
experimental design study, which aims to establish whether behavioural 
activation (a psychotherapy technique) reduces depression in people with 
secondary progressive Multiple Sclerosis.  
 
Name has indicated that they had been feeling low in mood and had been 
struggling to engage in activities that they previously enjoyed. Name was 
screened for study inclusion using the Hospital Anxiety and Depression Scale 
and scored X/X on the depression subscale and X/X on the anxiety subscale.  
 
During the study name will receive a single face-to-face session followed by up 
to four internet-based video sessions, delivered by a Trainee Clinical 
Psychologist. During the study name will complete outcome measures relating to 
low mood, fatigue, quality of life, and engagement in the intervention. Following 
the intervention sessions name may be asked to take part in a 30-minute phone 
interview with a Trainee Clinical Psychologist independent of the study design to 
explore their experience of the study. Name will be asked two-months after the 
interview if they would like to complete the outcome measures one final time.  
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A copy of the Participant Information Sheet is included for your information. If you 
have any questions or would like any further information about the study please 
contact me. 
 










This study is being undertaken as part of the qualification for a Doctorate in 
Clinical Psychology by Lloyd Oates. 
 
Chief Investigator:  
Dr. Nima Moghaddam: NMoghaddam@lincoln.ac.uk 
Phone: 01522 886029 (University of Lincoln - Doctorate in Clinical 
Psychology administration team) 
 
Supervised By: 
Professor Roshan das Nair: Roshan.dasnair@nottingham.ac.uk 
Dr. Nima Moghaddam: NMoghaddam@lincoln.ac.uk 
Dr. Nikolaos Evangelou: Nikos.Evangelou@nottingham.ac.uk 
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Appendix K 




PS ID  
Age  
Gender  
Relationship status  
Care status  
Ethnicity  
Education level  
Employment status  
Diagnosis  
Disease duration and progression history 
(When were you diagnosed? When were 
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Appendix L 
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Appendix M 











Thank you for your interest in the Engaged Living Scale. I happily grant you permission to use 
the scale in your research. You can find the items in the appendix of the published paper – 
items were thoroughly (back-)translated from Dutch to English (see page 92 of my attached 
dissertation).   
  





From: Lloyd Oates (16662517) [mailto:16662517@students.lincoln.ac.uk] 
Sent: dinsdag 4 september 2018 4:11 
To: h.r.trompetter@tilburguniversity.edu 
Subject: Engaged living scale permissions 
  
Dear Dr Trompetter, 
  
I am a Doctorate in Clinical Psychology student at the University of Lincoln and the 
University of Nottingham. For my upcoming thesis of Behavioural Activation for low 
mood in people with multiple sclerosis I would like to use the Engaged Living Scale as 
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an outcome measure. I hope I am correct in emailing you for permissions to use the 
measure. If I need to contact someone else in regard to permissions, I would be 





Trainee Clinical Psychologist 
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Appendix N 





  Depression 
Treatment Specialty Clinic 
Department of Psychology 
PO Box 413, Milwaukee, WI  53201 
Pearse Hall 179 (414) 229-5521 
October 2, 2012 
  
To whom it may concern,  
 
Thank you for your interest in the Behavioral Activation for Depression Scale – Short 
Form (BADS-SF).  
 
The short form is 9 items, 8 of which are from the original BADS (with a few minor changes) 
and one new item. The range of scores is 0 to 54, with high scores representing higher 
activation.  
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Factor analyses have identified 2 subscales of the short form, which are Activation (AC) and 
Avoidance (AV). Because of the small number of items in the subscales, we do not recommend 
that they be calculated and used separately from the total scale, but they do give a sense for 
the composition of the total scale and what a total scale score means.  
 
Even though we do not recommend it, if you do want to score the subscales, sum the 
items for each subscale to generate subscale scores (indicated by hash marks on the 
columns on the right). None of the items should be reverse scored for the subscales.  
 
For the total score (T), follow the markings on the column furthest to the right. High 
scores on the total scale indicate greater levels of activation. Items with an “R” in the 
scoring template should be reverse scored for the total score only. This means that an 
item on the Avoidance subscale will get reverse-scored when computing the total 
score of the BADS-SF, but it will not get reverse-scored when computing the Avoidance 
subscale score (which we don’t recommend you use anyway). This procedure makes 
the subscale and total scale scores consistent with the title of the subscale or scale. In 
other words, a high score on the total scale means more activation, while a high score 
on the Avoidance subscale means more avoidance.  
 
The short form has several advantages over the original and you may want to consider using it. 
Specifically, the BADS-SF is more focused directly on the types of activation and avoidance 
targets in BA treatments and does not contain items on impairment, which may be 
conceptualized as resulting from changes in activation and avoidance rather than part of the 
processes taking place in BA treatments. The BADS-SF is also shorter (9 items), has good 
construct validity demonstrated by significant correlations with measures of depression (CES-
D) as well as a variety of other measures (i.e., AAQ, ATQ, BAI, CBAS, EROS, PES), and predictive 
validity over a one-week time period predicting engagement in highly rewarding or pleasant 
activities or unrewarding and unpleasant activities.  
 
The proper reference for the short form is:  
 
Manos, R. C., Kanter, J. W., & Luo, W. (2011). The Behavioral Activation for Depression Scale-
Short Form: Development and validation. Behavior Therapy, 42, 726-739.  
Please contact Dr. Jonathan Kanter by email at jkanter@uwm.edu or by phone at 414-229-
3834 if you have any comments or questions about either the BADS or the BADS-SF.  
 
In accepting this scale from us, you are giving us permission to contact you at a later date so 
we may inquire about its use and any data you may have on it. There is no obligation to share 
data with us but we do hope for a collegial response to later requests for updates or possible 
collaborations on publications regarding the continued development and evaluation of these 
measures.  
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Jonathan Kanter, Ph.D.  
Director, Depression Treatment Specialty Clinic  
Coordinator, UWM Psychology Clinic  
Associate Professor, Clinical Psychology  
Research Scientist, Center for Addiction and Behavioral Health Research  
University of Wisconsin-Milwaukee 
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Appendix O 
Modified Fatigue Impact Scale – Short Form (MFIS-SF) and 
permission 
Patient's Name: Date:   _____/____/____ 
    month day year 
ID#: _____________________ Test#: 1   2   3   4 
 
 
MODIFIED FATIGUE IMPACT SCALE - 5-ITEM VERSION (MFIS-5) 
 
Following is a list of statements that describe how fatigue may affect a person. 
Fatigue is a feeling of physical tiredness and lack of energy that many people 
experience from time to time. In medical conditions like MS, feelings of fatigue 
can occur more often and have a greater impact than usual. Please read each 
statement carefully, and then circle the one number that best indicates how often 
fatigue has affected you in this way during the past 4 weeks. (If you need help in 
marking your responses, tell the interviewer the number of the best response.) 
Please answer every question. If you are not sure which answer to select, please 
choose the one answer that comes closest to describing you. The interviewer can 
explain any words or phrases that you do not understand. 
 
Because of my fatigue  
during the past 4 weeks.... 
 
              Almost 
   Never Rarely Sometimes Often always 
1. I have been less alert.  0  1   2   3  4 
 
2. I have been 
limited in my 
ability to do 
things away 
from home. 0 1 2 3 4 
 
3. I have had trouble      
 maintaining physical effort      
 for long periods. 0 1 2 3 4 
 
4. I have been less 
able to complete 
tasks that require 
physical effort. 0 1 2 3 4 
 
5. I have had trouble 
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Appendix P 
Short Form-12 version 2 and permission
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Appendix Q 
Email permission for the BATD-R 
 
Lejuez, Carl Wilborne <clejuez@ku.edu> 
Sun 13/05, 23:26 
Lloyd Oates (16662517) 
Lloyd, 
Good luck with your work and thanks I’ve attached the manual and an article that may be 
helpful with your questions (please feel free to ask me any follow up questions as would be 
useful). 
I’ve also attached a training video you might find 
helpful…https://www.dropbox.com/s/nuq3w071ry3z1v0/BW%20TrainingVideo%2011-
18-10%20FINAL.mov?dl=0– 50 MIN 
Best of luck. 
 Carl 
 ************************************** 
Carl W. Lejuez, PhD 
Interim Provost and Executive Vice Chancellor 
University of Kansas 
Strong Hall, Room 250 
1450 Jayhawk Boulevard 
Lawrence, KS 66045 
clejuez@ku.edu 
240.535.0467 (cell) 
From: Lloyd Oates (16662517) [mailto:16662517@students.lincoln.ac.uk]  
Sent: Sunday, May 13, 2018 3:58 PM 
To: Lejuez, Carl Wilborne <clejuez@ku.edu> 
Subject: BATD-R materials 
Dear Professor Lejuez, 
 I am emailing you as I am currently developing my research thesis protocol for my 
studies. I am looking at exploring the use of a values based behavioural activation 
intervention for people with Secondary Progressive Multiple Sclerosis.  
Having discovered the BATD-R I believe this manual could be beneficial for use in this 
population, due to the values assessment, structure, and the adaptability that has 
been demonstrated from the evidence base. I note that in the manual that you could 
be contacted for a modifiable manual suitable for patient use. I was wondering if with 
your permission I could have and use this.  
I would also appreciate any thoughts or considerations in the use of the manual or 
explaining values to clients in a user-friendly way. 
Best wishes 
Lloyd Oates, Trainee Clinical Psychologist, Trent Doctorate in Clinical Psychology 
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Appendix R 
BATD-R session scripts 
The Revised Treatment Manual for the  
Brief Behavioral Activation Treatment for Depression (BATD-R) 
 
Session One 
Session One Key Elements: 
1. Confidentiality 
2. Discussion of Depression 
3. Introduction to Treatment Rationale  
• What about stressful life events and loss in your life? 
4. Introduction to Daily Monitoring (Form 1) 
• Enjoyment and Importance Ratings  
• When should you complete the Daily Monitoring Form? 
5. Important Points about the Structure of this Treatment  
 
Discussion of Depression 
This treatment was designed to help you with depression, which is defined as an 
extended period of time of at least two weeks in which a person experiences a depressed 
mood or a loss of interest or pleasure in activities that were once enjoyed, along with 
several other symptoms. Many people will experience at least one episode of major 
depression in their lifetime and it can affect people of all ages, cultures, income, 
education, and marital status. Depression can have a major impact on your life including 
decreased optimism/motivation, low self-esteem, trouble concentrating (paying 
attention), self-harm, and/or suicidal thoughts and behaviour. Medical problems 
associated with depression include heart disease, chronic pain, type 2 diabetes, 
substance use, fatigue, and malnutrition. Individuals with depression often keep to 
themselves and avoid their normal activities. This isolation can cause additional 
problems, such as loneliness, relationship problems, decreased job satisfaction or 
unemployment, and educational failure. Given all of these resulting problems, the 
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The specific symptoms of depression may include: 
• Feeling sad or down most of the time 
• Loss of interest in usual activities 
• Significant weight loss or weight gain 
• A decrease or increase in appetite 
• Difficulty sleeping or sleeping too much 
• Feelings of agitation or irritability 
• Feeling tired or loss of energy (fatigue) 
• Feelings of worthlessness or excessive / inappropriate guilt 
• Difficulty thinking or concentrating or making decisions 
• Crying spells 
• Feeling hopeless 
• Suicidal thoughts and/or attempts 
Although most individuals experience some form of the above symptoms from 
time to time, a diagnosis of depression only is made if you feel strong feelings of 
distress, or you are having a lot of trouble with your day-to-day functioning. Some 
people can identify stressful life events including loss of a loved one, financial 
difficulty, or job loss as a reason for their depression. However, the specific causes of 
depression are rarely known, and depression might start without warning. Regardless of 
the initial cause of depression, depression results in a specific pattern of behavior that 
leads to feelings of loneliness, sadness, isolation, lack of purpose, and/or hopelessness. 
The key to feeling better is not in identifying the root cause of depression because this is 
nearly impossible, but rather in understanding and changing your depressed patterns of 
behavior. 
 
Introduction to Treatment Rationale for Behavioral Activation 
Treatment will involve an approach called behavioral activation. According to this 
approach, the key to a depression-free life is to develop healthier patterns of behavior 
where each day contains important and/or enjoyable activities that help you feel 
fulfilled and as if your life has purpose. Once you have identified the areas of your life 
you want to focus on and your values within those areas, we will begin to identify and 
plan daily activities that help you to live according to the values that are most important 
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to you. This is important because when you accomplish activities that are closely linked 
to what you value in life, you are more likely to have positive and enjoyable 
experiences, which will improve how you feel and think about your life. It is difficult to 
feel depressed and hopeless if you are regularly doing activities that you feel are 
valuable and worthwhile and that bring you a sense of pleasure and accomplishment.  
This manual targets changing your behavior as a method for improving your 
thoughts, feelings, and overall quality of life. Many individuals with depression often 
feel tired and lack the motivation to do various activities; thinking that once they have 
more energy and think more positively, they will be able to do the activities they have 
ignored or have been unable to accomplish in the past. The opposite approach is taken 
in this treatment – behavior is changed first as a way to increase energy and motivation, 
as well as positive thinking and feelings. The focus on behavior change, however, does 
not mean that we ignore thoughts and feelings. Instead, we suggest that negative 
thoughts and feelings will change only after you change your behavior and are having 
more positive life experiences. Healthy behavior is defined as behavior that is directed 
towards improving your quality of life, and is directed towards the attainment of the 
values you have in your life. In contrast with healthy behavior, unhealthy (depressed) 
behavior generally is not directly related to improvements in the quality of your life and 
does not move you closer to living according to your values. 
You should know that it is possible for you to be active, yet still be depressed. 
This can happen if you feel overwhelmed with activities that are unfulfilling or forced 
by others. For example, although you may be busy at work and home, these activities 
may be focused only on helping others. Although it certainly is important to help others, 
it is never a good idea to focus so much on others that your own needs and feelings are 
completely neglected. Focusing entirely on the needs of others may result in feelings of 
emptiness and dissatisfaction, followed by confusion and guilt for having such feelings. 
Thus, it is not only important to have many activities in your life, but specifically to 
have activities that bring you some degree of pleasure and fulfillment. 
What about stressful life events and loss in your life? Often people who have 
experienced stressful life events and loss end up having long standing feelings of 
depression. After something very bad has happened or loved ones are lost, life can feel 
empty, or meaningless. It can feel as if there is very little to live for and that all the 
support and happiness you once had is gone forever. Thoughts and bad dreams may 
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keep coming back about the bad experience or about the loved one who has passed 
away. In this treatment, it is very important for the therapist to understand what 
happened to you, how you felt about it, and most importantly, how it affects your life 
now. At every session, we will spend some time talking about events in your life that 
have led to your depression. However, this treatment requires more than just talking 
about what has happened. In addition, we also will spend some time trying strategies 
that will help you to live a more fulfilling and meaningful life going forward. Nobody 
can change events of the past, but we can plan for a better future by what we do today. 
Often when people have experienced stressful life events and loss, negative thoughts 
and feelings about the event come to mind all the time. It becomes hard not to think 
about it or feel terrible that it happened. We find that it is important to understand how 
these experiences impact your current behavior. Often after a loss or stressful life event, 
people change how they spend their time, and this can lead to depressed behavior 
patterns. For example, you might find it difficult to sleep at night, and so you spend a 
lot of time sleeping during the day. If you sleep during the day, you may be unable to 
perform important daily activities or lack the energy and desire to socialize with family 
and friends. This treatment will help you to identify activities that might be making 
your depression worse, and can help you modify or change those activities so that you 
feel depressed less often. After a loss or stressful event, it can often take time and focus 
to decide how you want to live your life moving forward, and this treatment is designed 
to help you with that. The goal is to help you make the best life possible for yourself. 
This can be hard work, but if you trust the process you will find that good things will 
come from your effort. We will work at a pace that is comfortable for you. Are you 
willing to work on this together? 
 
Daily Monitoring Form 
Because the main focus of this treatment is increasing your healthy behavior, it 
is important to become aware of what you do each day. Although you probably have a 
an idea of how you spend your time, we really need exact information about what you 
are doing each day. To that end, we would like you to spend the next week writing 
down all of your activities. This is useful for several reasons. First, it will help us to 
identify the pattern of your depressed behaviors and moods. Every person is different, 
so it is important for us both to see how depression is affecting your daily activities. 
Being aware of your patterns might motivate you to increase your healthy activity level. 
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Second, this will provide us a measure of your current activity level which we will then 
be able to compare with your activity level later in treatment, after you use the treatment 
strategies. Finally, a close look at your daily routine might lead you to develop some 
ideas about where you might consider adding some healthy activities to each day. To 
monitor your current activities, you keep a detailed log (hour by hour) of all activities 
that you do, including those that seem insignificant, such as sleeping or watching 
television. You will use the Daily Monitoring Form to record your activities. You will 
need to complete one form for each day. For now, just do things as you normally would 
do them. Your only task is to write down your activities, trying to be as accurate and as 
thorough as you can.  
 
Enjoyment, Importance, and Achievement Ratings. Once you have recorded the 
activity, you then rate the activity in terms of three things: Enjoyment, Importance, and 
Achievement. For the Enjoyment rating, think about how much you enjoy the activity. 
In other words, think about how much fun or pleasure you have when you are doing the 
activity. You will use a scale from 0 to 10 to rate Enjoyment. A rating of 0 will be for 
activities that you do not enjoy at all. A rating of 10 will be for activities that you enjoy 
very much. For example, going to a picnic might be considered a very enjoyable 
activity and be assigned a rating of 10, whereas washing the dishes might be considered 
no fun at all and be assigned a rating of 0.  
For the Importance rating, think about how important in your heart it is to have this 
activity in your life. On a scale from 0 to 10 rate each activity, with 0 meaning that the 
activity has no importance at all and 10 meaning that the activity is of the highest 
importance in your life. For example, going to work is probably a very important 
activity in your life because it is your source of income to support your family. You 
might give your work a rating of 10. On the other hand, watching television is probably 
a less important activity in your life. You might give watching TV a low rating such as 
a 2. 
For achievement think about how difficult the task may have been. This is not a rating 
of how hard a task is generally, but a rating of how hard it was for you on the day, and 
therefore how much effort it took. Once you have thought about the task in this way, 
which may have been hoovering one room, but you found it difficult to motivate 
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yourself, or became tired, think about what sense of achievement you had despite these 
barriers. 
Consider for a moment that some activities might be very important but not very 
enjoyable, and other activities might be very enjoyable but not very important. For 
instance, washing clothes might be high in importance but not very enjoyable, whereas 
watching a favorite TV program might be very enjoyable but not very important. 
Meanwhile some activities may be rated as high on both enjoyment and importance and 
others as low in enjoyment and importance. For example, eating dinner with family 
might get rated as a 9 in enjoyment and importance because it is both very enjoyable 
and important. On the other hand, lying in bed in the afternoon might be rated a 0 in 
both enjoyment and importance because it is neither important to your life nor very 
enjoyable. In addition to enjoyment and importance ratings for each activity, you also 
should provide a single rating for your overall mood for the day at the bottom of the 
form. The rating should be between 0 for the most negative mood and 10 for the most 
positive mood. You don’t have to rate your mood for each hour of the day, just a 
general rating of your mood for the day.  
When should you complete the Daily Monitoring Form? To complete your Daily 
Monitoring Form, you might choose to record your activities as you go through your 
day or you might prefer to wait until the end of the day to do so all at once. You may do 
whichever you prefer. However, it is best to record your activities on the day that they 
occurred, as opposed to several days later. For example, on Wednesday it will be 
difficult to remember the activities you did on Monday. We will spend a lot of time 
reviewing your Daily Monitoring Forms each week, so be sure to complete and bring 
the completed forms to each session. 
Important Points about the Structure of this Treatment  
Before we finish today, it is important to understand that this is a structured 
treatment. This means that treatment involves a series of steps. Depression is a problem 
that builds over time, so it is not possible for it to overcome it in a few days or after just 
one or two visits. It takes some work and it is very important to practice all of the 
strategies we will review in this treatment. Although you may notice some immediate 
benefits in the first few sessions, only coming to a small number of sessions may not be 
helpful in the long-term. We realize that sometimes unforeseen events can arise that 
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might cause you to miss a session, and this is understandable, but we urge you not to 
cancel a session because you are feeling depressed, tired, or unmotivated. Most people 
find that even when they are feeling depressed before a session, they are likely to feel 
much better after the session. This idea of motivating yourself to take positive steps like 
attending treatment sessions even when you are feeling depressed, tired, or unmotivated 
is an approach that will help you tremendously in this treatment and in overcoming 
depression.  
In addition to the importance of regular attendance, these sessions will include 
both assignments for you to complete during our session and assignments for you to 
work on at home. Completing the homework assignments is very important for progress 
as we find that people who regularly complete the homework assignments see the most 
improvement in their lives. If you find any homework assignments difficult or 
overwhelming, we can discuss this and come up with ways to make it easier for you to 
do. It is very important that we work together to make sure that this process feels 
comfortable and useful to allow you to complete these important assignments.  
Assignments: 
1. Complete Daily Monitoring Form 
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Session Two 
Session Two Key Elements: 
1. Daily Monitoring: Review Assignment (Form 1) 
• Troubleshooting 
2. Treatment Rationale: Review 
3. Complete Life Areas, Values, and Activities Inventory (Form 2) 
Daily Monitoring: Review Assignment (Form 1) 
 We will begin this session by reviewing your Daily Monitoring Forms (Form 1) 
from the past week. Notice the types of activities you are doing and if they are 
enjoyable, important, both, or neither. Often people with depression find themselves 
spending very little time in activities that are enjoyable. They often will also withdraw 
from activities that are important to them. We should discuss your level of activity and 
how often you are doing enjoyable and important activities. In the next few sessions, we 
will focus on making changes in your daily activities, but right now do not try to change 
anything. Instead, just pay attention to what your life is like every day, what you are 
doing, and to what extent these activities are leading you to feel better or worse.  
Troubleshooting. Some people find it difficult to complete the Daily Monitoring 
Forms. If you have not been able to complete this form in the past week, it first will be 
important to understand why. One reason it may be difficult to complete the monitoring 
is that you may feel you already have a good sense of how you spend your time and that 
it would not be useful to write activities down. You can probably recall a lot of things 
you have done in the past week, but there may be quite a few activities that you might 
have forgotten about by now. Having your daily activities recorded on paper for each 
day can be helpful for both me and you to identify those depressed patterns that we 
discussed last session. Many people are very surprised by patterns they notice on the 
forms and begin to gain a real understanding of how certain patterns lead to more 
depressed feelings, whereas others lead to more positive feelings. Having these forms 
for the session allows our work to be more efficient by allowing us a clear sense of 
exactly how you are spending your time moment-to-moment without having you try to 
recall all of that information in the session. 
A second reason it may be difficult to complete the monitoring is that you may 
feel like it is an overwhelming task. Writing down all of your activities of the day can 
feel like a lot of work, but in the end you are likely to find that what you learn is well 
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worth the effort. One way to make this easier is to keep your recordings as brief as 
possible (e.g., “lunch,” “took kids to school,” “cooked dinner”). Another way to keep 
this easier is to complete the form at the end of the day. Finally, if you find it extremely 
challenging to do the forms at all, you might consider initially doing the forms for 2 or 3 
days of the week (being sure to include both week and weekend days), and then 
gradually increasing the number of days each week that you complete the forms. You 
are likely to find that once you get into the habit of doing the forms, it will seem less 
burdensome. People who have some difficulty writing and/or reading also may find the 
forms difficult to complete. If this is the case, a modified form that does not require 
writing or reading is available.  
 If you were not able to complete any Daily Monitoring Forms for the past week, 
it is not recommended that you attempt to remember the entire week right before the 
session or in the session with your therapist. Remembering the necessary level of detail 
will be too difficult and with so much information missing it will be difficult to detect 
any consistent behavior patterns. Instead, you should complete a form right now in 
session for the past day or two. You will likely be able to recall most of your activities 
from today and one or two days ago. Even though it is only one or two day’s worth of 
activities, it is a starting point and you and we can begin to look for behavior patterns. 
Completing the forms for each day of the coming week will increase the chances of 
making good progress.  
Treatment Rationale: Review 
 Review Treatment Rationale as needed using content from Session 1. 
Life Areas, Values, and Activities (Form 2) 
Life Areas. An important step in this treatment involves thinking about the most 
important areas of your life. Think for a moment about each of the following life areas.  
1. Relationships: This life area refers to the part of your life that involves family, 
friends, and/or your romantic partner (for example, your spouse, boyfriend, or 
girlfriend).  
2. Education/Career: This life area refers to time spent developing your education 
and your career. This can include formal education such as college or a trade school, 
but could also be informal such as reading books on a particular topic. It also 
includes working at your current job or finding a new job. 
3. Recreation/Interests: This life area refers to leisure time, when you can have fun 
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and/or relax. It also may include doing things for others such as volunteering. 
4. Mind/Body/Spirituality: This life area refers to both physical and mental health as 
well as religion and/or spirituality. 
5. Daily Responsibilities: This life area refers to your obligations and responsibilities 
to others and your belongings. 
Values. Once we have considered these different life areas, we move to identifying 
your values in each of these areas. A value is an ideal, quality, or strong belief in 
certain way of living.  
In other words, what is important to you about each of these life areas? What are you 
striving to be in each life area? What are the qualities of that life area that are 
important to you? A value is something that is important to you, in your heart, about 
that life area. Be sure that the values you identify are very personal to you, and not 
necessarily the values of other people in your life or society in general.  
Activities. A primary goal of this session is to identify key values from each life area 
and translate them into activities. Life areas are the important parts of your life, 
values are how you want to live your life in each of those areas, and activities are 
things you can do to actually live according to the values. Become more aware of 
your values and using them as a guide to selecting your activities is key to this 
treatment. However, without the activities that help you live according to your 
values, the values are just words and ideas, and not a reality. Please see the examples 
of life areas, values, and activities provided in Appendix 1. 
The Life Areas, Values, and Activities Inventory allows you to turn your values 
across key areas of your life into reality. For each life area, you have space for both 
values and activities (you can add extra blank sheets for each life area to add 
additional values and activities). Each activity should be something that you might 
do to live consistently with the value that you identified. For example, if “being a 
good husband/wife” is something you value, list some activities that you think are 
consistent with being a good husband/wife. Possible activities might include 
planning a date with your husband/wife once a week or helping your husband/wife 
with a household chore she/he dislikes. When selecting activities it is important to 
remember that the activity must have two specific characteristics: they should be 
both observable by others and measurable. Therefore, "feeling better" is not what we 
mean by activity, but “eating dinner with my mother twice a week” would be 
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appropriate. This latter activity could be observable and measurable in the sense that 
you could meet with her twice per week. The activity should also be broken into its 
smallest piece. For example, if an activity is going for a bike ride, consider that a 
number of intermediate steps are required before one can do this. Such steps might 
include, bringing the bike up from the basement, checking the air in the tires, finding 
a tire pump, pumping the tires, etc. So the first step in the activity of going for a bike 
ride might just include checking that the bike is in good shape, with later weeks 
including the actual ride. Activities are far easier to accomplish if they are broken 
into the smallest pieces possible. Thus, if these three conditions (observable, 
measureable, smallest piece possible) are met, you have identified an acceptable 
activity.  
Sometimes it is tempting to select very difficult activities for which the benefits are 
in the future and not a guarantee. For example, getting a college degree is a long-
term goal that may take some time to achieve. It’s important to have these types of 
goals, but it’s even more important to be clear about the rewarding activities that are 
a part of achieving that long-term goal. This might include activities that get you to 
the goal but are important and/or enjoyable on a daily basis such as studying a topic 
you enjoy or having a discussion about something you learned in a class. Therefore, 
you should select activities across a range of difficulty, with only a few being smaller 
steps toward more difficult long-term projects. To improve the likelihood of initial 
success and to help you start this program, some of the activities you choose should 
be activities you already are doing regularly but would like to increase in frequency 
or duration (see your Daily Monitoring Forms for assistance). We will now complete 
this form together and you will continue adding to it and editing it for homework. 
Assignments: 
1. Complete Daily Monitoring (Form 1) 
2. Review and Edit Life Areas, Values, and Activities Inventory (Form 2) – 
today we have thought about a few values, but they can be really hard to 
identify when we have not thought about them before. I will email a list of 
examples values to help you review the work we have done today.   
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Session Three 
Session Three Key Elements: 
1. Daily Monitoring: Review Assignment (Form 1) 
2. Life Areas, Values, and Activities Inventory: Review Assignment (Form 2) 
3. Activity Selection and Ranking (Form 3) 
Daily Monitoring: Review Assignment (Form 1) 
 We will begin this session by reviewing your Daily Monitoring Forms (Form 1) 
from the past week. Notice the types of activities you are doing and if they are 
enjoyable, important, both, or neither. Often people with depression find themselves 
spending very little time in activities that are enjoyable. Some people withdraw from 
activities that are important to them and end up spending long periods of time during 
the day in activities that are neither enjoyable nor important. In this case, you may find 
it hard to find any activities that are rated high in either enjoyment or importance. On 
the other hand, some people with depression have many important activities in their 
week but very few that are enjoyable. These people often spend a lot of time working, 
taking care of others, and meeting various obligations to the exclusion of any time spent 
on self-care or pleasurable activities. For many people with depression, their important 
activities are not very enjoyable. How would you describe your activities? How often 
are you doing enjoyable and important activities? Today, we will focus on making 
changes in your daily activities.  
Life Areas, Values, and Activities Inventory: Review Assignment (Form 2) 
From last session you have learned about life areas, values, and activities. For example, 
the life area of “Education/Career” and the related value of “getting a college 
education” might include specific actions such as identifying a school, speaking to an 
enrollment counselor, enrolling in classes, etc. As another example, the life area of 
“family relationships” and the value of “developing a closer relationship with a 
particular family member” may include specific actions such as eating dinner together 
every Saturday, talking on the phone twice a week, or offering specific assistance (for 
example, baby sitting). Although completing activities aimed at one specific life area 
and value can be satisfying, it is important to select activities across a wide range of life 
areas because depression is rarely the result of only one aspect of your life. For 
example, someone with depression might think that if they could only get a certain job, 
they would not be depressed anymore. As a result, all of their focus might be on would 
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be activities that have to do with getting that job. In this situation, it would certainly be 
helpful to work on activities related to the job, but it is just as important to work on 
activities tied to other life areas. Living a fulfilling life is not about getting a certain job, 
achieving a certain body weight, being with one particular person and no other, or 
having a specific amount of money. By narrowing your focus on one aspect of your life, 
you limit your opportunity to have positive experiences and feel fulfilled in other areas. 
Ultimately, this can worsen your depression, especially if the goals you have in mind 
require a long period of time or are extremely difficult to obtain. Finally, be sure that 
you have both “enjoyable” and “important” activities in your plan, with emphasis on the 
type of activity that is less frequent in your Daily Monitoring Forms. Throughout 
treatment be sure to keep thinking about values in each life area and to generate new 
activities in line with these values.  
Activity Selection and Ranking (Form 3) 
By now, you will have identified many activities for each of the values in your life 
areas. Today, we will pick some activities to use as a starting point. As you select an 
activity, add it to the left column of Form 3 (Activity Selection and Ranking). 
Remember that the activities should be observable, measurable, in their smallest pieces, 
and directly relevant to the values you listed in the Life Areas, Values, and Activities 
Inventory (Form 2). The more your daily activities are linked to your values, the more 
likely you will experience the activities as both pleasurable and meaningful and the 
more you will feel that you are living the life you want to live. This is extremely 
important to pay attention to because there is no reason to busy yourself with activities 
that do not make you feel that you are living a richer, more meaningful life. Once you 
have your activities listed on Form 3, rank them from 1 (easiest to accomplish) to 
hardest to accomplish on the right column of Form 3. One way to do this is to first 
identify the easiest and assign it a 1 and then to identify the most difficult. From there, 
try to fill in the others. In activity planning, you will start with the easiest activities and 
gradually work towards the more difficult ones.  
Daily Monitoring with Activity Planning (Form 1) 
Once you have identified the target activities, you will need a plan for how you 
will include these activities in your daily schedule and how you will monitor your 
progress. We will use your Daily Monitoring Forms for the upcoming week to help you 
plan your new activities. Your opinion will be critical in deciding how many activities 
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to select and it is important that you challenge yourself without becoming overwhelmed. 
The simplest approach is usually to start with 1-3 of the easiest activities. We will begin 
now by identifying activities for the coming week and entering these activities into the 
blank Daily Monitoring Forms for each day at the time that you plan do them. For 
example, if your activity is “play with your daughter” you might enter that activity 
(Form 1) at 11am on Monday, 10am on Wednesday, and 9am on Thursday. 
Be sure to seriously consider whether you are ready for a particular activity and 
consider barriers that you might encounter. If there are barriers to doing the activity, we 
should discuss steps you might take to first overcome those barriers. Remember in 
previous sessions when we discussed breaking activities down into the smallest pieces 
possible? When you run into difficulty with an activity it can be useful to consider if 
you really have broken the activity down far enough. For example, if your activity is to 
go to the gym twice a week, you first might have to buy clothing, research gyms, find a 
partner to go to the gym with, or arrange for transportation. In this case, “going to the 
gym” may not be the smallest piece of this activity. You should add any additional 
activities to overcome these barriers on Form 2 (Life Areas, Values, and Activities 
Inventory). A key aspect of this treatment is to plan the specific day and time that you 
will do each activity. This will require you to really think through where you can 
realistically fit the activity into your schedule. By doing this, you will find that you are 
more likely to accomplish the activity.  
During the upcoming week, you will complete the Daily Monitoring Form just 
as you have been doing each day. However, circle each planned activity in your form if 
you completed it. Be sure to give it an enjoyment, importance, and achievement rating 
at this time too. This is important because it will allow us to see if you experienced the 
activity as more or less enjoyable or important than you originally thought. If you did 
not complete the activity at the scheduled time, put a line through it (but do not erase it) 
and write in the activity you did accomplish at that time. If possible, try to re-plan the 
missed activity for another time that week (or even that day) and be sure to circle it if 
you complete it. We will review your Daily Monitoring Forms next week as usual, but 
this time we will look for the circled activities you planned, how enjoyable and 
important they were, and if you encountered any problems trying to accomplish them. 
We can work together to address whatever challenges arise.  
When you begin to complete your activities, you will begin to move toward the values 
you have set out for yourself in important life areas and you will be living a fuller life 
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and feeling less depressed. The key is to not focus too much on whether you have 
succeeded at accomplishing the values but instead it is to focus entirely on completing 
the daily activities that come directly from your values. Many values require a lifelong 
effort (e.g., being a good parent) where you constantly try to live in a way that is 
consistent with your values. For this reason, values are not considered an endpoint of a 
process, but instead they are a guide throughout the process, proving information about 
how we want to live our lives and helping us to choose the activities are the vehicles 
that help us move in the direction of our values. 
Assignments: 
1. Daily Monitoring (Form 1)  
2. Continue to Review and Edit Life Areas, Values, and Activities Inventory 
(Form 2) 
3. Review and Edit Activity Selection and Ranking 
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Session Four 
Session Four Key Elements: 
1. Daily Monitoring with Activity Planning: Review Assignment (Form 1)   ____ 
2. Getting help from others 
3. Daily Monitoring with Activity Planning for the Upcoming Week (Form 1)   ____ 
Assignments: 
1. Daily Monitoring with Activity Planning for the Upcoming Week (Form 1)   ____  
2. Continue Adding/Editing Contracts (Form 4)   ____ 
 
Daily Monitoring with Activity Planning: Review Assignment (Form 1)  
Let’s review your forms of Daily Monitoring with Activity Planning for the 
week. How many of the planned activities did you accomplish? For those that you 
accomplished, how easy or difficult were they? How enjoyable and important did you 
find them? How did you feel about having accomplished those activities? Would you 
like to continue those activities or select different ones for next week? Are you finding 
that you feel better when you are more active? If so, this is good progress.  
Were there activities that you planned that you did not accomplish? If so, what 
happened? Was it because you really do not find the activity to be enjoyable and/or 
important? If this is true, then one option is to select a different activity instead. If it is 
an activity that you want to keep trying to do, then there are a few other issues to 
consider. Was the activity more difficult to accomplish than what you originally had 
expected? If so, we can discuss breaking it into smaller steps as we have discussed 
previously. Alternatively, you might have felt you just ran out of time and couldn’t 
complete this activity. We should revisit your monitoring forms and think about ways to 
fit new activities into your schedule. You might also have to seriously consider 
strategies for reducing your time spent in less valued current activities to make more 
time for these new more valued activities. This may include the difficult task of setting 
stricter boundaries around your time. In this case, we can discuss how to plan some 
activities to help set those boundaries and reclaim some time for yourself. Although 
these types of changes in your daily routine may be difficult, the planning and 
monitoring in this treatment can help reduce currently unfulfilling activities and to get 
you doing more enjoyable and important new activities.  
 Your chances of overcoming depression are much improved when you have 
support from others for your healthy activities. Family and/or friends can be a great 
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support in our lives, but sometimes they may be more likely to notice your depressed 
behaviour than your healthy activities. Other times, supportive people would like to 
help but they either do not know how or they tend to do things that they think are 
helpful but are not actually helpful. For example, sometimes friends or family take over 
your responsibilities because they see what a hard time you are having now or instead, 
they may nag or push you to do things you are not ready to do. In both cases, the 
support person wants to help, but is doing things that are not helpful. 
It would be helpful to ask people for help for your healthy activities in the ways 
that you need it. Let’s think about some activities that would be easier with support and 
let’s think about who could help you. We do this because you might find that going 
shopping once per week is difficult because of mobility. In this case we could think 
about who could help you with shopping. Additionally, you might find shopping really 
boring. In this case, going with others might make it more enjoyable.  
The next step is to tell each person what you are trying to accomplish and 
exactly how they can help. You might learn that involving others in your activities 
makes the activity not only more likely to occur but also more enjoyable. Involving 
others can also strengthen your relationships. All of these things will have a positive 
impact on the way you feel every day.  
 
Daily Monitoring with Activity Planning for the Upcoming Week (Form 1) 
Based on our discussion this session, you should now plan your activities for the next 
week. If you are able, try to plan for one or more new activities for the upcoming week 
in addition to the activities you accomplished the previous week.  
Assignments: 
1. Daily Monitoring with Activity Planning for the Upcoming Week (Form 1)  
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Session Five 
Session Five Key Elements: 
1. Daily Monitoring with Activity Planning: Review Assignment (Form 1) 
2. Life Areas, Values, and Activities Inventory: Concept Review and Edit 
(Form 2) 
3. Activity Selection and Ranking: Concept Review and Edit (Form 3) 
4. Daily Monitoring with Activity Planning for the Upcoming Week (Form 1) 
Daily Monitoring with Activity Planning: Review Assignment 
Let’s review your forms of Daily Monitoring with Activity Planning for the 
week. How many of the planned activities did you accomplish? For those that you 
accomplished, how easy or difficult were they? How did you feel about having 
accomplished those activities? Would you like to continue those activities or select 
different ones for next week? Are you finding that you feel better when you are more 
active? If so, this is good progress.  
Were there activities that you planned that you did not accomplish? If so, what 
happened? Was it because you really do not find the activity to be enjoyable and/or 
important? If this is true, then one option is to select a different activity instead. If it is 
an activity that you want to keep trying to do, then there are a few other issues to 
consider. Was the activity more difficult to accomplish than what you originally had 
expected? If so, we can discuss breaking it into smaller steps as we have discussed 
previously. Alternatively, you might have felt you just ran out of time and couldn’t 
complete this activity. We should revisit your monitoring forms and think about ways to 
fit new activities into your schedule. You might also have to seriously consider 
strategies for reducing your time spent in less valued current activities to make more 
time for these new more valued activities. This may include the difficult task of setting 
stricter boundaries around your time. In this case, we can discuss how to plan some 
activities to help set those boundaries and reclaim some time for yourself. Although 
these types of changes in your daily routine may be difficult, the planning and 
monitoring in this treatment can help reduce currently unfulfilling activities and to get 
you doing more enjoyable and important new activities. Finally, you might need help 
from others to complete scheduled activities.  
Life Areas, Values, and Activities Inventory: Concept Review and Edit (Form 2) 
Today, we will review the concept of values to make sure that the activities that 
you are accomplishing still seem consistent with the values you mentioned earlier in 
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treatment. Remember, an important step in this treatment approach involves 
determining the activities you would like to add to your life. Although becoming more 
active in life is important, we need to be sure that the activities that you select are ones 
that are enjoyable and/or important to you and that make you feel like you are living the 
life you want to live. One way to help identify activities that are important to you is to 
think about what you value in life. Let’s revisit each of the life areas and the values you 
have in these areas. Remember, a value is something that is important to you in your 
heart about that life area. Review your values for: Relationships, Education/ Career, 
Recreation/Interests, Mind/Body/Spirituality, and Daily Responsibilities. Think about 
how much the activities you have identified in the last few weeks fit into your values. 
Are there new values that have come to mind? Are each of the activities consistent with 
the values you mentioned?  
Activity Selection and Ranking: Concept Review and Edit (Form 3) 
Throughout treatment, you may have added, subtracted, or changed activities in 
your Activity Selection and Ranking Form (Form 3). We can take some time to review 
how to go about selecting activities to add (as well as activities to remove or change) in 
Form 3. In general, if you believe that completing a particular activity would bring a 
sense of pleasure and/or accomplishment, then it probably would be good to include it. 
It is also important to decide which life are and value each activity is associated with. 
This is a good reminder to revisit the activities on your list and to think of the relevant 
life values. Also, when selecting activities it is important to remember that they must be 
observable by others, measurable, and broken into the smallest piece. For example, 
"being a better daughter" is not an activity that you could plan, but “offering to help 
mom make dinner twice a week” would be appropriate. If these conditions are met, you 
have identified an appropriate activity. Although it is sometimes tempting to select very 
difficult activities for which the benefits are very delayed or uncertain. For example, 
having your own home is a long-term goal. To address this potential problem without 
limiting your ambition, break activities into small steps and select activities across a 
range of difficulty, from easy activities you are currently doing to extremely difficult 
activities that will take some effort. 
Daily Monitoring with Activity Planning for the Upcoming Week (Form 1) 
Based on our discussion this session, you should now plan your activities for the next 
week. If you are able, try to plan for one or more new activities for the upcoming week 
in addition to the activities you accomplished the previous week.  
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Assignments: 
1. Daily Monitoring with Activity Planning for the Upcoming Week (Form 1)  
 
Evaluation and Beyond Key Elements: 
1. Daily Monitoring with Activity Planning: Review Assignment (Form 1) 
2. Daily Monitoring with Activity Planning for the Upcoming Week (Form 1) 
3. Preparing for the End of Treatment 
Daily Monitoring with Activity Planning: Review Assignment (Form 1) 
Let’s review your forms of Daily Monitoring with Activity Planning for the 
week. How many of the planned activities did you accomplish? For those that you 
accomplished, how easy or difficult were they? How did you feel about having 
accomplished those activities? Would you like to continue those activities or select 
different ones for next week? Are you finding that you feel better when you are more 
active? If so, this is good progress.  
Were there activities that you planned that you did not accomplish? If so, what 
happened? Was it because you really do not find the activity to be enjoyable and/or 
important? If this is true, then one option is to select a different activity instead. If it is 
an activity that you want to keep trying to do, then there are a few other issues to 
consider. Was the activity more difficult to accomplish than what you originally had 
expected? If so, we can discuss breaking it into smaller steps as we have discussed 
previously. Alternatively, you might have felt you just ran out of time and couldn’t 
complete this activity. We should revisit your monitoring forms and think about ways to 
fit new activities into your schedule. You might also have to seriously consider 
strategies for reducing your time spent in less valued current activities to make more 
time for these new more valued activities. This may include the difficult task of setting 
stricter boundaries around your time. In this case, we can discuss how to plan some 
activities to help set those boundaries and reclaim some time for yourself. Although 
these types of changes in your daily routine may be difficult, the planning and 
monitoring in this treatment can help reduce currently unfulfilling activities and to get 
you doing more enjoyable and important new activities. Finally, you might need help 
from others to complete scheduled activities.  
 
Daily Monitoring with Activity Planning for the Upcoming Week (Form 1) 
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 Once again, plan for 1-2 additional activities  
 
Preparing for the End of Treatment  
We have done a lot of great work together throughout treatment and you have 
accomplished so much. When we look back at your Daily Monitoring (Form 1) from 
the first week of treatment and compare them to your Daily Monitoring with Activity 
Planning (Form 1) from the last week of treatment, what do you see? It is important to 
identify your patterns of behavior now but also at the start of treatment which will help 
you know what patterns to look out for in the future.  
At this point, you have learned a number of skills that can help you feel better 
and live healthier when you begin to feel depressed again. You are strongly encouraged 
to consider continuing to use these forms to monitor and plan, especially in the next few 
weeks. Eventually you may find you are living consistent with your values on a daily 
basis without having to use the forms to monitor and plan, but you might find it helpful 
to review this manual and practice all of the skills again should depressed feelings 
return. 
 
Of course, it is possible that feelings of depression could return, but you should remain 
aware that depression is far less likely to persist when you live a healthy, meaningful, 
and fulfilling life. No matter what has happened in the past, it is possible to make 
changes to our lives, to make the best of circumstances, and spend time doing activities 
that fill your life with purpose and meaning.  
Assignments: 
1. Daily Monitoring with Activity Planning for the Upcoming Week (Form 1) 
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Appendix S 
Resource pack from the BATD-R 
 















    
 
6-7 am 
    
 
7-8 am 
    
 
8-9 am 
    
 
9-10 am 
    
 
10-11 am 
    
 
11-12 am 
    
 
12-1 pm 
    
 
1-2 pm 
    
 
2-3 pm 
    
 
3-4 pm 
    
 
4-5 pm 
    
 
5-6 pm 
    
 
6-7 pm 
    
 
7-8 pm 
    
 
8-9 pm 
    
 
9-10 pm 
    
 
10-11 pm 
    
 
11-12 pm 
    
 
12-1 am 
    
 
1-2 am 
    
 
2 à 5 am 
    
     Overall Mood for the day (0-10)  
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Life Areas, Values, and Activities Inventory   
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Form 2. Life Areas, Values, and Activities Inventory   
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Form 2. Life Areas, Values, and Activities Inventory   
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Form 2. Life Areas, Values, and Activities Inventory   
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Form 2. Life Areas, Values, and Activities Inventory   
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Activity Selection and Ranking  
 
Instructions: List your desired 15 activities and rate the difficulty of each from 1 = least 





















   




Session One (Home) 
Session One Key Elements: 
1. Confidentiality ___ 
2. Discussion of Depression   ____ 
3. Introduction to Treatment Rationale   ____ 
• What about stressful life events and loss in your life?   ____ 
4. Introduction to Daily Monitoring (Form 1)   ____ 
• Importance, Enjoyment and Achievement Ratings   ____ 
• When should you complete the Daily Monitoring Form?   ____ 
5. Important Points about the Structure of This Treatment   ____ 
Assignments: 
1. Complete Daily Monitoring Form   ____ 
 
Session Two (Values) 
Session Two Key Elements: 
1. Daily Monitoring: Review Assignment (Form 1)   ____ 
• Troubleshooting   ____ 
2. Treatment Rationale: Review   ____ 
3. Complete Life Areas, Values, Activities Inventory (Form 2)   ____ 
Assignments: 
1. Complete Daily Monitoring (Form 1)   ____ 
2. Review and Edit Life Areas, Values, and Activities Inventory (Form 2)   
____ 
3. Review Appendix 1: Moving from Life Areas and Values to Activities   
____ 
 
Session Three (Int 1) 
Session Three Key Elements: 
1. Daily Monitoring: Review Assignment (Form 1)   ____ 
2. Life Areas, Values, and Activities Inventory: Review Assignment (Form 2)   
____ 
3. Activity Selection and Ranking (Form 3)   ____ 
4. Daily Monitoring with Activity Planning (Form 1)   ____ 
Assignments: 
1. Daily Monitoring (Form 1)   ____ 
2. Continue to Review and Edit Life Areas, Values, and Activities Inventory 
(Form 2)   ____ 
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Session Four (Int 2) 
Session Four Key Elements: 
1. Daily Monitoring with Activity Planning: Review Assignment (Form 1)   
____ 
2. Daily Monitoring with Activity Planning for the Upcoming Week (Form 1)   
____ 
Assignments: 
1. Daily Monitoring with Activity Planning for the Upcoming Week (Form 1)   
____  
 
Session Five (Int 3) 
Session Five Key Elements: 
1. Daily Monitoring with Activity Planning: Review Assignment (Form 1)   
____ 
2. Life Areas, Values, and Activities Inventory: Concept Review and Edit 
(Form 2)   ____ 
3. Activity Selection and Ranking: Concept Review and Edit (Form 3)   ____ 
Assignments: 




Session Nine Key Elements: 
1. Daily Monitoring with Activity Planning: Review Assignment (Form 1)   
____ 
2. Preparing for the End of Treatment   ____ 
Assignments: 





   





Title of Study: Behavioural Activation for Low mood in Multiple Sclerosis (BALMS) 
IRAS Project ID: 254182 






Behavioural Activation for Low mood in Multiple Sclerosis (BALMS) 
 
Post intervention interviews will be structured and guided by Elliott 
and Timulak’s (2005) Change Interview Outline: 
 
1. What has therapy been like for you?  
2. What changes, if any, have you noticed in yourself since therapy 
started?  
3. What changes have you noticed in your levels of depression? 
4. In general, what do you attribute these various changes to?  
5. What personal strengths or aspects of your current life situation 
have helped you make use of therapy to deal with your problems?  
6. What things about you or your life situation have made it harder 
for you to use therapy to deal with your problems?  
7. What have been the most helpful things about your therapy so far?  
8. What kinds of things about the therapy have been hindering, 
unhelpful, negative or disappointing for you? Was there anything that 
was difficult or missing from your treatment?  
9. What has been like for you to be involved in this research?  
10. What changes have you noticed in your quality of life? 
11. What changes in fatigue levels have you noticed? 
12. What were the best parts of the intervention? 
13. What were the worse parts of the intervention? 
14. Do you feel there were any other possible explanations for the 
changes in your depression/anxiety/quality of life? If so, what?
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Poster
   
 
Design
Mixed method, single case experimental design. 
Participants
Individuals with secondary progressive MS and depression 




Activation: Behavioural Activation for Depression Scale –
Short Form (BADS-SF)
QoL: Short Form – 12 version 2 (SF-12v2)
Values: Engaged Living Scale (ELS)
Fatigue: Modified Fatigue Impact Scale – Short Form 
(MFIS-SF)
Procedure
Baseline phase 2-4 weeks, followed by 5 sessions of 
behavioural activation using the BATD-R manual via 
telephone or Skype,7 followed by change interviews.
Data Analysis
Visual analysis using conservative dual-criterion and 
percentage exceeding the median.8,9 Complemented with 
Reliable Change (RC) and Clinically Significant Change 
(CSC).10 Framework analysis was used on change 
interview data.11
Behavioural Activation for Low mood in Multiple Sclerosis: 
Single Case Experimental Design
Lloyd L Oates, Nima Moghaddam, Chris Meek, Nikos Evangelou & Roshan das Nair





• Examine preliminary evidence of efficacy of a 
behavioural activation intervention, for people 
with secondary progressive MS experiencing low 
mood
• Examine impact on mood, fatigue, and quality of 
life (QoL)
• Understand participants’ experience of the 
intervention 
Discussion
There was some evidence to suggest behavioural activation led to a reduction in depressive 
symptoms when engagement in positively reinforcing behaviour increased. Despite increasing 
activities to engage in positive reinforcement there were no adverse effects to individuals’ mental or 
physical health.
Our findings are comparable to behavioural activation approaches used with individuals with other 
neurological conditions to reduce depression.12 When considering that the treatment approach was 
predominantly self-directed and short-term in nature, the intervention is promising for those with 
secondary progressive MS.   
Based on the results using both conservative dual-criterion and reliable change indices, the criteria to 
satisfy replicability allows us to conclude that the processes are demonstratable across cases, but 
with caution.13
Based on beneficial findings for some participants, further investigation is warranted. There is 
evidence that – despite declining MS symptomology – individuals with secondary progressive MS 
can identify and engage in positively reinforcing activities, which may then reduce depressive 
symptomology. A feasibility randomised controlled-trial would help answer feasibility of a future large 
scale group comparison study.
References. ¹ Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. American Journal of Psychiatry. 2002;159(11):1862-8. 2 Wilkinson HR, das Nair R. The 
psychological impact of the unpredictability of multiple sclerosis: a qualitative literature meta-synthesis. British Journal of Neuroscience Nursing. 2013;9(4):172-8. 3 Hakim EA, Bakheit AMO, Bryant TN, Roberts MWH, McIntosh-Michaelis SA, Spackman AJ, et al. The social impact of multiple sclerosis - a study of 
305 patients and their relatives. Disability and Rehabilitation. 2000;22(6):288-93. 4 Motl RW, McAuley E, Snook EM, Gliottoni RC. Physical activity and quality of life in multiple sclerosis: Intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support. Psychology, Health & Medicine. 
2009;14(1):111-24. 5 Hind D, Cotter J, Thake A, Bradburn M, Cooper C, Isaac C, et al. Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis. BMC Psychiatry. 2014;14(1):5. 6 Jacobson NS, Dobson KS, Truax PA, Addis ME, 
Koerner K, Gollan JK, et al. A component analysis of cognitive-behavioral treatment for depression. Journal of Consulting and Clinical Psychology. 1996;64(2):295-304. 7 Lejuez CW, Hopko DR, Acierno R, Daughters SB, Pagoto SL. Ten year revision of the brief behavioral activation treatment for depression: 
revised treatment manual. Behavior modification. 2011;35(2):111-61. 8 Fisher WW, Kelley ME, Lomas JE. Visual aids and structured criteria for improving visual inspection and interpretation of single-case designs. Journal of Applied Behavior Analysis. 2003;36(3):387-406. 9 Ma HH. An alternative method for 
quantitative synthesis of single-subject researches: percentage of data points exceeding the median. Behavior Modification. 2006;30(5):598-617.10 Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59(1): 
12-9. 11 Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13:117. 12 Oates LL, Moghaddam N, Evangelou N, das Nair R. Behavioural activation treatment for depression in 
individuals with neurological conditions: a systematic review. Clin Rehabil. 2019;34(3):310-9. 13 Kratochwill T, Hitchcock J, Horner R, Levin JR, Odom S, Rindskopf D, et al. Single-case designs technical documentation2010. Available from: http://ies.ed.gov/ncee/wwc/pdf/wwc_scd.pdf.
People with secondary progressive multiple sclerosis 
(MS) experience high rates of depression.1
Depression may result from illness-related 
challenges, which reduce opportunities to engage in 
or find new enjoyable activities.2,3,4
Cognitive Behavioural Therapy (CBT) has 
demonstrated reduced rates of depression in people 
with MS, but cognitive difficulties in those with 
secondary progressive MS may be a barrier to 
engagement.5
Behavioural activation may represent an accessible 
therapeutic intervention for this group. Behavioural 





Eight people were recruited, of which six 
established a stable baseline and proceeded to 
intervention. Five participants completed 
intervention and change interviews. One participant 
withdrew.
Depression
Systematic reduction in depression was observed 
in two participants (PS03 & 06). 
Three participants (PS01, 03, & 06) demonstrated 
highly effective treatment (≥.9) and two participants 
(PS02 & 05) demonstrated moderately effective 
treatment (0.7-0.9). 
Reliable and clinically significant reduction in two 
participants (PS05 & 06).
Activation
Overall, activation scores appeared to covary with 
depression scores.
Systematic increase in activation was observed in 
two participants (PS03 & 05). 
Two participants (PS03 & 05) demonstrated highly 
effective treatment (≥.9), and two participants 
(PS01 & 06) demonstrated moderately effective 
treatment (0.7-0.9).
Reliable change in one participant (PS05).
QoL
Two participants reported reliable improvement for 
mental health related QoL.
Values
Reliable and clinically significant improvement in 
two participants (PS05 & 06). Reliable deterioration 
in one participant (PS03). 
Fatigue
No changes were reported in fatigue or physical 
health related QoL. 
Feedback
Some participants reported benefits from the 
intervention and that it was acceptable, even in the 
face of competing demands.
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Individuals living in areas of higher deprivation are more likely to 
have requested mental health treatment but are less likely to have 
received treatment or benefitted from it. Less is known about the 
extent of access equality and treatment outcomes for individuals 
with a long-term health condition who experience mental health 
difficulties. The study aimed to evaluate the extent to which the 
neighbourhood Index of Multiple Deprivation predicted access to 
treatment, appointment attendance, treatment completion, and 
clinical outcomes in a British health psychology clinic.  
 
Design 
Retrospective data were used from 479 individuals referred to a 
health psychology clinic over 12-months. Clinical outcomes were 
measured using the Clinical Outcomes in Routine Evaluation – 
Outcome Measure (CORE-OM). Patient data were linked with their 
neighbourhood Index of Multiple Deprivation decile. Data were 




There were no significant associations between deprivation and 
whether an individual attended assessment, attended treatment, or 
completed treatment, or between deprivation and patients’ clinical 
outcomes. Exploratory evidence indicated that individuals from 
higher deprivation neighbourhoods may be over-represented in 
clinic referrals, and individuals from lower deprivation 
neighbourhoods may be under-represented, compared with local 
population distribution estimates. 
 
Originality 
This evaluation provides insights into treatment outcomes and 
deprivation in those with physical health difficulties. Further 
evaluation using a larger sample and comparing referrals with local 
prevalence estimates of comorbid mental and physical health 
problems would enable greater confidence in the conclusion that no 
evidence of inequality on the basis of neighbourhood deprivation 
was found.  
Key Words: Deprivation, Psychological therapy, Access gap, 
Physical health conditions, Inequality 
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Background and context 
 
Mental health problems account for 13% of disease burden 
worldwide (Ritchie and Roser, 2018), with the reported experience 
of mental health difficulties expected to increase globally, and by 
2030 be the leading cause of mortality and morbidity (World Health 
Organization, 2011). A review showed that mental health problems 
account for 21% of years lived with disability (Global Burden of 
Disease Study 2013 Collaborators, 2015). The socioeconomic costs 
of mental ill-health through treatment, social support, and losses to 
the economy by individuals who cannot work total $1-trillion a year 
worldwide.  
 
Poor mental health is also associated with physical health 
difficulties. Worldwide, chronic diseases account for 46% of burden 
(World Health Organization, 2002). In the United Kingdom (UK), 
more than 30% of the population have one or more long-term 
health condition, of which, over 25% also have a mental health 
difficulty (Naylor et al., 2012). The relationship between physical 
and mental health is bidirectional, whereby individuals with a 
physical health problem are at increased risk of developing a mental 
health problem and vice-versa (van Manen et al., 2002). Physical 
health disability can prevent people from working, which lowers 
people’s quality of life and increases the impact on health clinics 
(Kings Fund, 2012). Individual socioeconomic indicators such as 
employment are associated with living in areas of deprivation 
(Massey et al., 1991), and it is argued that physical and social 
environments of neighbourhoods are key to understanding health 
outcomes (Macintyre et al., 1993). It is important to consider the 
interaction between deprivation, physical, and mental health as 
there is the potential for a ‘perfect storm’ of poor physical health, 
deprivation, and poor mental health (Diez Roux, 2001).  
 
Deprivation refers to an individual’s level of resource in relation to 
others and is a multifactorial construct that may include factors 
such as: income, housing, social, recreational, educational, and 
health-related factors (Adler and Snibbe, 2003, Townsend, 1979). 
Socioeconomically deprived areas and socioeconomic inequalities 
are associated with health and social problems such as an increased 
prevalence of common mental health disorders (Wilkinson and 
Pickett, 2007, Fryers et al., 2003), and greater demand (number of 
referrals) for psychological care (Delgadillo et al., 2018). Similar to 
the relationship between mental and physical health, the 
relationship between deprivation and mental illness may be bi-
directional, as in the social causation (Dohrenwend and 
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Dohrenwend, 1996) and social selection (Dohrenwend et al., 1992) 
hypotheses.  
 
Despite increasing need for and use of mental health treatments 
and treatment providers (McManus et al., 2016), there are 
inequalities in who receives treatment. In particular, individuals 
living in lower income households are more likely to have requested 
mental health treatment than those from higher income households, 
but were less likely to have accessed or attended treatment 
(McManus et al., 2016, Saxon et al., 2007). 
 
Socioeconomically deprived areas have lower treatment access 
rates irrespective of local variations in the availability of therapists 
(Delgadillo et al., 2018). When individuals of low socioeconomic 
status or from deprived neighbourhoods do access psychological 
therapy, evidence consistently suggests that they find therapy less 
effective (Berzins et al., 2018, Finegan et al., 2018, Delgadillo et 
al., 2016), with some exceptions, (Silva et al., 2016). These 
associations have been demonstrated using both individual level 
and area (or neighbourhood) level measures of deprivation (Finegan 
et al., 2018). Therefore, it is prudent to ensure that clinicians are 
supporting those with the most need. 
 
The overwhelming majority of evidence linking deprivation and 
mental health treatment access and outcomes comes specifically 
from mental health contexts, whilst less is known about this 
relationship in physical health contexts where physical and mental 
health difficulties and deprivation have high rates of co-occurrence. 
Furthermore, there is little evidence focused on individuals once 
they are referred to treatment providers (typically, the access gap 
focuses on the incidence – referral gap). For example, some clinics 
require people to actively ‘opt-in’ after referral, and most require 
them to attend a series of outpatient appointments. If there are 
inequalities within the care pathway, action may be required of 





The aim of this evaluation was to use referral and treatment data to 
investigate the potential effects of neighbourhood deprivation on 
access to treatment, treatment completion, and clinical outcomes. 
The evaluation aimed to answer two questions. Firstly, ‘are there 
utilisation inequalities within the health psychology care pathway for 
individuals living in areas of higher deprivation?’’. Secondly, ‘does 
deprivation have an impact on health psychology clinical outcomes?’ 
Objectives 
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• use descriptive data to compare the relative distribution of 
neighbourhood deprivation in the sample with that of 
estimates for the population served by the clinic. 
 
• test associations between patients' IMD decile and their 
progress through the care pathway at three points: 1) 
attendance of assessment appointment; 2) attendance of at 
least one treatment appointment; and 3) completion of 
treatment. 
 
• for patients who complete treatment, test the association 
between patient IMD decile and clinical outcome (measured 




The data were routinely collected by the clinic and anonymised by 
the routine care team before evaluation. The evaluation was not 
classified as research and as such, the Health Research Authority 
(HRA) do not require Research Ethics Committee approval or HRA 
research approval.  
 
Setting and participants 
 
The health psychology clinic provides psychological care for people 
with physical health problems across five catchment areas in 
Derbyshire, UK. Common conditions include chronic pain, chronic 
fatigue, cancer, coronary heart disease, diabetes, sexual health 
conditions, neurological conditions, and respiratory disorders. 
Individuals are referred to the clinic by their General Practitioner 
(GP) or a health professional involved in their care. A triage process 
determines the appropriateness of the referral. If the referral is 
considered appropriate, an opt-in letter is sent to the individual, 
inviting them to opt-in to the clinic. Following opt-in, they are 
offered an assessment appointment. Treatment decisions are made 
at the assessment appointment. Typically, this might involve being 
placed on a waiting list to receive a short series (typically 6-8) of 
one-to-one follow-up treatment appointments. A small percentage 
of individuals are expedited for immediate treatment. Interventions 
delivered via groups, electronically, or by assistant psychologists 
(e.g., relaxation skills) may also at times be offered in certain 
circumstances. Discharge is also an option, either with referral to 
other more suitable treatment providers, or following a decision that 




   




The Index of Multiple Deprivation (IMD) is the official UK 
Government measure of relative area-level (neighbourhood) 
deprivation in England. Here, a neighbourhood is defined as the 
Lower-Layer Super Output Area (LSOA). Each LSOA is designed to 
include approximately 1,500 people. The IMD is comprised of seven 
domains: (a) income, (b) employment, (c) education, skills, and 
training, (d) health and disability, (e) crime, (f) barriers to housing 
and services, and (g) living environment. These domains are 
combined and weighted to produce an overall relative measure of 
deprivation (IMD) (Department for Communities and Local 
Government, 2016). The IMD therefore reflects the multifaceted 
nature of deprivation. IMD scores are then ranked across every 
LSOA in England from 1 to 32,844 (most to least deprived area). 
Areas are often described by the percentile or decile of relative 
deprivation they fall into. Deciles are calculated by dividing the 
32,844 ranks into ten equal groups, ranging from most deprived to 
least deprived. For example, ‘the area falls within the most deprived 
20% nationally’. In this study, all analyses used IMD deciles. The 
IMD is often used locally in the development of strategies and to 
support funding bids (Department for Communities and Local 
Government, 2016). 
 
The IMD is a relative measure and is only able to tell us that one 
area is more deprived than another area, but it is unable to tell us 
by how much. For example, an area with a rank of 500 is not twice 
as deprived as an area with a rank of 1000. Further, the IMD 
provides an indication of relative deprivation in a small area, but 
each area will contain variability in individual deprivation. Finally, 
the IMD is a measure of aspects of deprivation and not affluence - 
the income measure of deprivation represents individuals on low 
incomes who receive benefits and tax credits (Department for 
Communities and Local Government, 2016).  
 
The Clinical Outcomes in Routine Evaluation – Outcome Measure 
(CORE-OM) (Evans et al., 2000), which is used as a routine 
outcome measure by the clinic, provides a global measure of 
distress. The CORE-OM is a generic self-report measure suitable for 
assessing response to psychological therapy. The CORE-OM is 
sensitive to change and has high internal and test-retest reliability 
(Evans et al., 2000). The outcome measure comprises 34-items 
separated into four subscales (wellbeing, problems, functioning, and 
risk) and provides an overall mean score. Data were assessed using 
reliable and clinically significant recovery as indicated by Jacobson 
et al. (1984).  
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Other variables included patients’ age, sex, ethnicity, referral 




The health psychology clinic routinely seeks to collect all data 
described in the measures section, except for IMD, which is public 
data and was linked with patient records. The analysed dataset was 
drawn from data from all individuals referred to the clinic from the 
13th December 2017 to 11th December 2018 (one year). Sample 
inclusion criteria required that individuals had valid postcode data 
(in order to match individuals to IMD) and were not still awaiting 
assessment (and therefore had care pathway data). Data were 
anonymised within the clinic. 
 
Statistical methods and analysis 
 
Data were quantitative and were collected at nominal, ordinal, and 
interval level. Data were analysed using IBM SPSS (version 25). 
Summary statistics were reported in the following areas: 
demographics of individuals, referral source, attendance, and levels 
of deprivation.  
 
Distributions were examined using the Kolmogorov-Smirnov and 
Shapiro-Wilk tests, and histogram examination. Age data were non-
normally distributed and were summarised in terms of median and 
inter-quartile range. IMD decile data were non-normally distributed 
and were analysed using non-parametric tests such as Spearman’s 
correlation. A linear regression was completed to investigate 
predictors for the outcome variable. There were no missing data for 
the regression. All other data were categorical and were 
summarised by frequency and tests for significance for categorical 
data. Where counts were less than expected Fisher’s Exact test was 
used. Two-tailed tests were used throughout and the threshold for 
statistical significance set at 5%. 
 
Clinical outcomes were defined as follows. The reliable change index 
was used to assess patient outcomes (Guhn et al., 2014). The 
reliable change index consists of reliable and/or clinically significant 
recovery. Reliable change is represented by a change of five or 
more in the clinical score. Clinically significant recovery is indicated 
when a patient’s score moves from the clinical to the non-clinical 
population. On the CORE-OM clinically significant scores were 
observed when individuals scored over ten pre-therapy and under 
ten post-therapy.  
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In order to provide additional context to the results, demographic 
and IMD data of those in the clinic were compared to local area 





A total of 491 referrals were received by the team between the 13th 
December 2017 and the 11th December 2018. Of those 491 
referrals, one individual was excluded due to missing postcode data. 
Eleven individuals were excluded as they were still awaiting an 
initial assessment and so had no clinical pathway data. After 
exclusions 479 individual data remained in the sample and were 
included in analysis. Summary sample statistics can be seen in 
Table 15.  
 
Table 15. Sample summary statistics 
Demographic N=479 
Median Age (IQR; Range) 52 (43-61; 17-93) 
Females 308 (64.3%) 
Ethnicity White British: 304 (63.5%) 
Other European (White, Mixed, Unspecified): 3 (0.6%) 
Other Mixed: 2 (0.4%) 
Other: 1 (0.2%) 
Not stated: 169 (35.3%) 
Referral source Acute Hospitals: 218 (45.5%) 
Community Teams: 35 (7.4%) 
General/Family Practitioner: 167 (35.0%) 
Frontline Mental Health Team (“IAPT”): 4 (0.8%) 
Specialist Mental Health Team: 11 (2.3%) 
Mental Health Liaison: 40 (8.4%) 
Older Adult Psychology: 1 (0.2%) 
Missing: 3 (0.6%) 
Status on the 11th 
December 2018 
Not suitable: 4 (0.8%) 
Did not opt in: 10 (2.1%) 
Did not attend assessment: 19 (4.0%) 
Discharged after assessment: 83 (17.3%) 
Attended assessment awaiting treatment: 100 (20.9%) 
Treatment in progress: 134 (28.0%) 
Dropped out of treatment: 46 (9.6%) 
Completed treatment: 83 (17.3%) 
Reason for discharge 
following assessment 
(n=83) 
Not suitable: 12 (14.5%) 
Referred to other services: 15 (18.1%) 
Declined treatment: 14 (16.9%) 
Assessment only required: 42 (50.6%) 
Dropped out of treatment 
reason (n=46) 
Mental health factors: 7 (15.2%) 
Physical health factors: 3 (6.5%) 
Social factors: 5 (10.9%) 
No known reason: 31 (67.4%) 
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CORE-OM reliable change 
- completers only (n=83) 
Reliable deterioration: 2 (2.4%) 
Unchanged: 49 (59.0%) 
Reliable improvement: 32 (38.6%) 
CORE-OM recovery - 
completers only (n=83) 
No clinically significant recovery: 62 (74.7%) 
Clinically significant recovery: 21 (25.3%) 
CORE-OM = Clinical Outcomes in Routine Evaluation – Outcome 
Measure; IQR = Inter quartile range; IAPT = Increasing Access to 
Psychological Therapies; IMD = Index of Multiple Deprivation. 
 
Comparison of sample with local population 
 
There are 32,844 small areas across England including 491 in 
Derbyshire. Each small area contains on average 1,500 people. The 
clinic covers 282 of these small areas. As can be seen in Table 16, 
the area of Derbyshire covered by the clinic includes 12 small areas 
in the first decile (representing the top 10% of deprivation 
nationally). The majority of the small areas fall into the ninth decile. 
According to regional data taken from the mid-2015 Office of 
National Statistics population estimates, there were 444,467 
individuals living in the areas covered by the clinic (Office of 
National Statistics, 2015). Of which there were an estimated 
218,343 males and 226,124 females of all ages.  
 
The sample comprised 479 people across all deciles, and all deciles 
were represented. As seen in Table 16 if each ward were to contain 
1500 people, the estimated total representation for Derbyshire is 
shown and the percentage of representation of the sample is 
highlighted.  
 
When the number of referrals in the sample was compared to the 
regional population estimates, there was no evidence of significant 
under-representation from the most deprived deciles (Table 16). In 
contrast, the percentage of individuals referred to the clinic who 
lived in deciles 2 and 3 (more highly deprived) was significantly 
higher than the estimated percentage of individuals overall living in 
those highly deprived areas. Similarly, the percentage of referrals 
from deciles 7 and 9 (less deprived) were significantly under-
represented compared with population estimates. There was no 
significant difference between referrals and population estimates in 
the remaining 6 deciles.  
 
The average population age of Derbyshire is 42 years. The median 
age of individuals in the sample was 52 years (IQR 43-61, range 
17-93). It should be noted that the clinic only accepts individuals 
aged over 16 years. The gender split in the Derbyshire area is 
reported to be 50.9% female. In the sample there were 308 
(64.3%) females. 
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Table 16. A comparison of service referrals versus population estimates in the service catchment area across levels 
of deprivation 

















the service  
Percentage of evaluation 
sample representing 
decile (%) (95% CI) 
(n=479) 
1 10% most deprived 12 18,000 4.3 30 6.3  (4.0-8.5) 
2 10% to 20% 26 39,000 9.2 62 12.9  (9.8-16.1)* 
3 20% to 30% 31 46,500 11.0 83 17.3 (13.8-20.8)* 
4 30% to 40% 34 51,000 12.1 68 14.2 (11.0-17.4) 
5 40% to 50% 30 45,000 10.6 46 9.6 (6.9-12.3) 
6 50% to 60% 27 40,500 9.6 41 8.6 (5.9-11.2) 
7 60% to 70% 36 54,000 12.8 47 9.8 (7.0-12.6)* 
8 70% to 80% 30 45,000 10.6 41 8.6 (5.9-11.2) 
9 80% to 90% 38 57,000 13.5 38 7.9 (5.4-10.5)* 
10 10% least deprived 18 27,000 6.4 23 4.8 (2.8-6.8) 
* = significant difference from population estimate. LSOA = Lower-Layer Super Output Areas. LSOAs are designed 
so that approximately 1500 individuals live in each LSOA. 
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Attending assessment, attending treatment, and completing 
treatment 
 
As seen in Table 17, 33 individuals did not attend assessment; 
either they did not opt-in, did not attend the initial assessment, or 
they were not suitable for the clinic. There was no significant 
association between IMD decile and whether an individual attended 
assessment or not (Fisher’s p= .792). When considering the order 
of ranks the linear-by-linear association was statistically non-
significant (0.480, p= .511). Illustratively, when considering the 
ranked order of deciles, the logistic regression was statistically non-
significant χ2(1)= 0.481, p= .488. The model explained 0.03% 
(Nagelkerke R2) of the variance in attending assessment and 
correctly classified 93.1% of cases. IMD was not significantly 
associated with attending assessment β= 0.049, OR= 1.051 (CI 
95%= 0.914–1.208), p= .489. As the cell counts were less than 5 
in more than 20% of IMD deciles, these results are provided only to 
support the Fisher’s exact test. 
 
There was no significant association between IMD decile and 
whether or not an individual attended at least one treatment 
appointment, X2= (18, n= 479) 22.632, p= .205. When considering 
the order of ranks the linear-by-linear association was statistically 
non-significant (0.719, p= .403). The logistic regression was 
statistically non-significant χ2(1)= 0.724, p= .395. The model 
explained 0.03% (Nagelkerke R2) of the variance in attending 
treatment and correctly classified 69.4% of cases. IMD was not 
significantly associated with attending treatment β= 0.037, OR= 
1.037 (CI 95%= 0.953–1.129), p= .396, suggesting no association 
between increasing deprivation and non-attendance. 
 
Finally, there was no statistically significant difference between IMD 
decile and those that completed versus dropped out of treatment 
(Fisher's p= .349), or those that completed treatment versus those 
that did not (including those discharged after assessment and 
therefore did not start treatment). The model explained <0.001% 
(Nagelkerke R2) of the variance in completing treatment and 
correctly classified 66.1% of cases. IMD was not significantly 
associated with completing treatment β= 0.009, OR= 1.009 (CI 
95%= 0.912–1.116), p= .866, suggesting no association between 




Of those who completed treatment (n= 83), reliable improvement 
was seen in 32 (38.6%) and clinically significant recovery in 21 
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(25.3%) individuals. Two (2.4%) individuals experienced reliable 
deterioration. There was no significant association (rs= -.148, p= 
.182) between IMD and reliable change on the CORE-OM for 
individuals who completed treatment. There was no significant 
association between IMD and post-treatment CORE-OM scores (rs= 
.149, p= .200). An intention to treat sensitivity analysis (n= 479) 
also showed no significant association between IMD and reliable 
change on the CORE-OM (rs= -.026, p= .574).  
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Table 17. Deprivation by decile and care pathway outcome 
 Decile 




          Fisher's 
Exact  
p= 
0.792 Yes:446 28 (6.3%) 56 (12.6%) 76 (17.0%) 64 14.4%) 45 (10.1%) 36 (8.1%) 45 (10.1%) 39 (8.7%) 36 (8.1%) 21 
(4.7%) 




































Yes:263 12 (5.1%) 32 (13.6%) 39 (16.5%) 45 (19.1%) 27 (11.4%) 23 (9.8%) 26 (11.0%) 21 (8.9%) 26 (11.0%) 12 
(5.1%) 
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No:116 11 (9.5%) 15 (12.9%) 19 (16.4%) 14 (12.1%) 9 (7.6%) 14 (12.1%) 8 (6.9%) 12 (10.3%) 8 (6.9%) 6 
(5.2%) 
Completed or 
dropped out of 
treatment 
(n=129) 




Completed:83 5 (6.0%) 8 (9.6%) 14 (16.9%) 13 (15.7%) 9 (10.8%) 8 (9.6%) 7 (8.4%) 8 (9.6%) 9 (10.8%) 2 
(2.4%) 












0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (50.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 
(50.0%
) 
























1 (4.8%) 3 (14.3%) 1 (4.8%) 4 (19.1%) 2 (9.5%) 2 (9.5%) 1 (4.8%) 4 (19.0%) 2 (9.5%) 1 
(4.8%) 
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† percentage of participants by decile 
   




This evaluation explored the issue of deprivation and attending 
psychological therapy and patient outcomes in a clinic for people with 
physical health problems. The evaluation arose as a result of growing 
evidence that increased deprivation negatively impacts attendance at 
psychological therapy and treatment outcomes. The evaluation was 
designed to identify the extent of this potential problem in the specific 
clinic, as well as understand if and where resources and initiatives were 
required to reduce any gaps or inequalities. 
 
The results of this evaluation showed no significant association between 
deprivation and psychological therapy access, treatment completion, or 
clinical outcomes. This is contrary to the majority of evidence (McManus 
et al., 2016, Finegan et al., 2018), although other studies using IMD have 
also found no significant association (Firth et al., 2015, Poots et al., 
2014). 
 
Saxon et al. (2007) note that although those from areas of higher 
deprivation are often less represented in psychotherapy samples than 
those from areas of lower deprivation, some studies have detected no 
association. They hypothesise that conflicting findings may relate to 
differences in health systems, or by improvements in accessibility over 
time (Saxon et al., 2007). The current evaluation found no statistical 
evidence of under-representation for those from deprived areas. If 
anything, people from areas of higher deprivation were over-represented 
compared to locality population estimates, whilst people from areas of 
lower deprivation were under-represented. There is robust evidence 
linking deprivation with incidence of mental and physical health conditions 
(Naylor et al., 2012). As such, if clinics are equitable and accessible to all 
who need them, we would expect that the patient distribution would be 
skewed in the direction observed.  
 
These findings are encouraging, in that there was no explicit evidence 
found in this evaluation to suggest an access gap/inverse care law effect 
in the clinic’s current provision (either by way of a sample skewed 
towards less deprived areas, or in comparison with locality population 
estimates of deprivation). However, the current study was not able to rule 
out a relative access gap by comparing directly with estimates of the 
prevalence of need across levels of deprivation (in other words, the skew 
towards deprived areas may be even greater in estimates of need, 
compared with the current clinic sample). In addition, the current 
evaluation could only assess equality of access within the specific clinic 
(rather than the care system as a whole, or other sectors of care such as 
private clinics). This is important as, for example, variations in access to 
other sources of care can affect the flow of referrals (and therefore the 
distribution of deprivation) to the clinic under consideration. This is a 
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limitation of the current evaluation, and further evaluations should seek 
to compare more nuanced data regarding mental and physical ill-health 
comorbidity prevalence rates across deprivation deciles. 
 
Previous research has found that incidence and severity of psychological 
distress are associated with social and economic inequalities (Bruce et al., 
1992, Mirowsky and Ross, 1989, Prilleltensky, 2008). Social processes 
such as these have been hypothesised to shape identity and reduce self-
efficacy in the least privileged individuals (Bourdieu, 1984, Stoppard, 
2014, Wilkinson, 1998). We might therefore expect that the clinic would 
see inequalities across deprivation deciles in referrals and treatment 
utilisation, which were not identified in the evaluation.  
 
Help-seeking behaviour may help to understand these results. Three 
factors are critical in help-seeking behaviour - attitudes towards help-
seeking, intention to seek help, and actual help-seeking behaviour 
(Gulliver et al., 2012). Awareness of one’s subjective needs also 
influences the decision of whether or not to seek help (Gross and 
McMullen, 1983). The theory of planned behaviour (an extension of 
theory of reasoned action)(Ajzen, 1991) states that an individual’s 
attitude toward behaviour, subjective norms, and perceived behavioural 
control influence an individual’s behaviours. If an individual evaluates a 
behaviour as positive (attitude), and they believe that other individuals, 
such as a care team, want them to engage in the behaviour (subjective 
norm) then the individual’s motivation is higher, and they are more likely 
to engage in the behaviour.  
 
One hypothesis is that these factors differ in physical health focused 
contexts, compared with mental health contexts. There may be greater 
validation of help-seeking attitudes, and clearer understanding of 
subjective needs around physical versus mental ill-health. If individuals 
are already engaged within a health care system in relation to their 
physical health, this may impact on their subjective norms, compared 
with individuals suffering from mental ill-health where a) they are not 
already engaged with health professionals, b) there might be increased 
stigma and less understanding of difficulties, and c) where symptoms and 
consequences of difficulties may be less visible or more nebulous. These 
motivators may be counteracting the negative impact of deprivation in 
this evaluation.   
 
This explanation is consistent with the construct of candidacy regarding 
access to clinics (Dixon-Woods et al., 2006). Candidacy explains how an 
individual’s eligibility for healthcare is determined by healthcare providers 
and the individual. Candidacy is a continuous process that is defined and 
redefined by professionals and individuals in how cases are constructed. 
In deprived groups, early indicators or symptoms may be considered less 
important by socioeconomically deprived populations due to a lack of 
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positive conceptualisation of health (Dixon-Woods et al., 2006), 
consistent with the theory of planned behaviour. However, validation 
regarding physical ill-health may increase candidacy and protect against 
non-engagement or loss of agency. 
 
Strengths and Limitations 
 
This evaluation included over 97% of patients referred to the clinic during 
the evaluation period. Only one patient was unable to be linked with IMD, 
which allowed for a comprehensive review of the deprivation data for 
those accessing the clinic. The evaluation took a pragmatic practice-based 
approach to analysis, yet employed multiple methods of analysis, 
increasing the robustness of results.  
 
IMD (2015) scores were mostly calculated based on 2012/13 tax year 
data. Although consistency over time may be expected in most cases, 
differences in deprivation of certain small areas may have affected the 
results to some extent. This report does not explore potential associations 
between the seven specific domains of deprivation and attendance and 
outcomes, although the overall IMD uses a weighted combination of all 
seven domains.  
 
IMD provides a deprivation score for small areas throughout the UK. IMD 
does not provide information about deprivation to specific individuals. It is 
therefore possible that an individual referred to the clinic may live in an 
area rated high in deprivation but be a high earner or highly educated 
etc., or vice versa. This evaluation therefore considers the contextual 
effect of neighbourhood, not necessarily the direct deprivation of the 
individual. 
 
Some deciles are poorly represented, which may result in a masking of 
interaction in some cases. The small number of individuals from the least 
10% deprived areas means the non-significant association in worsening 
scores should be considered with caution, as low numbers of individuals 
within deciles reduces power. Deciles were used over quintiles as they are 
more frequently reported. Correlation analysis was conducted and used 
the whole data set to consider any relationship which may have been 
masked by reduced power in the Fishers exact test. Future analyses may 
benefit from using quintiles. 
 
Implications for practice 
 
Findings from this evaluation do not raise immediate concerns regarding 
inequality for this clinic. Instead, this clinic appears to be statistically 
equitable across the care pathway with respect to neighbourhood 
deprivation (with caveats as discussed).  
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It would be helpful to understand whether these findings reflect 
differences between mental health and physical health focused care 
contexts - for example, understanding which factors precipitate patient 
referrals, and whether physical health psychology patients differ from 
patients accessing mental health clinics, with regards to health seeking 
behaviours, subjective norms, or conceptualisations of health. These may 
potentially inoculate against or counteract negative effects of deprivation. 
Differences in practice may also be identifiable between these contexts. 
For example, whether practitioners or patients initiate conversations 
regarding referral, whether the conversation is focused initially on mental 
or physical health, etc. Understanding the process of what leads to a 
referral may allow the clinic to understand if there is still a gap in 
accessing treatment, or, it may indicate differences of working between 
referrers. It would also be helpful to explore other factors contributing to 
observed variability in patient access, completion and clinical outcomes.  
 
Repeating the analysis with an increased sample size, and comparison 
with more accurate estimates of comorbid physical and mental ill-health 
may provide stronger evidence of equality or inequality, respectively.    
 
Finally, this evaluation does not suggest that therapists ignore deprivation 
or social-class disparity when working with individuals (Delgadillo, 2018). 
The relative equality indicated in this evaluation may only be maintained 
by conscious efforts to address it, that may be undone if therapists 
become complacent about the impact of deprivation. Ignoring deprivation 
in this way may be harmful to therapeutic rapport (Trott and Reeves, 
2018). As therapeutic rapport has been shown to improve treatment 
engagement and outcomes (Karver et al., 2006), it would be interesting 
to see if acknowledgement of differences in sessions improved treatment 
utilisation and clinical outcomes. 
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